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 Perfusion-sensitive MR methods are increasingly utilized in preclinical and clinical MR 
research studies with the promise of providing quantitative estimates of parameters that describe 
in vivo microvasculature. One of these techniques, dynamic contrast enhanced (DCE) MRI, has 
found particularly common use in oncology for the detection, staging, and monitoring of highly 
vascularized tumors. DCE-MRI has been qualitatively validated by various studies that show a 
high correlation between modeled parameters from DCE and histologically measured 
microvascular density (MVD). However, in the absence of a matching “gold-standard” technique, 
DCE-MRI has not yet been quantitatively validated (i.e., the accuracy of the estimated 
parameters is unknown). Partly because of this inability to determine the accuracy of the 
measured parameters, there remains debate in the literature about which DCE signal model(s) 
best reflect(s) experimental data. 
 In order to address these scientific challenges, realistic DCE tissue phantoms have been 
constructed. These phantoms implement semi-permeable hollow fibers, found commonly in 
commercial hemodialysis cartridges, to simulate “leaky” vasculature. Their design and 
construction are cataloged in this thesis. In addition, the phantoms have been experimentally 
characterized. In conjunction with these experiments, an interesting example of diffusion driven 
longitudinal relaxation was observed and is described herein. Lastly, the permeability of the fiber 
wall with respect to Gd-based contrast agents has been measured independently and compared 
with values derived from a mock-DCE experiment performed on the phantoms. In general, the 
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CHAPTER 1. INTRODUCTION 
 
1.1. Abstract 
 Perfusion-sensitive imaging techniques attempt to probe the integrity of semi-permeable 
membranes via monitoring of endogenous or exogenous contrast agent perfusion. Dynamic 
contrast enhanced (DCE) MRI is one example. In DCE experiments, MRI is used to follow the 
perfusion of Gd-based contrast agents into tissue. The ultimate goal of DCE, and perfusion-
sensitive imaging in general, is to quantitatively estimate parameters that 1) accurately describe 
tracer perfusion and 2) are meaningful biomarkers of insult, injury, or disease. Herein, DCE-MRI 
is described and examples of its application are given. In addition, attempts to validate the 
technique are briefly reviewed. Lastly, additional validation studies using realistic tissue 
phantoms, the main focus of this dissertation, are justified, and the contents of all subsequent 
chapters and appendices are outlined. 
 
1.2. Motivation for monitoring, via imaging, semi-permeable membranes in biological systems 
Semi-permeable membranes, barriers that allow passage of only certain molecules, are 
found extensively in biological systems. They, in concert with more complex active transport 
mechanisms, regulate chemical concentrations throughout the body. Examples of semi-
permeable membranes include those found in the kidney that control the concentrations of 
different analytes in the blood, the blood brain barrier that prevents all but the most essential 
chemicals from passing from the blood to the cerebrospinal fluid, and, indeed, the entire capillary 
network where the exchange of analytes constantly occurs between blood and tissue. As semi-
permeable membranes are thus found throughout the entire body, they provide an appealing 
target for the various imaging modalities. 
 In addition to being ubiquitous throughout biological systems, semi-permeable 
membranes provide further motivation for targeted examination via imaging as the integrity of 
semi-permeable membranes can be altered in response to stress and insult resulting from 
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disease, injury, or illness. Thus, semi-permeable membranes can potentially be used as a handle 
for indirectly monitoring these internal and external stressors. 
Molecules preferentially cross a semi-permeable membrane in one direction in response 
to gradients; i.e., movement of molecules in both directions across the membrane, but a net 
movement of molecules in one direction. This transfer is defined as passive transport. The most 
common gradients that exist across semi-permeable membranes found in biological systems are 
gradients of potential, pressure, and concentration. In this dissertation, only concentration 
gradients are considered. 
The general approach employed in the imaging sciences to probe semi-permeable 
membranes is to create a concentration gradient across a membrane of interest with a molecule 
that can be observed with the imaging modality of choice. These molecules are called contrast 
agents (CA) or tracers*. Magnetic resonance imaging (MRI) is one such imaging modality. It is 
based upon the well-known phenomenon of nuclear magnetic resonance (NMR). The interested 
reader is referred to one of many texts for an in-depth review of general NMR and MRI theory and 
procedures [1, 2, 3]. 
MR techniques that monitor the integrity of semi-permeable membranes (perfusion-
sensitive MR) utilize endogenous or exogenous blood-born MR tracers to sensitize an image or 
group of images to perfusion (i.e., the perfusion of the tracer). This dissertation is concerned 
primarily with exogenous, Gd-based MR contrast agents and their use in a technique called 
dynamic contrast enhanced (DCE) MRI. Section 1.3 introduces these contrast agents and the 
basic theory surrounding their effects on MR. The implementation and potential impact of 
perfusion-sensitive MR methods are best demonstrated via examples. These examples also 
provide an effective venue for conceptually introducing DCE-MRI. Section 1.4 serves this dual 
purpose. Section 1.5 then discusses various approaches available to validate DCE-MRI and 
                                                 
* The terms contrast agent and tracer do not denote perfusion-sensitive methods, per se, but are 
more general. A more complete definition of a contrast agent/tracer is a molecule that increases 
the contrast in an image. An example of a contrast agent insensitive to semi-permeable 
membranes is barium, which is ingested in order to increase the contrast of the gastro-intestinal 
system to the rest of the internal organs (routinely used in conjunction with X-rays and computed 
tomography (CT) scans) [60]. 
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justifies the necessity of further validation with MR phantoms, the focus of this dissertation. As a 
conclusion to chapter 1, section 1.6 further defines the scope of the dissertation and summarizes 
its contents. 
 
1.3. MR contrast agents/tracers: theory 
A spinning top has angular (rotational) momentum. Thus, when the axis of the top is tilted 
(not parallel with the force of gravity), the top precesses. This is in response to the torque applied 
by the constant force of gravity. In the absence of friction, this precession would be continuous 
resulting in a fixed rate of precession, i.e., frequency. Protons and neutrons within a nucleus also 
have angular momentum. However, this angular momentum does not result from the particles 
physically spinning, but is intrinsic. Despite this fact, the total angular momentum of a nucleus 
(resulting from the angular momenta of its protons and neutrons) is referred to as the nuclear 
spin. 
Another distinction between the angular momentum of a spinning top and elementary 
particles is that the angular momenta of these particles are quantized. In other words, the angular 
momentum of the spinning top can be any value as dictated by the composition and shape of the 
top and how fast it is spinning, but the angular momentum of a proton can only be certain values 
as described by quantum mechanics. Subsequently, the nuclear spin can only be zero, half-
integer, or integer. For those nuclei where the nuclear spin is non-zero, such as that of hydrogen, 
multiple values are possible for the z-component of the nuclear spin (e.g., +1/2 and -1/2 for 1H). 
A nuclear magnetic moment is associated with each individual nuclear spin. Thus, in a 
magnetic field, nuclear spins with different spin numbers correspond to different energy levels. 
The difference between these energy levels is proportional to the applied magnetic field. NMR 
and MRI probe these quantized energy levels. Relating this back to the example of the spinning 
top, within a magnetic field, nuclear spins precess at a frequency proportional to the applied 
magnetic field known as the Larmor frequency (the applied magnetic field exerting a torque on 
the nuclear spins). The classical representation of the entire system is a vector sum of the many 
nuclear spins within a sample. This vector, termed the magnetization, suffices to conceptually 
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understand the two relaxation processes associated with the return of the magnetization to 
equilibrium after perturbation. 
At equilibrium, the magnetization lies coincident with the main magnetic field of the 
spectrometer/scanner. This axis, by convention, is labeled z. All MR experiments nutate or “tip” 
the magnetization away from the z-axis and into the xy-plane by applying electromagnetic 
radiation at an appropriate frequency (i.e., corresponding to the energy gap of the spin system) 
perpendicular to the z-axis. For MR, this electromagnetic radiation corresponds to radio 
frequencies (RF). In practice, these radiowaves are introduced into the sample by activating an 
RF transmitter for a short time (i.e., via an RF pulse). 
After tipping the magnetization, one can consider the z-component and xy-component of 
the magnetization separately. The return to equilibrium of the z-component of the magnetization 
is called longitudinal relaxation and is described by the rate constant R1 (the inverse of R1 is the 
time constant T1). The return to equilibrium of the xy-component of the magnetization is called 
transverse relaxation and is described by the rate constant R2 (the inverse of R2 is the time 
constant T2). For a detailed analysis of the mechanisms by which these processes occur one is 
referred to the following reference [4]. A simplistic explanation is that energy is transferred from 
the nuclear spins to the system (the energy systems of multitude of the molecules within the 
sample) resulting in equilibration. 
As mentioned, MRI techniques exist that utilize both exogenous and endogenous tracers 
(e.g., magnetically prepared areterial blood). Though the validation approach discussed in this 
dissertation (via MR perfusion phantoms, vide infra) can be of use to techniques that use either of 
these types of tracers, the focus is on exogenous MR contrast agents. Therefore, exogenous 
tracers are the sole focus of this conceptual introduction to contrast agents. The vast majority of 
all exogenous MR contrast agents, used both clinically and preclinically, utilize the gadolinium ion 
Gd3+. These chelated gadolinium compounds alter the observed relaxation rate constants in 
homogeneous solutions and in vivo. In well mixed solutions the relationship is linear over a large 
range, i.e., R1 and R2 are linearly proportional to contrast agent concentration (see chapter 2). 
Examples of currently used chelates are shown in Figure 1-1. The mechanisms by which these 
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relaxation processes are altered hinge upon the quantum-mechanical coupling of the unpaired 
electrons of the gadolinium ion with the nuclear spins of the water protons. This coupling provides 
a more efficient mechanism of longitudinal and transverse relaxation for populations of spins 
associated with water than that found in their absence both in homogeneous solution and in vivo 
[5]. 
Interestingly, these types of MR contrast agents are not directly detected (MR-active), but 
rather their effects are indirectly observed. For example, a “contrast-enhanced” image sensitized 
to longitudinal relaxation (a contrast-enhanced “T1-weighted” image) is an image of the bulk water 
where relatively high image intensity due to short water T1 is potentially caused by high contrast 
agent concentration at that location (high image intensity could also be due to a short native T1). 
Importantly, therefore, 1) signal will exist in regions void of CA, but filled with water, 2) the signal 
intensity observed in regions where CA is present will correspond to some combination of the 
native rate constant and that induced by the CA, and 3) both the exchange rates of water 
molecules and the CA may need to be considered (see chapter 2). All of these observations 
constitute both the benefits and challenges of exogenous MR contrast agents. For example, 
contrast-enhanced MR images of this type automatically include anatomical information, but 
signal intensity is not directly proportional to contrast agent concentration (points 1 and 2). 
Furthermore, dynamic data may include more information, but may be more difficult to 
interpret/resolve (point 3). 
 
1.4. Examples of perfusion-sensitive imaging techniques and applications 
 As mentioned in the introduction to this chapter, the technique most discussed in this 
dissertation is dynamic contrast enhanced MRI. To understand DCE, however, it is best to first 
understand the utility of contrast enhancement in general. This utility is illustrated in the following 
example in which contrast agents are used to probe the semi-permeable barriers in the brain. 
A well-known example of semi-permeable barrier breakdown is found in the response of 
the blood-brain barrier (BBB) to injury and disease. The blood-brain barrier is one of the most 
restrictive membranes in the body. In the brain, the endothelial cells lining the capillary network 
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are packed tightly together with only small passages remaining between the cells. These are 
known as tight junctions, and as their name implies, allow only the smallest of molecules; such as 
oxygen, carbon dioxide, and simple ions; to pass. This unique design protects the brain from 
most bacteria and foreign molecules. Case in point, when intact, the BBB will not allow Gd-based 
MR contrast agents to leave the blood. 
 Due to this complete impermeability of the healthy BBB to Gd-based CA, contrast 
enhancement in the brain is sometimes considered a binary function, i.e., either the BBB is intact 
or compromised. This information can be encoded into a single high-resolution, contrast-
enhanced T1-weighted image collected after (~30 min) a Gd-based contrast agent is injected 
intravenously. An example of this can be seen in Figure 1-2 where the insult to the BBB occurred 
due to tumorigenesis (panel D) [6]. The image is compared with an image collected with the same 
parameters in the absence of contrast agent (panel C). It is clear from this example that additional 
qualitative information can be obtained from contrast-enhanced images with exogenous Gd-
based tracers. For instance, the tumor volume can be more clearly delineated, and heterogeneity 
within the tumor is evident with CA enhancement. 
 As useful as a single contrast-enhanced image is, more information can be gleaned by 
considering multiple images and, further, applying mathematical modeling to more fully capture or 
describe the perfusion of the tracer. In particular, two widely used techniques exist that extend the 
reach of contrast-enhanced MR. These are DCE-MRI and dynamic susceptibility contrast (DSC) 
MRI. As previously mentioned, the thesis research presented in this dissertation focuses primarily 
on DCE. Briefly, however, DSC consists of tracking the first passage of a bolus of intravenously 
injected Gd-based constast agent with time-resolved, T2*-weighted MRI [7]. The utility of DCE 
compared with a simple contrast-enhanced T1-weighted image is presented in the following 
examples (see appendices B and D). 
Consider first, in contrast to the previous brain example, the semi-permeable membranes 
found in the kidney and their function. Though there are many different pathways, amino acids 
taken into the body, primarily from protein, are eventually converted to aspartate and glutamate 
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[8]. The nitrogen from the great majority of these two amino acids is then converted into urea by 
means of the urea cycle.  The overall reaction can be written as: 
 
NH3 + HCO3 + aspartate + 3 ATP  urea + fumarate + 2 ADP + 2 Pi + AMP + PPi 
 
One of the nitrogens in urea comes from glutamate (by means of glutamate dehydrogenase; 
shown as ammonia above) and the other from aspartate [9]. This process occurs in the liver and 
the resulting urea travels in the bloodstream to the kidneys for removal from the body. 
 Blood is introduced into the kidneys via the renal artery and then proceeds to the 
glomerulus. The double cell layer surrounding the vasculature in each glomerulus consists of a 
fenestrated endothiluim on the interior of the vessels (pores of dia = 70 – 90 nm) and an 
epithelium striated with podocites on the exterior of the vessels, effectively forming filtration slits 
approximately 25 nm wide (Figure 1-3). These two cell layers form a semipermeable membrane 
allowing the passage of uncharged molecules below 8 nm in diameter in response to 
concentration gradients across the membrane. Thus, clearance of urea from the vasculature is 
realized as well as low molecular weight Gd-based contrast agents [10]. 
In the kidney, effective transfer, of urea and other molecules considered biological waste, 
across the semi-permeable membrane is the desired mode d’emploi. Therefore, unlike the brain, 
a healthy kidney will appear hyperintense in a contrast-enhanced image. In addition, although it is 
possible for a kidney to completely cease function, many maladies result in a gradual decrease in 
functionality of the kidney. In these cases, both the healthy and diseased kidney may show 
contrast enhancement. Furthermore, when kidney function has been compromised, it is of clinical 
importance to measure the extent to which functionality has been limited. 
A common example of this type of gradual kidney deterioration is found in patients who 
have received a kidney transplant. In order to inhibit rejection of the kidney, an 
immunosuppresent, cyclosporin, is routinely administered at the time of transplantation and 
throughout the lifetime of the kidney. An ironic effect of this drug is eventual kidney failure. This 
pathway to kidney failure, which typically occurs ~3-5 years after transplantation, can be 
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reproduced over a period of several weeks in a mouse model [11]. In order to characterize 1) 
healthy kidney function, 2) the degree of functional loss in cyclosporine-damaged kidney, and 3) 
the degree of retention of function in unhealthy kidney protected by administration of a second 
drug, bosentin, Siedlecki et al., used DCE-MRI. In DCE-MRI, an exogenous tracer (most often 
Gd-based) is injected intravenously just as for a contrast-enhanced image. However, instead of 
just collecting a single image after the contrast agent has perfused into the system of interest, 
multiple T1-weighted images are collected before, during, and after injection of contrast agent. 
These images, consisting of a signal vs. time plot for each voxel in the field of view, record the 
perfusion of contrast agent into each voxel from the perspective of total signal enhancement due 
to contrast agent concentration in that voxel. 
Examples of DCE data from the study of Siedlecki et al., are shown in Figure 1-4. In the 
DCE experiment, the extent of the loss of kidney functionality is reflected in the time-resolved 
data (right panels). A variety of approaches have been proposed for interpreting these data, or 
more clearly, for deriving useful biomarkers from these data. These range from simplistic shape 
recognition [12] to ad-hoc quantification [13] to full mathematical modeling [14, 15]. Seidlecki et 
al., used an ad-hoc, yet quantitative, approach for their study. 
 Despite the advantages of an ad-hoc, quantitative analysis of DCE-MRI data, parameter 
estimation of quantitative and physiologically meaningful metrics remains the ultimate goal. This 
type of parameter estimation requires two steps: 1) accurate conversion of signal intensity to 
concentration of contrast agent on a voxel by voxel basis, and 2) accurate modeling of the 
concentration vs. time data via a mathematical description (equation) of contrast agent perfusion. 
The common mathematical equations used in these two steps are presented in chapter 2. A 
conceptual introduction is presented in the following example. 
 The cervix of the uterus is interesting in that it is composed of two distinct regions of 
epithelial cells (one region of squamous epithelium and one region of columnar epithelium). The 
barrier between these regions is called the squamocolumnar junction or transformation zone and 
moves physical location (via metaplasia) throughout life both in response to normal development 
and pregnancy [16]. The entire uterus is well supplied with blood by a dense network of 
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subepithelial microvasculature. This blood supply facilitates placental growth during pregnancy, 
but, to quote Karram, also “accounts for [the cevix’s] ability to miraculously heal and to survive the 
worst kind of iatrogenic insults [17].” 
 Microvasculature networks are the source of one of the most common semi-permeable 
membranes found in the body, the capillary wall itself. Parallel networks of capillaries, the 
smallest blood vessels found in the circulatory system, connect arteries to veins and are the 
actual site of oxygen supply and carbon dioxide recovery to and from the interstitium. Structually, 
the vessels consist of a single layer of endothelial cells surrounded by a thin layer of basement 
membrane and sporadic peri-endothelium [18]. Their diameter ranges from 4 to 10 µm and the 
thickness of the vessel wall ranges from 0.1 to 3 µm [19]. Three types of capillaries exist, 
continuous, where the endothial cells line up side by side; fenestrated, where the endothelial cells 
have periodic orifices such as in the kidney (vide supra); and discontinuous, where sporadic, 
unusually large gaps exist between endothelial cells [18]. Clefts between endothelial cells in 
healthy continuous capillaries, such as those in the cervix, allow passage of water soluble 
molecules less than 4 nm in diameter [19]. 
 The cervix is of great interest clinically due to the continued prevalence of cervical cancer 
worldwide. Cervical cancer is largely preventable as it can be detected premalignancy (e.g., via 
the Papanicolaou test). Screening is facilitated by unique progression from healthy to benign 
cancerous to malignant cancerous tissue in cervix. Briefly, human papillomavirus, if persistent 
increases the risk of cervical intraepithelial neoplasia (CIN). This growth of benign tumor cells 
originates in the transformation zone (intraepithelial) and progresses through three distinct 
stages. If CIN progresses to stage three, there is a greatly increased risk of malignancy.  
Angiogenesis, the growth of blood vessels, accompanies cervical cancer and is believed 
to be progressive through the stages of CIN [20]. Blood vessels resulting from this angiogenesis 
have many differences from the existing capillaries, including that they are fenestrated, as shown 
in Figure 1-5 [21]. Thus, from the perspective of DCE, one would expect to see greater perfusion 
of contrast agent into cancerous tissue than in healthy tissue due to the larger gaps in the 
epithelium of the cancerous tissue. 
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Garbow, et al., used DCE to probe the permeability of the cervical vasculature in a 
mouse model of premalignant cervical dysplasia [22]. Figure 1-6 shows the DCE data from the 
cervix of a single mouse from this study. The model used to interpret the DCE data contained 
three physiological parameters quantifying both the permeability and density of the blood vessels. 
These parameters and the associated model are introduced in chapter 2. They appear in Figure 
1-6 as the fitted smooth curve (red line) to the data (red circles). 
The figure also illustrates an additional challenge to parameter estimation of DCE data. 
Namely, that it is necessary to measure or estimate the arterial (or vascular) input function (AIF or 
VIF). The AIF is a measure of the concentration of contrast agent in the vasculature vs. time. Its 
determination is not a trivial matter, especially in preclinical imaging of mice and other animals 
where physical dimensions are smaller. Furthermore, errors in the determination of the input 
function translate into errors in the estimation of model parameters [23]. Thus, various 
approaches have been suggested for determining/deriving the AIF in DCE, including: 1) 
assuming a global AIF [24], 2) measuring a global AIF from a large artery or vein (citation), 3) 
deriving a global AIF from a reference tissue [25], 4) deriving a semi-local “blind” AIF from a 
region of interest (i.e., fitting the AIF and the model parameters iteratively by assuming the AIF to 
be fixed over the region of interest) [26], and 5) modeling the AIF on a voxel-by-voxel basis [27]. 
The input function shown in Figure 1-6 (blue line) was derived from modeling the signal 
enhancement in a reference tissue (blue circles). 
Both the ad-hoc and model-based approaches to DCE data analysis are important, and 
are expected to continue to be applied both preclinically and clinically. Further narrowing its 
scope, this dissertation will focus primarily on model-based parameter estimation. As noted, this 
type of parameter estimation requires two steps: 1) accurate conversion of signal intensity to 
concentration of contrast agent on a voxel-by-voxel basis, and 2) accurate modeling of the 
concentration vs. time data via a mathematical equation describing contrast agent perfusion. 
Hereafter, unless noted otherwise, all references to DCE data analysis will mean this more 




1.5. Validation of DCE-MRI 
 The first published example of DCE-MRI was in 1991 [28]. Since then, the technique has 
found widespread use both preclinically and clinically. An internet-based literature search (Google 
Scholar) using the keywords “DCE” and “MRI” supports this statement and reveals a steady 
increase in the number of published scholarly articles relating to DCE-MRI over the last ten years 
(Figure 1-7). The relatively recent development of DCE, combined with an increasing interest in 
application of the procedure, underscores the importance of validating this technique. 
 A large body of research qualitatively validating DCE-MRI now exists, wherein parameter 
estimation via DCE has revealed differences between healthy and compromised tissue. That 
statistically significant differences between groups can be seen is important and argues the 
merits of the technique, but does not validate the quantitation of estimated parameters. In order 
for DCE-MRI to be quantitatively validated, both the accuracy (i.e., closeness to the actual or true 
value) and the precision (i.e., reproducibility of the measurement) of estimated parameters must 
be assessed. Traditionally, this type of validation is carried out by comparison of the estimated 
parameters to measurements made with “gold standards”. 
 Three potential gold standard measurements have been suggested for the validation of 
DCE-MRI: histologically measured microvessel density (MVD), positron emission tomography 
(PET), and dynamic contrast enhanced computed tomography (DCE-CT). The following 
discussion reviews the literature for validation studies using these techniques. Though 
correlations are seen between DCE and these techniques, further justifying the qualitative value 
of DCE, they cannot be considered gold standards (vide infra). 
 Microvessel density is a measure of the number of capillaries (or vessels below a certain 
threshold dimension) in a tissue. It is assessed by 1) immunohistochemically staining a tissue and 
2) counting the number of vessels below a set threshold size [29]. All other variables held 
constant, tissue perfusion increases in concert with MVD (see equation 2-16, chapter 2). 
 Many attempts to validate DCE focus on its correlation with MVD [30, 31] and references 
therein. Given the proposed functional form of the modeled parameter Ktrans, this is to be 
expected (see chapter 2). Ktrans, the volume transfer constant of contrast agent from blood plasma 
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to the interstitial space, is scaled by the inverse of the fractional volume of the interstitial space. In 
DCE literature this fractional volume is labeled ve. The subscript refers to the extravascular 
extracellular space (EES), the term given to the interstitial space in the DCE literature 
(emphasizing with its name that this volume does not include intracellular spaces). If the number 
of extravascular cells remains the same, then one would expect any increase in MVD to result in 
a decrease in ve as the vessels would now occupy the volume previously ascribed to the EES. 
Interestingly, even though MVD has such a close relationship to ve, papers citing MVD for DCE 
validation focus on correlation of Ktrans or some ad-hoc parameter with the metric [30]. MVD 
cannot be considered a gold standard for Ktrans as other parameters, e.g., flow, permeability, and 
vessel surface area, are understood to affect its value (see chapter 2). One notable exception is 
the manuscript recently published by Egeland et al. where estimated parameters, including ve, 
were compared directly to histology [32]. 
 Positron Emission Tomography (PET) has also been explored for validation of DCE. PET 
utilizes tracers that emit radiation via positron decay [33]. Although much more sensitive, the 
spatial resolution of PET is generally less than that of MRI. The majority of papers comparing 
PET to DCE use PET to measure flow and correlate that flow value with Ktrans or some ad-hoc 
parameter [34, 35, 36, 37]. As with MVD, flow rate alone cannot serve as a gold standard as 
other parameters influence Ktrans. An alternate approach is to carry out a DCE-like experiment 
with PET [38]. The potential advantage of this approach is that, unlike MRI, the conversion of 
signal intensity to contrast agent concentration is linear in PET. One, therefore, could assess 
errors in the conversion of the dynamic MRI signal intensity to tracer concentration. However, 
both techniques would presumably rely upon similar mathematical models of tracer perfusion. 
Thus, PET also cannot be considered a gold standard. 
 Lastly, in analogy with the comparison of dynamic PET studies with DCE-MRI, some 
have carried out the DCE experiment using CT instead of MRI [39, 40]. As the relationship 
between signal intensity and contrast agent concentration is a direct relationship in CT, errors can 
be assessed regarding the conversion of signal intensity to tracer concentration in DCE-MRI. 
However, as the mathematical models describing perfusion for both techniques rely upon the 
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same assumptions, such a comparison cannot elucidate the exact accuracy of estimated 
parameters via DCE-MRI. Therefore, DCE-CT cannot be considered a gold standard. 
As no quantitative validation techniques currently exist in vivo, we decided to attempt to 
validate DCE-MRI ex vivo using realistic tissue phantoms. The design, construction, and testing 
of these phantoms are the major goal of the research described in this dissertation. The 
phantoms described herein share, as a major design feature, the use of semi-permeable hollow 
fibers to simulate vasculature (see chapter 3). 
 
1.6. Scope and summary of dissertation 
The scope of this dissertation is to describe the design and construction of these 
phantoms and the resultant attempts to validate DCE-MRI. Chapter 2 contains a mathematical 
introduction to the DCE data processing used in vivo as well as in the mock-DCE experiments 
carried out on ex vivo tissue phantoms. The starting point for the derivation of the mathematical 
models of perfusion in this chapter is Fick’s Law for membranes. The derivation of this law from 
more fundamental concepts is included as Appendix A. Chapter 3 catalogs the design and 
construction of realistic, perfusion-sensitive tissue phantoms. In addition, the results of a number 
of control experiments are reported and discussed. Chapter 3 is currently in press in Concepts in 
Magnetic Resonance B, Magnetic Resonance Engineering. Chapter 4 discusses diffusion driven 
relaxation observed in one of these phantoms (the single fiber phantom). These observations and 
the ensuing discussion represent an example of the utility of these phantoms in elucidating 
potential challenges in perfusion-sensitive MRI. Chapter 4 is currently in press in NMR in 
Biomedicine. Chapter 5 decribes the mock-DCE experiment. It includes materials and methods, 
experimental results, and conclusions derived therefrom and is to be submitted for publication in 
the near future. Chapter 6 concludes this dissertation. Major results and conclusions are 
discussed as well as future research opportunities. Appendices B-D contain reprints that, though 
not the focus of this dissertation, utilized DCE-MRI. The author of this thesis made major 
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1.7. Figures and captions 
 




Figure 1-2. Examples of contrast enhanced images of brain tumors. Panels A and B were 
acquired with computed tomography (CT) before, A, and after, B, contrast agent administration. 
Panels C and D were acquired with magnetic resonance imaging (MRI) before, C, and after, D, 
contrast agent administration. A T1-weighted acquisition was used. Red arrows show 
enhancement in the venous system. Yellow arrows show enhancement in vascularized regions of 
tumors where the blood brain barrier (BBB) has been compromised (C. Hess and D. Purcell, 5 
August 2008. [Online]. Available: http://knol.google.com/k/christopher-p-hess-md-phd/brain-ct-







Figure 1-3. Schematic representation of the kidney. A) the kidney showing the renal artery (red) 
and vein (blue), the ureter (orange), a renal pyramid (black arrow), and representative internal 
vasculature in the cortex; B) Bowman’s capsule (black arrow) containing a glomerulus; and C) a 








Figure 1-4. Dynamic contrast enhanced (DCE) MRI data in mouse kidneys collected following 
bolus injection of a low molecular weight, Gd-containing contrast agent. Selected images and 
adjusted signal intensity curves are shown for representative mice from three groups. These 
groups are, from top to bottom, control, compromised (cyclosporine treated), and protected 
(cyclosporine and bosentan treated). For each mouse, 250 images were collected with a temporal 
resolution of 1.3 s. Those images shown were collected at, from left to right, 12, 38, and 90 s 
post-contrast injection. At the right, in each panel are the complete adjusted signal intensity 
versus time curves for a medullary ROI for each of these mice (A. Siedlecki, J. Anderson, X. Jin, 
J. Garbow, T. Lupu and A. Muslin, "RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine-





Figure 1-5. Comparison of normal vasculature (A) with that due to tumor induced angiogenesis 
before (B) and after (C) antiangiogenic therapy. Endothelial cells are green, pericytes are red, 
and basement membrane is blue. Note that the vasculature in B and C is random compared to 
the organized arteries, capillaries, and veins seen in A (arrows). Note also that B is fenestrated 
whereas both A and C are continuous (P. Baluk, H. Hashizume and D. McDonald, "Cellular 
abnormalities of blood vessels as targets in cancer," Oncogenes and cell proliferation, vol. 15, no. 











Figure 1-6. Representative DCE-MRI results in a mouse model of precancerous cervical 
dysplasia. Panels A and B show transaxial MRI images in mouse with regions of interest drawn 
over the cervix (A) and leg muscle (B). Panel C shows the resultant concentration time curves 
from these regions of interest (red dots – cervix; blue dots – muscle) as well as the modeled 
tracer perfusion in the cervix (red line) and the muscle-derived arterial input function (blue line) (J. 
Garbow, A. Santeford, J. Anderson, J. Engelbach and J. Arbeit, "Magnetic Resonance Imaging 
Defines Cervicovaginal Anatomy, Cancer, and VEGF Trap Antiangiogenic Efficacy in Estrogen-







Figure 1-7. Scholarly article trends for DCE-MRI. Number of peer-reviewed articles published per 
year resulting from the search terms “DCE” and “MRI” using the Google scholar search engine. 
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CHAPTER 2. QUANTITATIVE DCE-MRI: THEORY 
 
2.1. Abstract 
 Validation of DCE-MRI consists of validation of 1) the equations relating signal intensity 
to tracer concentration and 2) the equations describing contrast agent perfusion. Herein, these 
mathematical equations are cataloged and progressively explained. In the case of the contrast 
agent perfusion, the various iterations of these equations found in the literature are reviewed and 
described. Sample calculations for the processing of in vivo DCE-MRI data, as well as for 
phantom data from a mock-DCE experiment, are presented. 
 
2.2. Introduction 
DCE-MRI is an MRI experiment that involves the indirect detection of an intravenously 
injected contrast agent (CA). The data, which consist of a plot of signal intensity vs. time for each 
voxel in the image, reflect the response in different tissues to the injected CA, the impulse. To 
derive physiologically relevant parameters from these data, a number of critical steps must be 
followed. These are: 
1. The signal intensities at each time point must be converted to R1 values at each time 
point; 
2. The R1 values at each time point must be converted to concentrations of CA at each time 
point; 
3. The concentration vs. time curves must be interpreted correctly by: 
a. Obtaining the impulse function, otherwise known as arterial input function (AIF), 
which is the concentration vs. time curve of the CA in the blood plasma; 
b. Analyzing the data with a mathematical model that correctly describes perfusion 
of the CA into the tissue. 
Section 3 of this chapter presents the signal equations that relate R1 to signal intensity. 
Section 4 describes the various approaches for relating CA concentration to R1. Section 5 then 
reviews the various mathematical approaches found in the literature for modeling CA perfusion. 
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Lastly, section 6 gives an example of the entire process with data synthesized utilizing equations 
from the previous three steps. 
 
2.3. Signal equations 
 Signal equations for a variety of experiments, including gradient-echo and spin-echo 
sequences, are described and derived in The MRI Pulse Sequence Handbook [1] 
 
2.3.1. Signal equation parameters and units 
Table 2-1. Parameter names, symbols, units, and descriptions used in the signal equations 
Symbola Name Units Descriptions 
S Signal intensity s In spectroscopy, this is the area under a peak. In 
imaging, it corresponds to the brightness of the image at 




AU The net magnetization of a sample of nuclear spins. For 
NMR active nuclei this value is non-zero when the 
sample is in a magnetic field. 
 Flip angle Degrees A measure of the nutation of an MR sample by 
radiofrequency excitation. e.g., a 180° flip angle 
corresponds to complete inversion of Mz. 
TR Repetition time s The length (time) of a pulse sequence. When a pulse 
sequence is repeated multiple times this is the time from 
the start of one iteration to the next 
TE Echo time s The length of time in a pulse sequence between 





s-1 The rate constant describing longitudinal relaxation. This 
relaxation process involves the return of the longitudinal 






s-1 The rate constant describing transverse relaxation. This 
relaxation process involves the dephasing of the 





s-1 The observed rate constant describing transverse 
dephasing of an MR signal that includes both R2 and a 
R2' (R2* = R2 + R2') where R2' reflects dephasing due to 
inhomogeneities in the static magnetic field, B0 
aAddition of a subscripted zero signifies a parameter in the absence of CA (i.e., pre-injection) 
 
2.3.2. Spoiled gradient-echo signal equation 
The most common approach to DCE data collection is to use a spoiled gradient-echo 
pulse sequence with a short TE, a short TR, and a relatively small flip angle. Spoiling is the act of 
destroying residual transverse phase coherence after the collection of a free induction decay 
(FID) and before any subsequent radiofrequency (RF) pulses. It can be carried out by applying 
gradients at the end of a pulse sequence and/or by cycling the phase of the RF pulses [1]. The 
practical result of spoiling is that no transverse steady state is established and the expression for 
signal intensity is somewhat simplified. The signal equation can be written as, 
  
S  Mz 
sin   1eTRR1 
1 cos   eTRR1  eTE R2 * .      (2-1) 
Though void of transverse steady state terms, as these are assumed to be suppressed 
with spoiling, this equation essentially describes the longitudinal steady state of the signal 
(magnetization). In the limit of a very long TR and very short TE the signal equation yields the 
equilibrium magnetization Mz. As mentioned, DCE is usually carried out with a small TE and TR, 
which has the effect of minimizing the T2*-dependent and maximizing the T1-dependent portions 
of the signal equation, respectively. This highly T1-weighted signal allows a further simplification 
of the signal equation by assuming negligible signal degradation due to T2* effects. This 
simplification facilitates the conversion from signal intensity to tracer concentration (vide infra). 




S  Mz 
sin   1eTRR1 
1 cos   eTRR1 .        (2-2) 
The standard approach in DCE is to assume Mz is invariant with tracer concentration [2]. 
By taking the ratio of signal at an arbitrary CA concentration (S) and signal in the absence of CA 
(S0), one can relate signal intensity to R1 (which can be altered by a CA). The resultant signal 
equation, now relating S to S0 and R1,0 is, 
  
S  S0 
1eTRR1















.       (2-3) 
To provide a measure of S0, precontrast images are always collected before contrast 
agent administration in DCE. Equation 2-3 also reveals the necessity of acquiring, prior to 
contrast agent injection, an estimation of the native R1 (R1,0). 
Equation 2-3 is shown graphically in figure 2-1 for various values of TR. The figure, 
calculated with S0 set to 1,  set to 20, and R1,0 set to 1 s-1, shows that these calibration curves 
(solid lines) are neither linear nor single valued (i.e., a given signal intensity can correspond to 
two different R1 values). The dashed lines in figure 2-1 correspond to the full equation in which 
R2* equal R1 (this is a best case scenario as R2* is usually greater than R1). Graphical 
comparison of the signal equations with and without R2* weighting reveals how crucial it is to 
assure the image is heavily T1-weighted for all expected R1 values [3]. 
 
2.3.3. Spin-echo pulse sequence 
 Signal-to-noise ratio (S/N) remains a challenge in DCE due to the demand for high 
temporally resolved data. Because of their lower S/N, spin-echo pulse sequences are not 
normally used in DCE-MRI. However, due to the unique design of the phantoms presented in this 
thesis, slice-selective spin-echo pulse sequences can be used. Thus, the spin-echo signal 
equation is presented here. 
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 The spin-echo signal equation contains the same variables as that of the gradient-echo 
with one important exception. Signal loss is not dictated by T2* decay. Instead, it is a function of 
true T2 decay. The equation can be written as, 
  





1 cos 2 1  e TRTE 2 R1 cos 2  eTRR1 
1 cos 1  cos 2  eTRR1  eTE R2 . (2-4) 
This complex equation can be greatly simplified when 1 is set to 90 and 2 to 180: 
  
S  Mz  12 e TRTE 2 R1 eTRR1  eTE R2 .     (2-5) 
Similar to the gradient echo, for short TE experiments, it can be assumed that there is 
negligible signal decay due to T2-weighting. However, unlike R2*, R2 can easily be related to 
tracer concentration. Thus, this simplifying assumption is not necessary as long as the transverse 
relaxivity, r2, is known (vide infra). Taking the ratio of signal vs. initial signal, while including the R2 
term, results in the following signal equation, 
  
S  S0 
12 e TRTE 2 R1 eTRR1 
12 e TRTE 2 R1,0 eTRR1,0  eTE  R2 R2,0  .    (2-6) 
Equation 2-6 is shown graphically in figure 2-2 for different values of TR. The signal 
intensities in the figure, analogous to figure 2-1, were calculated with S0 set to 1, R1,0 set to 1 s-1, 
and, for the dashed lines, R2 set equal to R1 (again, a best case scenario). Unlike the gradient-
echo result, the calibration curves are nearly linear over the range shown. This is due to the use 
of such a large excitation flip angle (i.e., 90). When T2-weighting is assumed negligible, it is 
again important to assure that images are heavily T1-weighted. 
 
2.4. Determination of contrast agent concentrations from relaxation rate constants 
 The simplest, and by far the most common, approach for relating the signal intensity to 
tracer concentration in DCE is to assume a linear relationship between R1 and the concentration 
of contrast agent in tissue (Ct) [2]. This assumption, carried over from studies of homogeneous 
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solutions, may not always be valid. At least one alternative approach has been proposed in the 
literature [4]. 
 
2.4.1. Homogeneous solutions and the fast exchange limit 
 Over a large range of concentrations, a linear relationship is observed in homogeneous 
solutions between tracer concentration ([CA]) and the relaxation rate constants R1 and R2 [2]. The 
equations describing these relationships are, 
  R1  R1,0  r1 CA , and        (2-7) 
  R2  R2,0  r2  CA .         (2-8) 
The slopes in these equations are termed relaxivities; r1 is the longitudinal relaxivity and 
r2 is the transverse relaxivity. No such simple equation relates R2* and [CA] [5]. 
Most of the mathematical models used to describe tracer perfusion in DCE-MRI are built 
upon a two compartment model. These mathematical equations are presented in the next full 
section of this chapter. An understanding, however, of the actual compartments is required for the 
current discussion. As Gd-based tracers remain extracellular, the two compartments of general 
interest in DCE are the blood plasma compartment and the EES. Figure 2-3 shows a schematic 
of these compartments as well as a large intracellular compartment. The arrows are meant to 
indicate that contrast agent molecules can exchange only between the plasma and EES 
compartments. 
Even though CA motion is restricted, water molecules are freely diffusible and can 
transfer between all compartments within the model. In principle, each compartment can have a 
different R1 value. This is especially true in DCE as the contrast agent concentration can be 
unique in each of the three compartments during the DCE experiment. However, if water 
exchanges between the compartments on a timescale much faster than that of the NMR 
experiment (i.e., spin-echo or gradient-echo acquisition), then only a single, average R1 value will 
be detected. This is known as the fast exchange limit [4]. Using equation 2-7 to convert from R1 to 




2.4.2. The slow exchange limit 
 The opposite of the fast exchange limit is the slow exchange limit (SXL), in which water in 
the different compartments does not communicate at all. In this limit, multiple R1 values can 
theoretically be detected. For instance, for a two-compartment system in the slow exchange 
regime, the signal response to an inversion recovery experiment would be the following bi-
exponential, 
  ba RTIbRTIaz evevMS ,1,121   .      (2-9) 
The rate constants of the bi-exponential would correspond to the R1 values of the two 
compartments (i.e., a and b). Furthermore, the amplitudes of the two exponentials would scale 
with the fractional volumes of the two compartments (lower case v). When the rate constants are 
similar to one another, it is difficult to resolve the different fractional components [6]. 
 
2.4.3. FXL vs. SXL 
The validity of the FXL approximation is a function of both the rate of water exchange and 
the difference between the native R1 values in the absence of exchange. For example, if the R1 
values in the two compartments are the same, then no exchange is necessary to achieve the 
FXL. (i.e., even in the absence of exchange only a single relaxation rate will be observed.) 
Similarly, if the R1 values in the two compartments are close in value, then even a little exchange 
will be adequate to invoke the FXL. In contrast, if the R1 values are very different, then a lot of 
exchange must occur for the FXL to be assumed. Accordingly, 1) the largest deviations from the 
FXL occur when high concentrations of CA are present and 2) the FXL is always assumed for 
precontrast R1 acquisition (i.e., R1,0). 
Accordingly, one can define the FXL limit by relating the relaxation rates of the two 
compartments to the rate of exchange of the water between the compartments. Specifically, 
considering the generic compartments a and b, the FXL can be assumed when the following 
equation holds true [7], 
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baab RRk ,1,1'  .         (2-10) 
The prime denotes that this is the rate constant of water exchange not CA exchange. The 
R1 values are those in the absence of water exchange. 
 
2.4.4. The fast and slow exchange regimes 
 The fast exchange regime (FXR) and slow exchange regime (SXR) both fall between the 
FXL and the SXL. Yankeelov et al. have proposed that assuming the EES and extravascular 
intracellular space (EIS) are in the FXR is more correct than assuming the FXL [4]. The fast 
exchange regime is based upon an alteration of equation 2-9. In the presence of water exchange, 
the amplitudes and exponential rate constants no longer represent the fractional volumes and 
rate constants of the two compartments, but instead, represent apparent values as follows, 
  LS RTILRTISz eaeaMS ,1,121   .      (2-11) 
The subscripts S and L refer to small and large rate constants, and a denotes an 
apparent fractional volume. (Note that in the publication by Yankeelov et al., where the following 
equations are presented, S and L refer to short and long as the equations are written with time 
constants rather than rate constants.) In addition, if neither the fast exchange limit nor the slow 
exchange limit can be assumed, it has been proposed that the following equations can be applied 
for a two-compartment system (subscripted e and i in reference to the EES and EIS of relevance 

























































































































































































C represents the tracer concentration in a given compartment. If both R1,L and the R1,S 
are required for adequate fitting of the concentration curve then one is in the SXR and no closed 
form solution is available. However, if a single rate constant dominates then one is in the FXR. 
When this approach is applied to DCE, it is taken that the short rate constant dominates and the 























































R .  (2-15) 
 
2.4.5. More complex models 
It is important to note that equation 2-15 ignores CA in the vasculature (i.e., the 
expression does not reference the plasma compartment). An even more complex set of equations 
results when all three compartments; the blood plasma, the EES, and the EIS; are considered in 
tandem. The interested reader is referred to the article by Springer et al. [8]. 
 
2.5. Mathematical equations describing contrast agent perfusion 
 As noted above, the mathematical equations used to describe tracer perfusion are based 
upon compartmental tissue models. These models share parameters which have been given 
standard names and symbols within the DCE literature [9]. The parameters, their symbols, and 






Table 2-2. Parameter names, symbols, and units used in the DCE tracer perfusion equations. 
(For a more complete table see [9]) 
Symbola Name Units  Symbola Name Units 
Ct Total tissue 
concentration 
mM Ci EIS concentration mM 
Cp Blood plasma 
concentration 
mM Ce EES concentration mM 
vp Fractional blood 
plasma volumea 
Unitless ve Fractional volume of 
the EES 
Unitless 
kep Rate constant of flux of 
an agent from blood 
plasma to EES 
min-1 Ktrans Transfer constant of 
flux of an agent from 
blood plasma to EES 
min-1
avp is, to a good approximation, equal to one minus the hematocrit (Hct)  
 
2.5.2 The modified Tofts model 
 The most commonly used model for DCE data analysis is referred to as the modified 
Tofts model. This model is derived from more fundamental physical principles in Appendix A and 
is rewritten with the symbols listed above as, 
     .tCeKtCvtC ptktransppt ep   .      (2-16) 
The symbol  denotes the convolution operation (see Appendix A). This equation derives 
from the two compartment model (with respect to CA) shown in figure 2-3 and is similar to the 
equation originally utilized by Tofts and known as the standard Tofts model [10]. Note that Ktrans is 
equal to kep·ve. Tofts has shown that this model is mathematically equivalent to the models used 
by Brix and by Larsson [11]. Note that in order to determine vp, Ktrans, and kep; both Ct(t) and Cp(t) 
must be known. Cp(t) is the AIF (in terms of concentration vs. time) and must be assumed or 
measured (vide infra). Also note that the equation does not depend upon any specific functional 
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form for the AIF. However, if a functional form can be assumed then it is sometimes possible to 
explicitly solve the convolution integral (vide infra). 
Equation 2-16 can be explained in broad terms by referring to the following equation 
which can be found as an intermediary in its derivation, 
     .tCvtCvtC eeppt          (2-17) 
Equation 2-17 states that the concentration of CA in the tissue equals the weighted 
concentration of CA in the blood plasma plus the weighted concentration of the CA in the EES. 
Equation 2-16 is derived by setting Ce(t) equal to the response of the system to the impulse Cp(t). 
In other words, the convolution of Cp(t) and kep·e-kep·t. The product of ve and kep is normally 
expressed as a single constant, Ktrans. 
The validity of the modified Tofts equation rests on several assumptions which are listed 
below [11]. 
1. The compartmental model shown in figure 2-3 is accurate 
a. All compartments are well mixed 
b. CA is found only in the EES and the plasma compartments 
c. Any CA in the EES originated from the plasma compartment 
2. Fick’s law for membranes holds and is time dependent (equation A-14) 
a. Complex transport mechanisms and multiple transport boundaries can be 
expressed by one effective permeability 
b. Intercompartmental flux is linear and is determined solely from concentrations on 
each side of the compartmental barrier 
3. Ce(0) is equal to zero 
In addition, there is the implicit assumption in data processing that the discrete data (i.e., 
the sampled time course) are of sufficiently fast temporal resolution to accurately reproduce the 
continuous concentration curves Cp(t) and Ct(t). Including additional assumptions will generally 





2.5.3. Less complex models 
There are two additional assumptions sometimes added to the list above. By 
understanding these assumptions, one can more clearly understand their judicious application. 
 
2.5.3.1. No vascular component 
The vascular component of the tissue concentration is expressed as vp multiplied by 
Cp(t). This value is equal to zero if vp is equal to zero or if Cp(t) is equal to zero. Neither of these 
conditions is true after contrast agent injection in a DCE experiment. However, this assumption is 
effectively achieved if the quantity vpCp(t) is much less than veCe(t). Alternatively, this can be 
achieved experimentally if signal corresponding to plasma tracer is not detected (e.g., due to 
time-of-flight or T2* effects). 
As Cp(t) and Ce(t) both change over the time course of the DCE experiment, the validity 
of this assumption can change as the experiment progresses. If a bolus injection of CA is used, 
then at short times Cp is much larger than Ct, and at long times (after leakage has occurred) Cp 
and Ct are closer in value. Thus, this assumption is least valid at short times and most valid at 
long times. Also, the smaller the value of Ktrans (the less leaky the vasculature), the longer the 
potential invalidity of the assumption persists. 
The general solution, under the assumption of no vascular component of tissue 
concentration is known as the standard Tofts model [11] and simplifies to, 
   .tCeKtC ptktranst ep           (2-18) 
 
2.5.3.2. kep equals zero 
Expressing kep as the ratio of Ktrans and ve, one can see that the assumption that kep is 
zero is never achieved, as both Ktrans and ve are positive by definition and non-zero in practice. 
However, it is effectively true if kep is very small. Therefore, this assumption becomes increasingly 
valid in the limit of small Ktrans and/or large ve. Under this assumption, the resulting equation is 
known as the Patlak model [12], and the solution can be written as, 
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     .tCKtCvtC ptransppt         (2-19) 
As Ktrans is a constant, this equation is equivalent to: 
      .
0
 t ptransppt dCKtCvtC         (2-20) 
These assumptions and the resultant general solutions are summarized in Table 2-3. 
Table 2-3. Summary of compartmental model assumptions, solutions, and modeled parameters 
 Assumptions General solution Modeled 
parameters 
1        tCeKtCvtC ptktransppt ep    vp, Ktrans, and kep 
2 Ct=veCe    tCeKtC ptktranst ep    Ktrans and kep 
3  kep=0       t ptransppt dCKtCvtC
0
  vp and Ktrans 
4 Ct=veCe kep=0     t ptranst dCKtC
0
  Ktrans 
 
2.5.4. More complex models 
As mentioned, more complex physiological models result from removing or relaxing 
restrictions imposed by the modified Tofts model. The advantage to additional complexity is the 
potential of more accurately describing tissue perfusion. A number of such models are presented 
here. 
 
2.5.4.1. The concentration of contrast agent in the plasma compartment is not homogeneous (i.e., 
the compartment is not well mixed), but instead is represented by a concentration gradient from 
higher arterial concentrations to lower venous concentrations 
It has been shown that the parameter Ktrans can be written in terms of more fundamental 
constants [9, 13]. The general form is as follows, 
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 HctfEK trans  1 .        (2-21) 
The parameter f is blood flow per unit mass of tissue (ml/g/min), Hct is the hematocrit 
(which is assumed to be invariant and homogeneous within the voxel throughout the time course 
of the experiment), ρ is the density of the tissue (g/ml), and E is the initial extraction ratio which is 
defined as the fraction of contrast agent that is removed from the arterial blood supply as it 
passes through the tissue. Despite this analytical expression for Ktrans, one cannot decompose the 
transfer constant into its more basic components with a two compartment model (see table 2). 
Instead, one must use a more complex kinetic model such as the one proposed by St. Lawrence 
and Lee, the tracer kinetic model [14]. 
Recall that the two compartment model assumed well-mixed compartments. Restated for 
the plasma compartment, the model assumes that the contrast agent mixes instantaneously 
within the vasculature after injection and that arterial and venous concentrations are the same. 
The tracer kinetic model addresses this assumption by allowing a spatial gradation of 
concentration along the “temporal” axis of the vasculature (from higher, arterial to lower, venous 
concentrations) as is shown in block diagram in figure 2-4. 
An analytical solution to the concentration of contrast agent in the the tissue can only be 





dC ep           (2-22) 
This is the known as the adiabatic approximation and states that the time rate of change 
in concentration in the plasma is much greater than the change in concentration in the EES.  
Under this assumption, the concentration of contrast agent in the tissue can be written as: 
















KtC       (2-23) 
Tc is called the mean capillary transit time (s); functionally it represents the average time 
for a bolus of CA to traverse the vascular bed within the voxel (i.e., come into and pass out of the 
vascular compartment). If one assumes that Hct and ρ are known, then flow can be derived by 
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applying equation 2-21. This is made clear by rewriting equation 2-23 as a function of F and E 
rather than Ktrans and E (6), 












deCHctfEdtCHctftC    (2-24) 
Furthermore, it can be shown that this equation reduces to equation 2-16 when t>Tc [14]. 
The same modification to account for incomplete mixing can be applied to the other models of 
table 2 that contain the term vpCp. 
The appropriateness of this model hinges upon the validity of the adiabatic assumption. 
The change in CA concentration in the plasma with respect to time depends largely on the 
clearance of the contrast agent from the body. The change in CA concentration in the EES with 
respect to time, however, is described by the modeled vascular parameters. Therefore, the 
validity of the assumption increases as Ktrans decreases and as ve increases. In addition, for this 
model to be applied, the temporal resolution and S/N of the collected data must be very high. This 
is stated as an assumption for all the models (see section 2.5.2), but is particularly important 
here, as the time period 0<t<Tc must be well sampled for both Ct and Cp. 
 
2.5.4.2. The plasma compartment is not well mixed during the first pass of the CA, but is 
represented instead as a distribution of concentration gradients during the first pass 
Koh et al. expanded the work of St. Lawrence and Lee by allowing for a distribution of 
capillary transit times [15]. The single Tc value, introduced by St. Lawrence and Lee, results from 
treating all the blood vessels within the voxel as one compartment or, equivalently, as one central 
vessel. Allowing for a distribution of Tc values, therefore, is to model the blood compartment as 
numerous smaller compartments or vessels with different Tc values. The mean value of this 
distribution of vessels is equal to the single Tc obtained by taking all the vessels as one. This 
effect is introduced into equation 2-24 by means of a normalized probability density function, 
g(Tc,µ,σ) where µ and σ are the mean and standard deviation, respectively, describing the 
probability of all possible correlation times. The expression thus becomes [15]: 
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       

































  (2-25) 
In Koh’s paper, both a Gaussian and a similar, but slightly asymmetric, function were 
introduced as possible probability density functions. This model is most valid in the same 
situations as equation 2-24. However, for the addition of two modeled parameters to be justified, 
the concentration from 0<t<Tc must have strong deviations from equation 2-24 (manifested as a 
curve near time t=Tc instead of a sharp drop [15]) and the experiment must have adequate 
temporal resolution to sample effectively such deviations. 
 
2.6. Sample data processing 
As a final example, the general two compartment equation (equation 2-16), the FXL 
equation for R1 (equation 2-7), and the full gradient echo signal equation (equation 2-3) are 
combined into a single function expressing signal intensity vs. time in terms of MRI and DCE 
parameters as well as the input function Cp(t). Pros and cons of this approach are discussed, 
after which, a stepwise data analysis of a simulated data set is demonstrated. 
 
2.6.1. Combined signal equation 
Equation 2-7 can be substituted into equation 2-3 to yield the following equation, 
 
  
































.    (2-26) 
In order to apply this equation in a time-resolved manner to DCE data, one additional 
assumption must be made. Recall that equation 2-3 describes a steady state signal. During a 
DCE experiment, signal intensity changes in response to changing contrast agent concentration 
(resulting from the perfusion of a bolus of intravenously injected contrast agent). After any change 
in contrast agent concentration, the signal requires some equilibration time before steady state is 
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again reached [1]. However, as the change in concentration is gradual throughout the entire 
experiment, the signal intensity can be treated as if it is continually at steady state. This 
assumption is most strongly challenged when large changes in concentration occur between 
consecutive data points, a situation most likely to occur with a large TR and during the initial 






































.   (2-27) 
Equation 2-16 can now be substituted directly into equation 2-27, 
 
 
    












































 In practice, the input function is assumed, measured in a major artery, or derived from 
reference tissue [16]. If the AIF is measured in a major artery, then equation 2-27 is used to 
convert Sp(t) to Cp(t) as well as St(t) to Ct(t). If a reference tissue is used, then Cp(t) is derived by 
assuming perfusion parameters for the reference tissue and using an equation such as 2-16 [17]. 
 
2.6.2. Explicit solutions to the arterial input function 
The convolution of the exponential and Cp(t), as seen in equation 2-28, can be expressed 
in full integral form as, 
          t tkpepptkepe deCktCektC epep
0
  .    (2-29) 
If a functional form for the input function is assumed, this integral can potentially be 
explicitly solved. For instance, if the arterial input function is a square function that changes from 
0 mM CA to Cp,max and back, then equation 2-29 can be written as a set of three equations. The 
first describes the signal intensity from time t=t0 (the beginning of the experiment) to time t=ta (the 
front edge of the square function). The second describes the signal intensity from time t=ta to t=tb 
(the back edge of the square function). The third describes the signal intensity from time t=tb to 
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infinity. This approach is used in the ideal mock-DCE experiment described in chapters 4 and 5 of 
this dissertation. This set of equations is, 
    
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max,
max, .    (2-30) 
 With current DCE injection protocols, a square input function would not be observed in 
vivo. Most rely on a bolus injection of contrast agent. Perhaps the simplest functional form that 
could be applied to the resultant input function would be a single exponential decay from some 
maximum tracer concentration Cp,max (where Cp,max is less than or equal to the injected CA 
concentration). The set of equations resulting from this assumed functional form, i.e., 
Cp(t)=Cp,max·exp(-kAIF·t), are, 
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max,
.     (2-31) 
 Potentially, as more parameters are added to the equation describing the AIF, it more 
realistically reflects the shape of a measured input function. For example, adding a third 
parameter, one could use the equation A·(exp(-kAIF,1·t)-exp(-kAIF,2·t)) to describe the input function. 
This would give, 
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2,1, .  (2-32) 
Many other more advanced ad-hoc functional forms for the AIF could also be applied [18, 
19, 20]. Advantages to using an ad-hoc equation for the input function include: 1) one can avoid 
numerical convolution/deconvolution techniques and 2) modeling of the input function can be 
performed on a voxel-by-voxel basis [21]. A significant disadvantage is that DCE data processing, 
requires mathematical modeling of the AIF. 
Whether or not modeling of the input function is part of the DCE analysis, there is at least 
one potential reason to avoid completing the analysis in a single step. When this is done, the 
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calculated concentrations in the tissue (Ct) and the blood plasma (Cp) are not available 
individually for inspection. Though maximum concentration values for the tissue or input function 
are not known a priori, they should be equal to or less than the concentration of the injected 
solution. Similarly, both values should be less than or equal to the concentration of the injected 
solution diluted by the total blood volume of the patient or animal, and Cp,max should be greater 
than or equal to Ct,max. 
 
2.6.4. Simulated data example 
 A simulated signal vs. time curve is shown in figure 2-5 as well as an accompanying AIF. 
TR and α are assumed to be 0.025 s and 20°, respectively. The temporal resolution was set to 
6.4 s which corresponds to an imaging experiment having a TR of 0.025 s, a field of view of 
64×64, and collecting four averages for each image. Figure 2-6 shows the concentration vs. time 
curves that result by applying equation 2-27 with these parameters. As the relationship between 
tracer concentration and signal intensity is not single valued, a look up table was prepared for the 
expected concentration range of the experiment as opposed to algebraically reformulating the 
equation. Lookup tables were made using R1,0,t = 1 s-1, R1,0,p = 0.5 s-1, and r1 = 5 mM-1 s-1. S0 was 
set to the mean value of the first 20 data points. 
 Lastly, using the “conv” function in Matlab, the signal concentration curve was fitted 
iteratively to minimize the mean residual using equation 2-16. The modeled results are presented 
in figure 2-7. The actual kinetic parameters vs. fitted parameters are given in table 2-4. 
 
Table 2-4. Results from the DCE analysis of a simulated data set. 
 Ktrans kep vp ve 
True 0.10 0.50 0.050 0.20 
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2.8. Figures and captions 
 
Figure 2-1. Calibration curves for a gradient-echo pulse sequence. The relationship between 
signal intensity and the longitudinal relaxation rate constant (R1) is shown for various values of 






Figure 2-2. Calibration curves for a spin-echo pulse sequence. The relationship between signal 
intensity and the longitudinal relaxation rate constant (R1) is shown for various values of TR. Solid 





Figure 2-3. Diagram of a three compartment system. C stands for concentration of CA; p, e, and i 
denote the plasma, extravascular extracellular, and extravascular intracellular spaces 
respectively; Ktrans is the transfer constant of CA from p to e; and kep is the rate constant of CA 
from e to p. The crossed out arrows indicate that CA cannot cross the cell wall even though water 









Figure 2-4. Block diagram for the tracer kinetic model. This model does not assume a well mixed 
plasma compartment, but instead, assumes a linear gradient along the effective length of the 




















Figure 2-5. Simulated DCE-MRI signal intensity data. The black points correspond to temporally 
resolved signal intensities measured in a tissue of interest. The red points correspond to 
temporally resolved signal intensities measured in an artery feeding the tissue of interest, the 





Figure 2-6. Simulated DCE-MRI concentration data derived from signal intensities shown in figure 
2-5. The black points correspond to a tissue of interest. The red points correspond to the arterial 





Figure 2-7. Simulated DCE-MRI concentration data derived from signal intensities shown in figure 




CHAPTER 3. SEMI-PERMEABLE HOLLOW FIBER PHANTOMS 
 
3.1. Abstract 
 Two semi-permeable, hollow-fiber phantoms for the validation of perfusion-sensitive MR 
methods and signal models are described. Semi-permeable hollow fibers harvested from a 
standard commercial hemodialysis cartridge serve to mimic tissue capillary function. Flow of 
aqueous media through the fiber lumen is achieved with a laboratory-grade peristaltic pump. 
Diffusion of water and solute species (e.g., Gd-based contrast agent) occurs across the fiber wall, 
allowing exchange between the lumen and the extra-lumenal space. Phantom design attributes 
include: (i) small physical size, (ii) easy and low-cost construction, (iii) definable compartment 
volumes, and (iv) experimental control over media content and flow rate. 
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3.3. Introduction 
 Perfusion-sensitive magnetic resonance (MR) techniques, such as dynamic contrast 
enhanced (DCE) and arterial spin labeled (ASL) MR, are powerful methods for defining and 
monitoring tissue vascular status, and changes therein, in the face of physiologic challenge, 
normal and pathologic. DCE and ASL MR methods employ exogenous and endogenous MR-
sensitive diffusible tracers, respectively. Analysis of the DCE or ASL MR signal characterizes 
tissue vasculature by estimating parameters associated with multi-compartment kinetic models, 
which seek to describe the relevant biophysical properties of a given tissue’s vascular system. 
Quantitative validation of a particular DCE or ASL MR method and its related signal model is 
 56 
 
difficult, often impossible, in vivo. Phantoms, designed to mimic salient properties of tissue 
vasculature, provide a platform for validation of perfusion-sensitive MR methods and signal 
models. Importantly, phantoms allow MR-derived kinetic parameters to be compared with 
alternative, “gold standard” measurements of these same parameters. 
The ideal MR perfusion phantom should contain simulated vasculature enabling (i) 
lumenal flow, i.e., media flow through the interior of the mock capillaries, and (ii) diffusion of water 
and solutes (e.g., Gd-based contrast agent) across the vessel wall, i.e., exchange of water and 
solutes between lumenal and extra-lumenal spaces. The phantom should allow independent 
determination of parameters characterizing the relevant kinetic model, such as the DCE model’s 
volume wash-in transfer constant (Ktrans) and wash-out rate constant (kep), and the ASL model’s 
perfusion rate (f) and mean transit time (MTT). 
MR methods and signal-model validation would be enabled by a simple multi-
compartment phantom constructed of spaces with known dimensions, as fractional volumes are 
often important model parameters. Likewise, MR-independent knowledge of experimental 
parameters would allow quantitative comparison to MR-derived signal/kinetic model-parameter 
values. These include, for example, media flow rate and velocity, contrast-agent “arterial” input 
function, and diffusivity of water and contrast agent across the fiber wall. Lastly, a phantom 
requiring only inexpensive, simple components and construction methods, while maintaining an 
overall diameter of a few centimeters or less, would facilitate testing/validation of a broad range of 
perfusion-sensitive MR techniques on pre-clinical (small-animal) MRI scanners. 
Hollow fiber modules (HFM), in the form of commercial hemodialyzers (e.g., Fresenius 
Medical Care AG & Co., Bad Homberg, Germany; Baxter International Inc., Deerfield, IL, USA), 
hollow-fiber bioreactors, and small-volume filtration and concentration systems (e.g., Spectrum 
Laboratories Inc., Rancho Dominguez, CA, USA; FiberCell Systems Inc., Frederick, MD, USA) 
could potentially serve as such phantoms. HFM contain semi-permeable hollow fibers that mimic 
vasculature. The straw-like polymer fibers permit restricted diffusion of small molecules across 
the fiber wall, while blocking passage of larger particles such as cells, hence the term “semi-
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permeable”. The design of HFM permit media flow; thus, simulated perfusion experiments are 
possible.  
MR imaging and spectroscopy studies of HFM have been published, including one in 
which a commercial dialyzer was used as a phantom for validation of perfusion measurements1. 
However, most imaging studies have focused on testing and improving the efficacy of dialyzers 
by directly measuring flow (velocity) within the dialysis fibers to probe homogeneous fluid 
transport2-9 and assess the impact of different design innovations10,11. MR imaging and 
spectroscopy studies of HFM bioreactors have also been reported. As the native application of 
bioreactors is support of cell cultures, the majority of this literature is focused on monitoring and 
characterizing cell growth within the bioreactor via diffusion weighting, velocity encoding, or 
contrast enhancement12-14. HFM perfusion measurements employing spectroscopic methods 
have also been reported9,15-17. 
Despite the many advantages of commercial HFM, there are limitations to their use as 
perfusion-sensitive MR phantoms. HFM fiber-packing density is fixed by the manufacturer for 
optimal hemodialysis/micro filtration-concentration/cell growth, limiting the options available for 
perfusion-sensitive MR phantoms. The chemical composition of the semi-permeable hollow 
fibers, and thus the porosity/molecular weight cutoff, is likewise fixed by the manufacturer. We 
further note that human dialyzer HFM, manufactured with clinical efficiency in mind, have a 
relatively large size that constrains both MR protocols (e.g., field-of-view (FOV) vs. spatial 
resolution) and access to smaller magnet-bore scanners. 
Herein, we present the design and construction of two perfusion-sensitive MR phantoms. 
These laboratory constructed phantoms can be designed with specific fiber dimensions and 
numbers, allowing accurate calculation of fractional compartment volumes. Further, fibers of 
various compositions can be obtained from commercial suppliers, allowing selection of 
permeability characteristics appropriate for the research question of interest. Finally, other 
parameters salient to perfusion-sensitive MR techniques; including media flow rate, velocity, and 
input function, can be controlled experimentally. The phantoms are of small dimensions, thereby 
facilitating high spatial-resolution imaging on preclinical MR imaging scanners by permitting the 
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use of small, high sensitivity volume coils. Ebrahimi et. al., recently presented a phantom with 
microfluidic channels18. The “vessels” (channels) of the phantom are similar in size to those found 
in vivo. The phantoms presented in this manuscript contain “vessels” of larger dimensions that, 
unlike microfluidic channels, allow diffusion of water and other molecules through the fiber wall. 
Demonstrating two extremes, one phantom consists of a single fiber suspended through 
the center of a capillary tube; the other phantom consists of multiple fibers densely packed in 
heat-shrink tubing. Both phantoms permit lumenal and, if desired, extra-lumenal flow/access. 
Uniformity of commercial fibers allows controlled “gold standard” experiments on a single or a 
small number of fibers, e.g., measurement of the diffusivity or permeability of water or contrast 
agent across the fiber wall. 
 
3.4. Phantom Design 
 
3.4.1. Single-fiber Phantom Overview 
The overall design of the single-fiber phantom is shown in Fig. 1. The phantom consists 
of a single, semi-permeable hollow fiber (inner diameter (ID) = 0.20 mm; thickness (TH) of the 
wall = 0.04 mm) suspended in a capillary tube (ID = 1.00 mm). The fiber was harvested from a 
commercial HFM used for clinical hemodialysis, vide infra. Three physical compartments exist 
within the phantom: the fiber lumen, the fiber wall, and the extra-fiber space. For many 
experiments (e.g., T1 in the absence of lumenal flow or with respect to a molecule that is freely 
diffusible in both the fiber wall and the extra-lumenal space), the fiber wall and the extra-fiber 
space constitute a single compartment, collectively referred to as the extra-lumenal space.  
In the single-fiber phantom, the lumenal and extra-fiber compartments are independently 
accessible. For the fiber lumen, access is provided by Luer fittings, mounted directly on the two 
ends of the capillary tube (Fig. 1), through which a single hollow fiber passes. For the extra-fiber 
space, access is via a catheter, consisting of a 10” piece of tubing (ID = 0.20 mm; TH = 0.10 mm) 
with an attached Luer fitting. The lumenal and extra-fiber compartments communicate only 
through the wall of the fiber. The connectors allow for efficient purging of these compartments, as 
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well as flow in either compartment during experimentation. In our experiments, flow was achieved 
with a standard laboratory peristaltic pump, vide infra. 
A design feature of the single-fiber phantom is the ability to control the relative sizes of 
the lumenal and extra-fiber compartments by changing capillary tubes. The phantom shown in 
Fig. 1 employs a capillary tube with ID = 1.00 mm; we have also constructed phantoms using 
capillary tubes with ID = 0.50 mm. These two arrangements result in lumen:fiber wall:extra-fiber 
space fractional volumes of 0.16:0.15:0.69 and 0.04:0.04:0.92, respectively. The length of the 
phantom can also be adjusted as required. Typically, capillary tubes for our phantoms are 
approximately 3 cm long. 
 
3.4.2. Multi-fiber Phantom Overview 
The overall design of the multi-fiber phantom is shown in Figs. 2 and 3. The phantom 
consists of multiple semi-permeable fibers bundled inside heat-shrink tubing (ID = 2.6 mm after 
shrinkage). As with the single-fiber phantom, three physical compartments exist within the multi-
fiber phantom: the fiber lumen, the fiber wall, and the extra-fiber space. Again, under many 
experimental conditions, the fiber wall and the extra-fiber space can be considered as a single 
compartment, the extra-lumenal space. 
External access to compartments is shown in two different configurations in Figs. 2 and 
3. Figure 2 shows the geometry more commonly used in our lab. In this configuration, external 
access is available only to the lumenal compartment, via Luer fittings mounted directly on the two 
ends of the heat shrink tubing. Figure 3 presents a second geometry, in which both the fiber 
lumen and the extra-fiber space are accessible externally. 
The relative ratios of the different compartments can be altered by changing (i) the 
number of fibers in the bundle and/or (ii) the diameter of the heat-shrink tubing, as illustrated in 
two example setups (Figs. 4 and 5, panels C and D). In one case (panel C), 75 fibers placed into 
heat-shrink tubing that is then contracted produce a densely-packed fiber-bundle phantom having 
an inner diameter (ID) of 2.6 mm and lumen:fiber wall:extra-fiber space fractional volumes of 
0.44:0.43:0.13. In a second case (panel D), 50 fibers placed into 4.0 mm ID heat-shrink tubing 
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that is not further contracted produce a loosely-packed fiber-bundle phantom with lumen:fiber 
wall:extra-fiber fractional volumes 0.13:0.12:0.75. Multi-fiber phantoms have been constructed 
with heat-shrink tubing lengths from 5 cm to 10 cm. 
 
3.5. Construction of phantoms 
 
3.5.1. General Considerations 
Devcon 5 Minute Epoxy was used for the construction of all phantoms (ITW Devcon; 
Danvers, MA, USA). To facilitate precision application of epoxy, a 10 mL syringe with a 19G 
blunt-tipped needle was used to first draw and then apply the freshly mixed epoxy. Care was 
taken not to plug the ends of catheters and fibers used in phantoms with epoxy. All fibers used 
were harvested from a Fresenius Optiflux F-160NR dialyzer. Fibers were cut with a razor blade. 
 
3.5.2. Single-fiber Phantom 
 In preparation for phantom construction, two Luer-lock end pieces were fashioned from 1 
mL Luer-Lok syringes (P/N 309628; Beckton, Dickinson and Company; Franklin Lakes, NJ, USA). 
The syringes were cut to size (~1.5 cm) and 1.0 mm diameter holes were drilled at an 
approximately 45° angle, as shown in the left inset of Fig. 1. Mouse tail-vein catheters (MTV-01; 
Strategic Applications Inc.; Libertyville, IL, USA) were threaded through the holes. 
A semi-permeable hollow fiber (length: ~15 cm) was threaded through a capillary tube cut 
to the desired length. The tips of the two catheters, providing access to the extra-lumenal space, 
vide supra, were inserted ~0.5 cm into opposite ends of the capillary tube. After axially centering 
the fiber in the capillary, the fiber and catheter tips were fixed in place with epoxy while applying 
gentle tension to the fiber. Once the epoxy cured, the ends of the semi-permeable hollow fiber 
were carefully trimmed, leaving ~0.2 cm extending from the capillary on each side. Next, the two 
Luer-lock end pieces were centered axially on the ends of the capillary and fixed in place with 





3.5.3. Multi-fiber Phantom 
 Value Plastics “Build-A-Part” components (Value Plastics, Inc.; Fort Collins, CO, USA) 
were used to construct the Luer-lock connectors for the multi-fiber phantoms. These preformed 
building-block components can be connected to each other, using a small amount of acetone, to 
form various parts. The “Build-A-Part” components used in these phantoms consisted primarily of 
cubes with various pass-through holes, as seen in both Figs. 2 and 3. The end connectors for the 
multi-fiber phantom shown in Fig. 2 were constructed from “Build-A-Part” components before 
assembly of the phantom, but those used in the multi-fiber phantom shown in Fig. 3 were 
assembled as part of the phantom-building process, as noted below. 
 The phantom shown in Fig. 2 was constructed by first bundling together seventy-five 
fibers with a small amount of fishing line and then threading the fiber bundle through generic 1/8” 
polyolefin heat-shrink tubing. Epoxy was carefully, but liberally, applied on and around the fibers 
at one end of the phantom. The epoxy was allowed to seep ~0.5 cm (axially) into the heat-shrink 
tubing and to completely cover the fibers extending outside of the tubing, also a length of ~0.5 
cm. After the epoxy cured for 40 minutes, the fibers at the epoxied end were carefully trimmed 
with a razor blade, leaving ~0.2 cm exposed beyond the edge of the heat-shrink tubing. Trimming 
fibers that have been completely encased in epoxy results in a very clean cut and ensures little to 
no fiber occlusions (Fig. 2, panel D). Next, the heat-shrink tubing was gently contracted with a 
heat gun. The exposed portions of the fibers were covered with aluminum foil to prevent potential 
heat damage. Epoxy was then applied to the opposite end of the phantom, allowed to cure, and 
the fibers trimmed. Lastly, the Luer-lock connectors were fixed to the ends of the phantom with 
epoxy, taking care not to bend or otherwise constrict any of the fiber tips. 
 Construction of the multi-fiber phantom shown in Fig. 3 was somewhat more challenging. 
To ensure that the phantom had a uniform, cylindrical shape, a length of 1/4” heat-shrink tubing 
was “pre-conditioned” by contracting it around a 4-mm outer-diameter glass rod, which was then 
removed from the tubing. (A light coating of glycerin applied to the 4-mm glass rod prior to 
contracting the tubing made it easier to withdraw the rod.)  Fifty fibers were bundled and fed 
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through the “pre-conditioned” (now 4-mm ID) heat-shrink tubing. The bundle of fibers was then 
threaded through the first “Build-A-Part” component (Fig. 3, right side) until ~0.2 cm of the heat-
shrink tubing was nested inside the “Build-A-Part” component. The heat-shrink tubing was fixed to 
the “Build-A-Part” component with epoxy, taking care to avoid applying any epoxy to the fibers. 
The fibers were carefully fed through the second component (Fig. 3, center), which was then 
connected to the first. The fibers were fixed to each other, and then to the inside of the second 
component with epoxy, and were trimmed to leave ~0.2 cm exposed. Finally, the third “Build-A-
Part” component was connected (Fig. 3, left side). 
 Persistent air bubbles, remaining in the interior of the phantoms after being filled with 
media, were flushed out using the following two-step procedure. First, the phantom was gradually 
submerged in a 250 mL Erlenmeyer flask with a sidearm and placed under house vacuum. While 
under vacuum, the phantom was agitated gently by tapping the flask. Second, the phantom was 
placed inline and purged with media for 10 to 60 min, as required. 
 
3.6. Materials and methods 
 
3.6.1. Peristaltic Pumping 
 Peristaltic pumps (single-fiber phantom: Carter Manostat Cassette Pump; Thermo 
Scientific-Barnant, Barrington, IL, USA; multi-fiber phantom: Masterflex L/S Digital Economy 
Drive; Cole-Parmer Instrument Company; Vernon Hills, IL, USA) were placed just outside the 5-G 
line of the magnet’s fringe field. To minimize peristalsis, pump heads with 8 and 6 rollers were 
used for the single- and multi-fiber phantoms, respectively. Also, small-diameter pump tubing was 
used to facilitate increased pump-head speeds. Pump tubing with an ID of 0.25 mm was used 
with the single-fiber phantom (Masterflex Santoprene Tubing; Cole-Parmer; Vernon Hills, IL, 
USA), while tubing with an ID of 1.6 mm was used with the multi-fiber phantom (Masterflex Tygon 
Tubing; Cole-Parmer). 
 
3.6.2. MR Imaging 
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 Images were collected on scanners employing Oxford Instruments 4.7-T horizontal-bore 
magnets of either 33 or 40 cm clear bore (Oxford Instruments; Oxford, UK). Both scanners are 
interfaced with Agilent/Varian DirectDriveTM consoles, and Agilent/Magnex gradient coil 
assemblies (Agilent Technologies; Santa Clara, CA, USA). The gradient-coil assemblies have the 
following respective characteristics: bore IDs = 12 and 21 cm; max gradient amplitudes = 58 and 
28 G/cm; and rise times = 295 and 650 µs. Slice-selective gradient-echo images were acquired 
without lumenal flow, while spin-echo images were acquired with lumenal flow; flow rate = 0.65 
mL/min for single-fiber phantoms and 50 mL/min for multi-fiber phantoms. The experimental 
imaging parameters were: repetition time (TR) = 500 ms, echo time (TE) = 10/13.5 ms (gradient-
echo/spin-echo), TH of slice = 1.00 mm, and number of transients (NT) = 32. Although the in-
plane FOV varied from 6.4 x 0.8 mm2 (Figs. 4 and 5, panel A) to 6.4 x 6.4 mm2 (Figs. 4 and 5, 
panel D), in-plane voxel dimensions were fixed for all images at 25 x 25 µm2. 
 
3.6.3. Contrast-Agent Enhancement 
 To mimic a DCE-MRI experiment, a low molecular weight Gd-based contrast agent was 
“injected” into the lumenal compartment of the multi-fiber phantom (ID = 2.6 mm; 75 fibers). This 
“injection” was achieved by means of a 4-way valve located near the phantom that rapidly 
switched the flowing lumenal solution between pure water and an aqueous solution containing 0.2 
mM Gd-BOPTA (gadobenate dimeglumine; MultiHance; Bracco Diagnostics Inc.; Princeton, NJ, 
USA). The switching apparatus, shown in Figs. 6 and 7, consists of the valve, located 
immediately adjacent to the phantom, and the actuating handle, located outside the bore of the 
magnet. A “dummy” phantom was added to the setup, as shown in Fig. 7, so that the pressure in 
both lines was equivalent. Slice-selective, spin-echo spectroscopy was used to monitor signal 
intensity vs. time as the flowing media was cycled from water (60 sec) to 0.2 mM Gd-BOPTA (60 
sec) and back to water (60 sec). The acquisition parameters were: TR = 50 ms, TE = 10 ms, TH 
= 1.00 mm, and NT = 4. The flow rate was 55 mL/min. 
The longitudinal relaxivity of Gd-BOPTA (r1, mM-1 s-1) was determined for the multi-fiber 
phantom. Media Gd-BOPTA concentrations of 0, 0.25, 0.50, 0.75, and 1 mM were allowed to 
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completely equilibrate throughout all compartments of the phantom prior to relaxation 
measurements. At each equilibrated Gd-BOPTA concentration, the longitudinal relaxation rate 
constant (R1; s-1) was determined via inversion-recovery, spin-echo MR spectroscopy 
experiments without and with lumenal flow (10 mL/min). The experimental parameters were: TE = 
10.0 ms, TH = 1.00 mm, NT = 4, number of steady-state scans (SS) = 5, and spectral width (SW) 
= 4006 Hz. For each experiment, the relaxation pre-delay (PD) was set to at least five times the 
inverse of R1, (5 x T1 (s)). Table 1 lists these PD values and the inversion times (TI) used. 
Inversion-recovery time-course experiments were repeated three times at each Gd-BOPTA 
concentration and the R1 values estimated with Bayesian analysis methods developed in our lab 
(software available for free download; see Bayesian Analysis of Common NMR Problems; 
http://bayesiananalysis.wustl.edu/index.html)19. 
The mock-DCE experiment was repeated with the following additional contrast agents: 
0.2 mM GdCl3 (gadolinium (III) chloride hexahydrate; P/N G7532; Sigma-Aldrich, St. Louis, MO, 
USA), 0.2 mM Gd-DTPA-BMA (gadodiamide; Omniscan; GE Healthcare, Piscataway, NJ, USA), 
and 0.02 mM Gd-DTPA-BSA20. Signal intensities were converted to concentrations via the signal 
equation, measured relaxivities, and the T1 of bulk water in the presence of flow21,22. The uptake 
curves were quantitatively compared by calculating the initial slope from the first 20 data points 
immediately following contrast agent “injection”. 
 
3.7. Results 
 Figure 4 shows representative gradient-echo transaxial images from two single-fiber 
phantoms (panels A and B) and two multi-fiber phantoms (panels C and D). Due to differences in 
proton density, the fiber walls appear hypointense in these images. R1-mapping has established 
that, in the absence of lumenal flow, there is no significant difference in longitudinal rate constant 
in the fiber wall compared to homogeneous solution23. Figure 5 shows representative spin-echo 
transaxial images from the same phantoms as in Fig. 4. Flow has suppressed signal in the 
lumenal compartment in these images via time-of-flight effects. The fibers in this figure appear 
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hyperintense; the region of hyperintensity extends into the extra-fiber space. This interesting 
effect is due to diffusion-driven longitudinal relaxation (vida infra)23. 
 No fluid leakage was observed from any of the phantoms and no diminution of signal was 
seen in compartments assumed to be non-flowing (i.e., the extra-lumen space). Following a 
period of several days of being continuously filled with water, the fiber within the single-fiber 
phantom, which had originally been taught, appeared flaccid. This change in physical appearance 
was accompanied by a decrease in proton-density contrast between the fiber wall and the extra-
fiber space (data not shown). As a consequence, we routinely use a new phantom for each set of 
experiments. Nonetheless, this effect did not impact any of our individual experiments, the 
longest of which lasted 15 hours23. 
 The results of a mock DCE-MRI experiment with Gd-BOPTA are shown in Fig. 8. Short-
lived transients in the highly time-resolved (TR = 50 ms) signal profile accompany each 
“switching” of the flowing media (with/without contrast agent). These transients provide a 
convenient time stamp and can be seen in Fig. 8 at the 1- and 2-minute marks of the signal 
profile. 
 The expected linear relationship between concentration of contrast agent and R1 of the 
equilibrated extra-fiber space was verified, both in the absence and presence of lumenal flow 
(Fig. 9). However, while the slopes of this relationship, r1, are equivalent in the absence and 
presence of flow, the intercepts (R1,0 = R1 at 0 mM contrast agent) are different. This is because, 
in a slice-selective protocol, the flowing media brings fully polarized water 1H magnetization into 
the slice, which, during the TI period of the relaxation experiment, exchanges by diffusion with 
magnetization-perturbed water in the extra-fiber space. (Recall, lumenal water is not observed 
directly due to time-of-flight effects.) As noted, this diffusion-driven relaxation effect, a 
phenomenon described in more detail elsewhere, can also be seen in Fig. 5 as an increase in 
signal amplitude within the fiber wall and in the extra-fiber space near the fiber wall23. 
 Concentration vs. time curves from the mock-DCE experiment are shown in figure 10. 
Clearly, extravasation of contrast agent from the lumenal compartment to the extra-lumenal 
compartment is a function of the size of the contrast agent, with GdCl3 leaking the most rapidly 
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and Gd-DTPA-BSA not diffusing through the fiber wall at all. The rate of contrast agent 
extravasation is compared quantitatively in table 2 via the initial slope of the concentration uptake 
curve. These simple examples demonstrate the utility of the perfusion-sensitive MR phantom in 
revealing phenomena, perhaps unanticipated, that can impact various MR protocols and 
accompanying kinetic models. 
 
3.8. Conclusions 
 Design and construction details for two semi-permeable hollow-fiber phantoms, useful for 
testing and validation of perfusion-sensitive MR protocols and signal models, are described. The 
phantoms, single- and multi-fiber, are robust and allow control over the fractional volumes of the 
lumenal and extra-fiber compartments. The phantoms’ small sizes allow high spatial resolution to 
be achieved with small, high sensitivity volume coils on preclinical MR imaging scanners, 
resolving individual compartments: fiber lumen, fiber wall, extra-fiber space. The small size also 
facilitates purging of air bubbles within the phantom, as the entire phantom can easily be 
submerged under vacuum. Complete suppression of lumenal signal can be achieved, if desired, 
with slice-selective, spin-echo protocols via time-of-flight. Mock-DCE experiments clearly 
demonstrate extravasation of low molecular-weight contrast agents from lumenal to extra-fiber 
compartments. While the expected linear relationship between concentration of contrast agent 
and longitudinal relaxation rate constant is demonstrated, modification of this linear relationship 
by flow-enabled, diffusion-driven relaxation is revealed. These phantoms will contribute to efforts, 
ongoing in many laboratories, to develop, test, and validate, quantitative perfusion-sensitive MRI 
methods and associated signal models. 
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3.10. Figures and captions 
 
Figure 3-1. Single-fiber phantom. Left inset: schematic of the interior of the Luer-lock end piece. 
Center inset: schematic interior of the center portion of the phantom; sagittal view. Right inset: 





Figure 3-2. Multi-fiber phantom; lumenal compartment access only. Panel A: schematic of the 
design and dimensions of the multi-fiber phantom. Panel B: photograph of the multi-fiber phantom 
(scale bar = 2.50 cm). Panel C: microscope image of a transaxial cross-section of a single fiber 
(40X magnification, scale bar = 100 µm). Panel D: microscope image of a transaxial cross-section 
of the end of the phantom, i.e., fibers fixed in epoxy (4X magnification, scale bar = 1 mm). Panel 
E: microscope image of a transaxial cross-section of the center portion of the phantom; fibers 
tightly bundled (4X, scale bar = 1 mm). Note: the slight deformity seen in some fibers in panel E 





Figure 3-3. Multi-fiber phantom with lumenal and extra-fiber compartment access. Inset: 
schematic of the interior of the “Build-A-Part” Luer-lock connector. 
 
 
Figure 3-4. Gradient-echo images of various semi-permeable hollow-fiber phantoms, without 
lumenal flow. Panel A: single-fiber phantom; ID = 0.5 mm. Panel B: single-fiber phantom; ID = 1.0 
mm. Panel C: multi-fiber phantom; 75 fibers; ID = 2.6 mm. Panel D: multi-fiber phantom; 50 





Figure 3-5. Spin-echo images of various semi-permeable hollow-fiber phantoms with lumenal 
flow. Panel A: single-fiber phantom; ID = 0.5 mm. Panel B: single-fiber phantom; ID = 1.0 mm. 






Figure 3-6. Four-way valve used in the switching apparatus. Panel A: polyoxymethylene (Delrin) 
valve-chamber casing. The eight threaded holes are for attaching the valve lid to the valve casing 
(top four) and for securing the valve to the switching apparatus (bottom four). Panel B: 
polyoxymethylene valve plug. Panel C: polyoxymethylene valve chamber lid. Note that one of the 
four small through-holes has no counterbore. The screw at this position, which can be seen in 
Fig. 7, is used as a guide for switch actuation. Panel D: Assembly of the valve. Assembly was 
aided by applying a thin layer of high vacuum grease (Dow Corning Corporation; Midland, MI, 





Figure 3-7. Switching apparatus used to rapidly switch the lumenal media between water and 
contrast agent in the mock-DCE experiment (Fig. 8). Panel A: The apparatus in position one, with 
water flowing to the phantom. Panel B: The apparatus in position two, with 1 mM contrast agent 





Figure 3-8. Mock-DCE experiment, as measured in the multi-fiber phantom. Signal intensity was 
monitored as a function of time, while lumenal media was cycled from water (duration ~60 s) to 
0.2 mM Gd-BOPTA (duration ~60) and back to water (duration ~60 s). Short-lived transients, 





Figure 3-9. . Longitudinal relaxation rate (R1; s-1) measured in the multi-fiber phantom, as a 
function of Gd-BOPTA concentration, with (squares) and without (circles) lumenal flow. Linear 
regression fits, used to derive relaxivity values (r1, s-1 mM-1), are shown. 
 
 
Figure 3-10. Mock-DCE experimental results for GdCl3 (squares), Gd-DTPA-BMA (circles), Gd-
BOPTA (up-pointing triangles), and Gd-DTPA-BSA (down-pointing triangles). The concentration 
of contrast agent in the extra-lumenal compartment (mM) was derived from dynamic signal 
intensity in the presence of lumenal flow (see Materials and Methods). Panel B is an expanded 
view of panel A that highlights the initial contrast agent uptake, or, in the case of Gd-DTPA-BSA, 





Table 1. Additional experimental parameters, not noted in the text, corresponding to Fig. 6. 
Concentration of Gd-
BOPTA 
Pre-delay (PD) First inversion time 
(TIfirst)a 
Last inversion time 
(TIlast)a 
0.00 mM 11.50 s 0.23 s 11.50 s 
0.25 mM 3.00 s 0.05 s 3.00 s 
0.50 mM 1.75 s 0.03 s 1.75 s 
0.75 mM 1.25 s 0.02 s 1.25 s 
1.00 mM 1.00 s 0.02 s 1.00 s 
aThirty TI values were used spaced logarithmically from TIfirst to TIlast 
 
Table 2. Initial slopes calculated from the various contrast-agent uptake curves shown in Fig. 10. 
Contrast agent GdCl3 Gd-DTPA-BMA Gd-BOPTA Gd-DTPA-BSA 
Molecular weight 157 Daa 574 Da 668 Daa ~68 kDa 
Initial slope 0.024 mM/s 0.013 mM/s 0.015 mM/s 0.000 mM/s 




CHAPTER 4. SINGLE-FIBER PHANTOM 
 
4.1. Abstract 
Diffusion of spins between physical or virtual, communicating compartments having 
different states of longitudinal magnetization leads to diffusion-driven longitudinal relaxation. 
Herein, in two model systems, the effects of diffusion-driven longitudinal relaxation are explored 
experimentally and analyzed quantitatively. In the first case, longitudinal relaxation in a single 
slice of a water phantom is monitored spectroscopically as a function of slice thickness. In the 
second case, mimicking vascular flow/diffusion effects, longitudinal relaxation is monitored in a 
two-compartment, semi-permeable fiber phantom. In both cases, apparent longitudinal relaxation, 
though clearly multi-exponential, is well-modeled as bi-exponential. 
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4.3. Introduction 
 The remarkable performance capabilities of modern MR scanners are redefining the 
limits of spatial resolution, signal sensitivity, and data interpretation. Data are often of such high 
quality that subtle signal characteristics, ones that could previously be safely ignored, must now 
be recognized in accurate signal-modeling and parameter estimation. This is especially true when 
testing signal models against “ideal” data obtained from phantoms and phantom-like systems. 
This laboratory has, for some time, been interested in signal models that describe 
systems characterized by coherent and incoherent displacement motions, e.g., flow, perfusion, 
and diffusion. Despite the multi-compartment complexity of most tissues, data modeling is 
typically performed using relatively simple mathematical representations of the signal. The utility 
of the resulting parametric maps depends upon the validity of the underlying simplifying 
assumptions, which can be difficult to assess. Recently, while pursuing control experiments with 
phantoms, we encountered diffusion-driven relaxation, a phenomenon that could, if unrecognized, 
compromise data interpretation. 
Diffusion of spins between physical or virtual, communicating compartments having 
different states of longitudinal magnetization leads to diffusion-driven longitudinal relaxation [1-5]. 
The population of spins in one physical or virtual compartment will demonstrate altered 
longitudinal relaxation when exchanging, via diffusion, with a population of spins of different 
magnetization state from a communicating second compartment. 
Herein, deviations from mono-exponential longitudinal relaxation due to diffusion-driven 
relaxation are examined in two limiting cases. In the first case, a sample consisting of a single 
physical compartment is divided, by slice selection, into two virtual compartments. Experiments 
are performed in which signal is only detected from one compartment - the selected slice. In the 
second case, a two-compartment, semi-permeable fiber phantom is constructed. Experiments are 
performed in which, due to time-of-flight flow effects, signal is only detected from one of the two 
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compartments - the extra-lumenal compartment. The effects of diffusion between virtual and 
physical communicating compartments are observed and modeled, and the implications of 
diffusion-driven relaxation are discussed. 
 
4.4. Materials and methods 
 
4.4.1. Longitudinal Relaxation Rate Constant Determination 
 All longitudinal relaxation rate constants were measured with a modified fast inversion 
recovery (MFIR) pulse sequence [6]. MFIR is a variation on the standard inversion recovery 
experiment, in which images are collected at different inversion times (TI), where the repetition 
time (TR) is fixed at a value that is shorter than required for full recovery of longitudinal 
magnetization. This method realizes a portion of the time savings of fast inversion recovery (FIR), 
for which both TI and TR are varied in concert in order to fix the pre-delay, but, unlike FIR, can be 
modeled even in the presence of imperfect flip angles by the following three parameter equation, 
S(TI) = A + B exp(-R1·TI),           [1] 
where S(TI) is the signal intensity for inversion time TI and R1 is the longitudinal relaxation rate 
constant, the inverse of the time constant, T1 [7,8]. 
 
4.4.2. Slice Thickness Experiments 
Apparent longitudinal relaxation was monitored in a water-filled, 1.0-mm ID capillary tube 
via a slice-selective (transverse to the tube’s long axis), spin-echo, MFIR spectroscopy 
experiment. To observe the effect of diffusion on the measurement, experiments were performed 
with four different slice thicknesses (TH): 1.00, 0.500, 0.250 and 0.125 mm. Crafted 90° and 180° 
pulses, similar in shape to SLR pulses, were used to minimize imperfections in slice profile [9,10]. 
To this same end, symmetric left and right crusher (“butterfly”) gradients were implemented with 
both the inversion and refocusing 180° pulses. 
For all slice thicknesses, the acquisition parameters were: TR = 20.0 s, TE = 10.67 ms, 
and spectral width (SW) = 4006 Hz. To compare data at similar signal-to-noise ratio (SNR), the 
 81 
 
number of transients (NT) was varied: NT = 1 (TH =1.00 mm), 4 (TH = 0.500 mm), 16 (TH = 
0.250 mm), and 64 (TH = 0.125 mm). In addition, a single relaxation data set was acquired at 
higher SNR with TH = 10.0 mm and NT = 4, a slice thickness greater than the active region of the 
coil. Thirty logarithmically spaced TI values ranging from 0.01 – 15 s were employed throughout. 
Signal amplitudes were calculated from the total integrated intensity of the water 1H 
resonance via in-house programs developed using Matlab (Mathworks; Natick, MA, USA). 
Relaxation data were modeled as exponential functions by Bayesian analysis methods developed 
in our lab (Bayesian Analysis of Common NMR Problems; 
http://bayesiananalysis.wustl.edu/index.html) [11,12]. 
 
4.4.3. Non-permeable and Semi-permeable Fiber Phantom Design 
A non-permeable hollow fiber (polyurethane catheter; ID = 300 µm, OD = 400 µm) or 
semi-permeable hollow fiber (polysulfone dialyzer; ID = 200 µm, OD = 280 µm) was suspended 
through the middle of a capillary tube (ID = 1.0 mm) and held in place with epoxy applied at the 
ends of the capillary tube. (Note: in this paper, semi-permeable denotes a material allowing free 
diffusion of water and allowing, but potentially slowing, diffusion of aqueous Gd-based contrast 
agents; and non-permeable denotes a material completely blocking diffusion of both water and 
aqueous Gd-based contrast agents.) The phantom consisted of two physical compartments, the 
lumen, i.e., the interior of the fiber, and the extra-lumenal space. The phantom design allowed 
controlled flow of media in the fiber lumen. The semi-permeable hollow fiber, similar to those 
used in hollow-fiber bioreactors, was harvested from a commercial dialyzer (Optiflux F-160NR; 
Fresenius Medical Care AG & Co., Bad Homburg, Germany). As the extra-lumenal space was 
closed and water is an incompressible fluid, there were no pressure gradients across the 
transverse axis of the phantom (i.e., between lumenal and extra-lumenal compartments).  
Lumenal flow was achieved via a peristaltic pump. Flow rates were periodically measured 
just downstream of the phantom to assure constant flow velocities throughout the experiment. 
 
4.4.4. Non-Permeable and Semi-permeable Fiber Phantom Experiments 
 82 
 
For both the semi-permeable and non-permeable fiber phantoms, T1 maps were obtained 
with and without aqueous flow at 0 and 1 mM concentrations of Omniscan (gadodiamide; Gd-
DTPA-BMA; GE Healthcare, Piscataway, USA). A flow rate of 0.4 mL/min was maintained during 
experiments requiring flow. If plug flow is assumed, this flow rate corresponded to a lumenal 
velocity of 0.2 mm/ms, translating to clearance of lumenal spins within TE/2 when TE = 10 ms 
and TH = 1 mm. Experiments with aqueous gadodiamide solution allowed sufficient equilibration 
time to ensure homogeneous distribution of gadodiamide (1 mM) throughout the extra-lumenal 
space. 
Four single-slice images (transverse to the fiber’s long axis) were acquired to monitor 
longitudinal relaxation, with TI values 0.002, 0.080, 2.500, and 8.000 s for 0 mM gadodiamide 
experiments and 0.002, 0.025, 0.080, 0.250 s for 1 mM gadodiamide experiments. To ensure 
images at each TI had approximately the same SNR, variable numbers of transients (NT) were 
averaged for each image, corresponding, respectively, to the different TI values: NT = 8, 16, 32, 
and 8. To assure that no steady-state transverse magnetization was present during the MFIR 
experiment, the shortest value of ∆ = TR-TI was set equal to three times the transverse relaxation 
time constant (T2) of the bulk (non-flowing) solution: TR = 13.5 s for 0 mM gadodiamide 
experiments and 0.8 s for 1 mM gadodiamide experiments [8]. (Note: T2 was measured 
independently for 0 mM and 1 mM gadodiamide solutions via spectroscopic methods with a 
standard CPMG sequence.) All images were acquired with the following parameters: TH = 1 mm; 
TE = 10 ms; in-plane field of view, 5.12 x 1.28 mm2; in-plane voxel dimensions, 20 x 20 µm2. 
Modeling of the data was carried out using signal intensities from phased (absorption 
mode) images [13,14]. Parameters A, B, and R1 (Eq. [1]) were estimated from the phased images 
by non-linear least-squares analysis in Matlab. The image acquired at the longest TI was used for 
thresholding prior to modeling the relaxation data. R1 values were only estimated for those voxels 
in which the signal intensity was greater than five times the standard deviation of the noise. 
To identify regions corresponding to the fiber wall, proton-density weighted, gradient-
echo images of the semi-permeable fiber phantom were acquired without flow (TR = 500 ms; TE 
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= 9.7 ms; NT = 256; and flip angle, α = 20°). These images were collected with the same field of 
view, slice thickness, and in-plane voxel dimensions as the images acquired for R1 analysis. 
A region of interest (ROI) consisting of voxels with different R1 values would be expected 
to exhibit non-mono-exponential relaxation behavior. To examine this phenomenon, an ROI 
covering one sixteenth of the entire image (0.64 x 0.64 mm2) was selected with the fiber at its 
center; lumenal voxels were discarded (976 voxels selected after thresholding). For each extra-
lumenal voxel within the ROI, mono-exponential relaxation recovery curves (Eq. [1]) were derived 
based on the measured voxel intensities at the four TI values. These simulated relaxation 
recovery data sets, one for each voxel within the ROI, were averaged to derive a single relaxation 
recovery data set for the ROI as a whole, sampled at  ten logarithmically-spaced TI values 
ranging from 0.017 to 15 s. Bayesian analysis was then applied to this derived, single ROI 




4.5.1. Slice Thickness Experiments 
 As shown in Fig. 1, the MFIR relaxation time course observed for a 1-mm thick slice was 
well-modeled as mono-exponential, yielding an estimated T1 essentially equal to that estimated 
for the bulk sample, 2.8 s vs. 2.7 s, respectively. However, deviation from mono-exponential 
relaxation became increasingly apparent as slice thickness decreased. This can be illustrated 
using standard deviations of the residuals from these fits as a goodness-of-fit metric (Table 1). 
Further, Bayesian analysis was used to determine the probabilities of mono-, bi-, and tri-
exponential models for each data set. A mono-exponential model was the most probable for data 
obtained at slice thicknesses of 1.00 and 0.500 mm, and a bi-exponential model was most 
probable for data obtained at slice thicknesses of 0.250 and 0.125 mm (Table 1). This bi-
exponentiality is clearly illustrated in Fig. 2 (TH = 0.125 mm). Apparent longitudinal relaxation 
time constants, computed from mono-exponential and bi-exponential fits to the MFIR data 
obtained from slices with different thicknesses, are shown in Table 2. 
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 Within a thin slice, the observed relaxation time course was non-mono-exponential. While 
such time-course data are well-modeled as bi-exponential (Fig. 2, Tables 1 and 2), neither of the 
bi-exponential decay time constants corresponds to the “true” longitudinal relaxation time 
constant. For example, bi-exponential modeling of MFIR data from a 0.125-mm thick slice yielded 
time-constant estimates of 2.2 ± 0.2 s and 0.17 ± 0.02 s with component fractional amplitudes of 
0.68 and 0.32, respectively. Both time-constant estimates are substantially different from the bulk 
sample T1, 2.7 s. 
 
4.5.2. Fiber Phantom Experiments 
Non-permeable Fiber: 
 For the non-permeable fiber phantom, water 1H T1 maps of the region surrounding the 
fiber (extra-fiber space) in the presence or absence of lumenal gadodiamide solution (0 and 1 
mM) were homogeneous, with a mean relaxation time constant that agreed with spectroscopic 
(non-imaging) measurements (~3 s and ~0.2 s, respectively). In the presence of lumenal flow, the 
lumenal water spin-echo signal intensity decreased to the noise level, independent of lumenal 
gadodiamide concentration (0 and 1 mM). 
Semi-permeable Fiber / Absence of Flow: 
 For the semi-permeable fiber phantom in the absence of flow, water 1H T1 maps of the 
region surrounding the fiber lumen (extra-lumenal space, which includes the fiber wall and the 
extra-fiber region) in the absence or presence of gadodiamide solution (0 and 1 mM) were 
homogeneous. As expected, T1 was markedly shortened in the presence of 1-mM gadodiamide 
solution (~0.2 s). Proton-density weighted images and the individual images acquired for T1-
mapping clearly defined the region of the fiber wall (e.g., Fig. 3, panel C). 
Semi-permeable Fiber / Presence of Flow / Absence of Gadodiamide: 
For the semi-permeable fiber phantom in the presence of flow but without gadodiamide, 
apparent T1 values varied as a function of voxel distance from the lumen boundary. Figure 3 
shows a T1 map, as well as a gradient-echo image identifying fiber-wall position. Compared to T1 
measured in the absence of flow, the presence of lumenal flow results in shorter T1 values in 
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voxels near the fiber, an effect most pronounced within the fiber wall. Moving radially away from 
the fiber wall, voxel T1 values lengthen, returning to 95% of that observed in the absence of flow 
at a distance of 120 µm from the outer edge of the fiber wall. The lengthening of T1 showed a 
mono-exponential dependence on radial distance from the fiber wall. The distance-rate constant 
governing this spatial change in T1 (modeled from the combined data shown in Fig. 3, Panel B; 
solid line) was 0.018 ± 0.003 µm-1 (or equivalently, 0.36 ± 0.05 voxel-1). 
As described in the Methods Section, an ROI covering one sixteenth of the entire image 
(0.64 x 0.64 mm2; 976 voxels after thresholding to remove lumenal voxels) was selected, with the 
fiber at its center, and the relaxation time course for this entire ROI was derived from knowledge 
of the individual voxel T1 values, Fig. 4. The derived ROI relaxation time-course data were 
preferentially modeled as bi-exponential. Bayesian model selection probabilities (P), expressed 
as natural log P, were -7.78, -0.232, -1.63, and -4.95 for mono-, bi-, tri- and quad-exponential 
models, corresponding to probabilities of ~ 0, 79, 20, and 1% respectively. 
Semi-permeable Fiber / Presence of Flow and Gadodiamide: 
 For the semi-permeable fiber phantom in the presence of lumenal flow and gadodiamide 
(1 mM), variation in voxel T1 with distance from the fiber was not observed, i.e., T1 was 
homogeneous throughout. However, as for the no-flow case, voxel T1 values were shortened 
markedly (~0.2 s) compared with the situation in which gadodiamide was absent (~3 s). 
 
4.6. Discussion 
 Perfusion-sensitive MR methods, such as arterial spin labeling (ASL) and dynamic 
contrast enhanced (DCE) MRI, are valuable techniques for the detection and staging of illness 
and disease. However, these techniques only reach their full potential when derived parameter 
estimates are quantitative (i.e., accurate and precise). When using a signal model employing a 
single R1 value (i.e., mono-exponential longitudinal relaxation), both ASL and DCE-MRI implicitly 
assume the presence of well-mixed compartments. Errors in parameter estimates occur with 
deviations from mono-exponential relaxation. As described previously by others, such deviations 
are observed for systems in which the detected signal arises from multiple, internally well-mixed 
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compartments that are not in fast exchange [15-17]. The examples presented in this paper 
demonstrate that deviations from mono-exponential longitudinal relaxation can also be detected 
when the signal arises from a poorly mixed single compartment, due to diffusion of spins from a 
communicating second compartment (physical or virtual). 
 The slice-thickness experiment separated a homogeneous phantom (single physical 
compartment) into two virtual compartments, consisting of spins either initially inside or outside 
the selected inversion slice. Deviations from mono-exponential longitudinal relaxation were most 
dramatic when TH = 0.125 mm (Fig. 2). These deviations were not due to errors in slice profile, 
which were themselves minimized by crusher gradients and shaped RF pulses, as residual errors 
in slice profile would not result in non-mono-exponential relaxation with MFIR [7]. Rather, non-
mono-exponential longitudinal relaxation occurred due to diffusion of thermal-equilibrium-state 
(non-inverted) spins from the second, virtual compartment into the selected slice and, 
correspondingly, diffusion of non-thermal-equilibrium-state (inverted) spins out of the slice. 
Decreasing the slice thickness decreased the number of spins initially in the slice, increasing the 
population of detected spins originating from outside the slice relative to the population of 
detected spins originating and remaining inside the slice. With decreasing slice thickness, 
Bayesian model selection analysis increasingly favors (more probable model) a bi-exponential 
characterization of the relaxation data, Table 1. Indeed, for the 0.250 and 0.125 mm thick slices, 
Bayesian model selection overwhelmingly favors the bi-exponential relaxation model compared to 
mono- or tri-exponential models. Likewise, consistent with the Bayesian model selection, 
qualitative examination of the residuals, presented in Table 1, illustrates that there is no 
improvement in bi-exponential vs. mono-exponential fitting of the thick-slice relaxation data, but 
marked improvement for the thin-slice relaxation data. 
 This example of diffusion-driven longitudinal relaxation is expected to result in a broad 
distribution of relaxation rates, with spin populations at the very edge of the slice having the 
greatest diffusion-driven-contribution to relaxation and those spin populations in the middle of the 
slice having the least diffusion-driven-contribution to relaxation. Although a broad distribution of 
relaxation rates is expected, the single-slice-relaxation spectroscopy data (sum of all spin 
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populations) are remarkably well-modeled as “simply” bi-exponential, even for the thinnest slice 
examined (TH = 0.125 mm). It is worth noting that for the thinnest slice, TH = 0.125, neither 
exponential time constant, 2.2 ± 0.2 s nor 0.17 ± 0.02 s, corresponds to the true spin-lattice 
relaxation time constant, 2.7 s. Furthermore, the measured fractional amplitudes and component 
time constants depend upon slice thickness. As slice thickness increases and diffusion-driven 
relaxation becomes less significant, the fractional amplitude of the rapidly relaxing component 
decreases toward zero, the time constant for the slowly relaxing component approaches that of 
the true spin-lattice relaxation time constant, and relaxation appears mono-exponential (Table 2). 
While the manner in which a bi-exponential function can well-approximate signals that 
are, a priori, more complex, is a recurring theme in MR data analysis, diffusion-driven bi-
exponential relaxation is not limited to experiments utilizing thin slices, as is demonstrated herein 
with thick slices and the semi-permeable fiber phantom. 
 Control experiments with the non-permeable fiber phantom in the presence and absence 
of flow and the semi-permeable fiber phantom in the absence of flow were well-characterized by 
spatially homogeneous, mono-exponential relaxation maps of the extra-fiber space (more 
precisely, in the case of the semi-permeable fiber phantom, extra-lumenal space). Further, 
imaging-derived voxel T1 values agreed with T1 values obtained by spectroscopic methods. 
Likewise, the semi-permeable fiber phantom in the presence of flow and 1 mM gadodiamide was 
well-characterized by a spatially homogeneous, mono-exponential, relaxation map of the extra-
lumenal space with voxel T1 values markedly shortened (~0.2 s) from values obtained in the 
absence of gadodiamide (~3 s). Thus, (i) in the absence of flow or (ii) in the presence of flow but 
the absence of diffusion-driven magnetization exchange or (iii) when de novo relaxation is 
sufficiently rapid relative to exchange between compartments (vide infra), irrespective of the 
presence of flow or diffusion-driven magnetization exchange, extra-fiber relaxation is spatially 
uniform and mono-exponential in nature. 
 The situation is quite different for the case of the semi-permeable fiber phantom in the 
presence of flow, but the absence of gadodiamide. Here, spatially-inhomogeneous relaxation is 
observed for the extra-lumenal space, with T1 values dependent on the distance from the lumenal 
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boundary (see Fig. 3 panel B, modeled curve). Recall that no signal is observed for spins 
remaining within the lumen because of time-of-flight, spin-echo signal suppression. Variations in 
T1 are, therefore, due to diffusion of thermal-equilibrium-state spin populations from the lumenal 
compartment to the extra-lumenal compartment and concomitant diffusion of partially saturated 
spin populations from the extra-lumenal compartment to the lumenal compartment. T1 shortening 
is most pronounced in the fiber wall and dies away with increasing radial distance from the lumen 
boundary. This effect is independent of slice thickness. 
 The summed signal from an ROI with the fiber at its center (see Materials and Methods) 
will include voxels having different T1 values and, thus, will be characterized, a priori, by multi-
exponential relaxation behavior. Nevertheless, the derived ROI data are seen to be fit 
preferentially to a bi-exponential model. It is worth noting that neither resulting exponential time 
constant, 2.5 s nor 0.82 s, corresponds to the true spin-lattice relaxation time constant, 2.7 s. 
Likewise, the fractional amplitudes and component time constants will vary with the size and 
position of the ROI relative to the fiber location. 
 Returning briefly to the case of the semi-permeable fiber in the presence of flow and 
gadodiamide, recall that, for parallel kinetic processes, rate constants (not time constants) are 
additive. The presence of 1 mM gadodiamide dominates water relaxation to the extent that the 
additional relaxation pathway provided by diffusion-driven exchange makes only a minor, 
essentially undetectable, contribution. For example, consider the innermost voxels associate with 
the fiber wall, where diffusion-driven relaxation contribution is maximal (Fig. 3.). In the absence of 
gadodiamide but in the presence of flow, the longitudinal relaxation rate constant increased from 
0.38 s-1 to 1.88 s-1, an additive diffusion-driven contribution of 1.50 s-1. In the presence of 1 mM 
gadodiamide and flow, this additive diffusion-driven relaxation contribution is predicted to 
increase the rate constant from 4.3 s-1 to 5.8 s-1, a decrease to the time constant of 0.06 s. 
However, for the semi-permeable fiber in the absence of flow but in the presence of gadodiamide, 
the average T1 in the extra-lumenal space was 0.23 ± 0.06 s. Thus, in the presence of 1 mM 
gadodiamide, the expected maximal relaxation contribution from diffusion in the presence of flow 





As scanner technology advances, MR experiments performed with phantoms allow for 
the testing and modeling of biophysical phenomena with unprecedented accuracy and precision. 
The two “simple” phantoms and associated experiments described herein are part of such an 
effort, relating to dynamic contrast enhancement and flow/perfusion measurement protocols. 
However, even such simple phantoms and relatively uncomplicated MR protocols yield multi-
exponential relaxation data. Further, the data -- while a priori clearly multi-exponential -- are well 
approximated as bi-exponential, a consistent theme with MR relaxation data of realistic SNR. 
These experiments specifically highlight the effects of diffusion-driven exchange on 
careful relaxation measurements and serve as another cautionary reminder about the risks of 
over-interpretation of bi-exponential data [18,19]. When bi-exponential signals are observed in 
MR, it is tempting to ascribe physical/physiologic significance -- such as unique compartments -- 
to the component fractional amplitudes and decay-rate constants. As demonstrated in both the 
thin-slice and single-fiber experiments, this need not be the case. 
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4.10. Figures and captions 
 
Figure 4-1. Slice selection experiment: thick slice (TH = 1.00 mm). A: Signal intensity vs. 
inversion time (TI); squares are experimental data values and the solid line corresponds to a 
mono-exponential model: SI(TI) = 1.012 - 1.744·e-TI/2.76. B: Residuals from panel A vs. inversion 





Figure 4-2. Slice selection experiment: thin slice (TH = 0.125 mm). A: Signal intensity vs. 
inversion time; squares are data values, the solid line corresponds to a mono-exponential model: 
SI(TI) = 0.84 - 1.79·e-TI/1.2 and the dashed line corresponds to a bi-exponential model: SI(TI) = 
0.95 - 1.40·e-TI/2.2 - 0.65·e-TI/0.17. B: Residuals from panel A vs. inversion time; circles denote the 






Figure 4-3. Semi-permeable fiber (absence of gadodiamide). A: Longitudinal relaxation time-
constant (units expressed as s) map of the phantom with lumenal flow. B: Longitudinal relaxation 
time constant vs. voxel position from a single line of the image as indicated in panel A where the 
data selected are within the outlined narrow rectangle. A mono-exponential fit (solid line in panel 
B; left side, 2.54 - 2.1·e-0.018·x; right side, 2.64 - 2.3·e-0.018·x) and gray shading rectangles denoting 
the location of the fiber walls are also shown. C: Proton-density-weighted gradient echo image of 
the same phantom, without lumenal flow, included for visualization of the fiber wall. (Artifact at 
bottom of image is from susceptibility effect of an out-of-slice air bubble attached to wall of 
capillary tube.) D: Signal intensity vs. voxel position from a single line of the image shown in 
panel C where the selected data are within the outlined narrow rectangle. Gray shading 





Figure 4-4. Semi-permeable fiber (presence of flow, absence of gadodiamide) derived ROI data. 
A: derived ROI signal-intensity vs. inversion time; squares are derived data values, the solid line 
corresponds to a mono-exponential model: SI(TI) = 0.998 - 1.811·e-TI/2.34, and the dashed line 
corresponds to a bi-exponential model: SI(TI) = 1.0034 - 1.67·e-TI/2.487-0.15·e-TI/0.97. B: Residuals 
from panel A vs. inversion time; circles denote the mono-exponential model and triangles the bi-






Table 1. Goodness-of-fit, expressed as the residual standard deviation, assuming either mono-
exponential or bi-exponential fits to the data, for different slice thicknesses. A decrease in the 
residual standard deviation corresponds to a better fit. A decrease in the ratio of the values 
corresponds to the mono-exponential being preferred (more probable model).  
σresidual TH = 1.00 mm TH = 0.500 mm TH = 0.250 mm TH = 0.125 mm 
Mono-exp 0.0196 ± 0.0005 0.0169 ± 0.0004 0.047 ± 0.001 0.110 ± 0.003 
Bi-exp 0.0197 ± 0.0005 0.0156 ± 0.0006 0.029 ± 0.001 0.033 ± 0.001 
Ratioa 1.0 1.1 1.6 3.3 
Probabilitybib,c -3.8 x 10-3 -7.1 x 10-3 -8.5 -8.5 
Probabilitymonob,c -8.5 -8.5 -2.8 x 10-2 9.2 x 10-3
Probabilitytrib,c -8.5 -8.5 -3.7 -4.9 
aThe ratio of the standard deviation of the residual with a mono-exponential fit to the standard 
deviation of the residual with a bi-exponential fit. 
bProbabilities are those estimated by Bayesian analysis. 
cExpressed as log base e of the probability. 
 
Table 2. Apparent longitudinal relaxation time constants, assuming either mono-exponential or bi-
exponential fits to the data, for different slice thicknesses. These values are to be compared with 
the “true” T1 value of 2.708 ± 0.002 s. 
T1,app TH = 1.00 mm TH = 0.500 mm TH = 0.250 mm TH = 0.125 mm 
Mono-exp 2.76 ± 0.05 s 2.56 ± 0.04 s 2.00 ± 0.09 s 1.2 ± 0.1 s 
Bi-exp 3 ± 1 s 2.7 ± 0.5 s 2.9 ± 0.4 s 2.2 ± 0.1 s 





CHAPTER 5. MULTI-FIBER PHANTOM 
 
5.1. Abstract 
 DCE-MRI was carried out in a multi-fiber tissue phantom and the results compared to 
gold standard measurements to assess the precision of estimated parameters. Both experiments 
are described as well as control experiments that characterized the shape of the contrast agent 
input function. The DCE-estimated rate constant describing contrast agent extravasation was 
found to be marginally dependent upon flow rate. General agreement of estimated parameters, 
however, was found comparing DCE-MRI with gold standard measurements. 
 
5.2. Materials and methods 
 
5.2.1. Gold standard measurements 
 The permeability coefficient of the fiber with respect to the Gd-based contrast agent Gd-
BOPTA was measured in a single fiber. The experimental setup is shown schematically in figure 
5-1. Briefly, a single fiber was suspended in a vial such that 1) lumenal flow was permitted in the 
fiber, and 2) exchange of water and contrast agent molecules could occur between the fiber 
lumen compartment and the vial compartment via diffusion through the fiber wall. 
For the experiment, the vial was filled with a known volume of water. Then, 1 mM Gd-
BOPTA (gadobenate dimeglumine, MultiHance, Bracco Diagnostics Inc., Princeton, NJ, USA) 
was continuously introduced into the system via lumenal flow at a flow rate of 0.2 mL/min. To 
monitor contrast agent concentrations in the two compartments, 100 µL aliquots were sampled 
during the time course from both the exit port of the fiber (the effluent) and the internal 
compartment of the vial. The solution in the vial was continuously stirred with a magnetic spin bar 
throughout the experiment. 
To assure that exchange between the compartments only occurred due to diffusion, the 
system was sealed from the atmosphere. This fixes the pressure in both compartments at the 
same value. Aliquots from the vial were sampled through a septa with a syringe. Also, when the 
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aliquot was taken from the vial, the total volume of the vial was physically decreased by the 
volume of the aliquot (via partial insertion of a threaded screw; see figure 5-1). 
 Contrast agent concentrations in the sampled aliquots were determined by measuring the 
longitudinal rate constant R1 at a temperature of 4° C and at a field strength of 0.55 T with an 
Oxford Instruments MARAN Ultra NMR spectrometer (Oxford Instruments, Oxfordshire, UK). A 
calibration curve was prepared with the following contrast agent concentrations as standards: 0, 
0.2, 0.4, 0.6, 0.8, and 1 mM Gd-BOPTA as shown in figure 5-2 (see equation 2-7). Triplicate 
samples were prepared at each concentration. Inversion recovery experiments were used to 
measure R1. To balance signal-to-noise and scan time, the predelay (PD) on the spectrometer 
was always set to 1.4 times the reported T1 (where T1 = 1/R1). For each T1 measurement, 20 data 
points were acquired with inversion times spaced exponentially from 0.1·T1 to 5·T1. Additional 
acquisition parameters were as follows: dwell time = 10 µs, number of transients (NT) = 4, 
spectral width (SW) = 100 KHz, number of complex points (NP) = 1024 points, steady state scans 
(SS) = 4. A representative signal response from one of these inversion recovery experiments is 
shown in figure 5-3. 
 The concentration of contrast agent in the vial vs. time was plotted. These data were 
modeled as a mono-exponential assuming an asymptotic (t = ∞) value equal to the average 
lumenal contrast agent concentration along the length of the fiber within the vial. This walue was 
approximated as the mean of the measured value in the effluent and the known value of the stock 
lumenal solution (1 mM) feeding the fiber (entry value). The total surface area of the suspended 
fiber within the vial was calculated using fiber dimensions obtained from the manufacturer and 
measured vial dimensions. The fiber permeability coefficient of Gd-BOPTA was derived from the 
estimated mono-exponential rate constant according to equation 5-1 (see Appendix A): 
e
ep V
PSk  .          (5-1) 





5.2.2. DCE-MRI of the multi-fiber phantom 
 DCE-MRI was performed in accordance with the technique described in chapter 4. The 
contrast agent input function for the experiment was a step function from 0 to 0.1 mM Gd-BOPTA. 
Thus, the following equation was used for calculation of rate constant kep (see chapter 2): 
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.    (5-2) 
A slice selective spin-echo pulse sequence was used to collect 3,600 temporally resolved 
spectra during the experiment (at 4.7 T). All slice selective spectroscopy as well as all imaging 
experiments were performed with an Oxford Instruments (Oxford Instruments, Oxfordshire, UK) 
magnet with a 40 cm clear bore equipped with 21 cm gradient-coil (max gradient amplitude = 28 
G/cm and rise time = 650 µs). The scanner was operated with an Agilent/Varian DirectDriveTM 
console (Agilent Technologies, Santa Clara, CA, USA). 
The MRI acquisition parameters for the experiment were: repetition time (TR) = 50 ms, 
echo time (TE) = 10 ms, slice thickness (TH) = 1 mm, NT = 1, SS = 200, SW = 8.012 MHz, NP = 
128, and acquisition time (AT) = 15.97 ms. The effective NT was increased to 4 post acquisition 
by a simple averaging of signal intensities. The leading edge of the input function occurred 
roughly 1 minute after commencement of the experiment. The experiment was repeated three 
times at lumenal flow rates: 56 mL/min, 62 mL/min, and 68 mL/min with three different phantoms 
each (i.e., nine experiments in total). 
 Data were analyzed from these experiments as follows. Each spectrum was individually 
phased and the signal intensity estimated by taking the numerical integral. Temporally resolved 
signal intensities were converted to contrast agent concentrations employing equations 2-6 and 
2-7 (via a look-up table). As is illustrated in figure 5-4, the relaxivity used for this conversion was 
obtained from spectroscopic measurements of homogeneous standards, whereas, the R1,0 was 
determined in the presence of lumenal flow immediately prior to the DCE experiment and under 
matched experimental conditions to the DCE experiment (i.e., matched TE, TH, flow rate, etc.). 
All R1 measurements were achieved with an inversion recovery approach (see chapter 3). 
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The contrast agent concentration time course data were modeled with equation 5-2. 
Bayesian analysis methods developed in our lab were used for these parameter estimations 
(software available for free download; see Bayesian Analysis of Common NMR Problems; 
http://bayesiananalysis.wustl.edu/index.html) [2]. Permeability coefficients were then derived 
according to equation 5-1. Data acquired in the first few seconds after “injection” of contrast agent 
were often affected by deviations in the input function from its assumed shape (vide infra). 
Accordingly, the “outlier” functionality available in the Bayesian software was implemented. This 
option within the software looks for outliers from the mathematical model on a point by point 
basis. 
 
5.2.3. Input function validation 
 Equations 5-2 assumes a stepped contrast agent input function. Validation experiments 
were carried out to investigate this assumption for the DCE experiment. A high molecular weight 
contrast agent, Gd-DTPA-BSA (MW ≈ 68 kDa), was synthesized as described in the literature [3]. 
Four transaxial spin-echo images were acquired from a multi-fiber phantom without lumenal flow. 
The first two images were acquired sequentially; they were collected immediately after 30 
minutes of lumenal CA perfusion and 1 additional minute of water perfusion, respectively. The 
second two images were also acquired sequentially; they were collected immediately following 3 
days of lumenal CA perfusion and 1 additional minute of water perfusion, respectively. The 
relevant acquisition parameters for all images were: TR = 500 ms, TE = 13.5 ms, TH = 1 mm, NT 
= 16, in-plane field of view = 6.4 mm × 3.2 mm, and in-plane voxel dimensions = 25 µm × 25 µm. 
In addition, a single experiment, identical in form to the DCE experiment described above, was 




5.3.1. Gold standard measurements 
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The inner and outer diameter of each fiber was reported by Fresenius to be 200 µm and 
280 µm, respectively. The diameter of a representative multi-fiber phantom was 2.6 mm (see 
chapter 3). As the phantom contained 75 fibers, the extralumenal volume was 3.2×10-3 cm3 (for a 
1 mm slice) and the fractional volumes were 0.43:0.57 (lumenal:extralumenal compartments). 
The surface area of the 75 fibers, for a 1 mm slice, was 0.47 cm2. 
The volume in the experimental apparatus shown in figure 5-1 was 16.1 cm3 (a density of 
1 mg/mL was assumed for water). The length of the suspended fiber within the apparatus was 
measured to be 2.42 cm resulting in a surface area of 0.152 cm2. 
 Figure 5-5 shows the results of this experiment. The average measured contrast agent 
concentration of fiber effluent was 0.94 mM, thus, the asymptote was set to 0.97 mM. The rate 
constant for contrast agent extravasation was 0.00025 min-1. As expected, this value was well 
approximated by taking the slope of the first two measured points (truncated Taylor series 
expansion): 0.00025 min-1. The permeability coefficient of the fiber with respect to Gd-BOPTA 
was thus found to be 0.00045 cm s-1 (0.00044 cm s-1 from the Taylor series approximation). 
 
5.3.2. DCE-MRI of the multi-fiber phantom 
 A representative concentration vs. time curve can be found in figure 5-6. The modeled 
results for this data set as well as the residual between data and model are also plotted. The 
average rate constants and permeability coefficients resulting from all DCE experiments are given 
in table 5-1. As can be seen in figure 5-6, outliers from the model were identified only within the 
first couple of seconds following injection. This trend was rigidly consistent throughout all data 
sets. 
 
5.3.3. Input function validation 
 Spin-echo images are shown of multi-fiber phantoms after various stages of perfusion 
with Gd-DTPA-BSA in figure 5-7. In addition, the signal response from a DCE experiment using 
Gd-DTPA-BSA is shown in figure 5-8. It should be noted that, although a slight increase in signal 
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intensity is observed after contrast agent administration, this does not correspond to an 





5.4.1. Gold standards 
The data from the gold standard experiment were well modeled by a mono-exponential 
(figure 5-5). Furthermore, the rate constant was well estimated by a first order approximation of a 
Taylor expansion (initial slope). The concentration of contrast agent measured at the exit port of 
the single fiber was very close to the concentration of the stock solution, with measurements 
made throughout the time course randomly scattered about a mean value. Thus, the lumenal flow 
rate is sufficiently fast enough, relative to the rate of contrast agent extravasation, to assume that 
exchange kinetics are defined by the “PS-limited” regime [4]. 
 
5.4.2. DCE-MRI of the multi-fiber phantom 
It should first be noted that the calculated asymptotic concentration was consistently 
underestimated (see figure 5-6). On average, this value was found to be 0.08 ± 0.02 mM (as 
compared with a known value of 1 mM). The origin of this incorrect conversion from signal 
intensity to concentration is unknown at the time of this writing. One potential source of error may 
be residual transverse magnetization between sequentially acquired data points. Although 
routinely ignored when using a spin-echo imaging sequence, the abnormally short TR (desired for 
high T1-weighting and temporal resolution) may require more careful consideration here. These 
errors are expected to add random noise and bias to the measured permeability coefficients. 
A slight dependence of measured permeability coefficient on lumenal velocity was seen 
(see table 5-1). While it is possible that flow rates are not sufficiently rapid to completely ensure 
PS-limited exchange kinetics, the origin of this unexpected result is unknown at this writing. It 
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may be due non-idealities in data acquisition or modeling (e.g., deviations from the assumption of 
total suppression of the lumenal signal). 
 
5.4.3. Input function validation 
Recall that the analysis of the DCE data using equations 5-2 is only valid if the assumed 
stepped shape of the contrast agent input function is correct. In the case of strong deviations from 
this ideal input function, the derived exchange rate constant will be substantially dependent upon 
the actual shape of the input function. Thus, defining/confirming the actual shape of the input 
function is of import. The contrast agent Gd-DTPA-BSA was used to interrogate the input function 
as its high molecular weight, ~68 kDa, prevents it from diffusing through the walls of the fibers 
which have a molecular weight cutoff ≈ 40 kDa. Both the impermeability of the fibers to Gd-DTPA-
BSA and the shape of the input function were validated as follows. 
First, consider figure 5-7. If a contrast agent were to pass readily from the lumenal space 
to the extralumenal space, then one would expect a homogeneously enhanced image after total 
equilibration. Panel A shows that after a half an hour this equilibration is not reached. If any small 
amount of contrast agent had permeated the fiber wall in that half an hour, then panel B should 
reveal it. One would expect that if this were the case, the image in panel B would reveal fiber 
lumens (corresponding to pure water) less intense then the extralumenal space (corresponding to 
some small concentration of CA). However, in contrast, a homogenous image is observed. 
Panels C and D emphasize and repeat these results over a much longer period of time. 
 Having shown that the fiber is not at all permeable with respect to Gd-DTPA-BSA, the 
increase in signal intensity observed in figure 5-8 must correspond to another phenomenon. One 
possible explanation is that this slight signal increase is a manifestation of small deviations from 
plug flow. In a laminar flow regime the velocity on the outermost rim of the tubing is considerably 
slower than that toward the center of the tubing. Due to the very small diameter of the fibers, the 
calculated Reynolds number (Re) is very small (~0.01; Re = ρ·v·d/µ = 1·0.05·0.0002/0.001 where 
ρ, v, d, and µ are density (kg/m3), velocity (m/s), diameter (m), and viscosity (m2/s), respectively). 
Thus, deviations from plug flow could be expected. 
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However, regardless of the mechanism, when coupled with figure 5-7 it is clear that the 
features in figure 5-8 correspond to changes in lumenal contrast agent concentration. Figure 5-8 
reveals that peak concentration in the lumen is achieved after just a few seconds. With the 
kinetics of contrast agent extravasation being on the order of minutes, e.g., asymptotic values are 
reached ~1 min post contrast agent initiation, the assumption of a stepped input function is 
reasonable as long as the initial couple of seconds of time course data are ignored, especially the 
large deviations from ideal model behavior immediately following switching from contrast agent 
free media to media with contrast agent (see chapter 3). 
 
5.4.4. Comparison of gold standard techniques with DCE-MRI 
 Generally good agreement is seen between the DCE-estimated and the gold standard 
determined permeability coefficients. However, there is some, as yet not fully understood, 
apparent flow-rate dependence to the permeability coefficients derived by DCE-MRI. DCE-
estimated permeability coefficients mores closely approach the gold standard value as flow rate 
increases. We hypothesize that this high flow rate behavior reflects a closer approach to PS-
limited kinetic modeling where negligible flow rate independence is postulated. 
 
5.5. Conclusions 
 The rate constant governing the extravasation of contrast agent from the lumenal to 
extra-lumenal compartments was estimated in two different experimental systems. One method 
mimicked DCE-MRI, while the other was meant to be a “gold standard.” Extravasation occurred 
due to diffusion (in response to a concentration gradient) through the wall of semi-permeable 
hollow fibers. From this rate constant the permeability of the fiber wall, with respect to the contrast 
agent Gd-BOPTA, was calculated and compared. A slight apparent dependence on flow rate was 
seen in the DCE experiment suggesting the PS-limited regime had not been fully accessed at the 
flow rates employed. Nonetheless, general agreement (within one to two standard deviations) 
was seen between the two methods at all flow rates.  
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Though potential biases were evidenced in the current experiment, this stands as the first 
quantitative validation of the accuracy of DCE-MRI. In addition, this approach can be modified, in 
future experiments, to further test the technique. For instance, one could introduce cells into the 
extralumenal space and probe the correctness of assumptions surrounding fast and slow 
exchange of extra and intra-cellular water populations (see chapter 2). 
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5.7. Figures and captions 
             
Figure 5-1. Experimental setup for the gold standard experiment. Panel A, schematic showing the 
suspended fiber, lumenal flow, and internal stirring. Panel B, photograph highlighting the method 
for aliquot sampling: in order to draw a sample and keep the pressure in the vial constant, the 
screw is inserted (down red arrow) and the aliquot sampled (up red arrow) simultaneously. The 






Figure 5-2. Longitudinal relaxation rate calibration curve at 0.55 T. A linear dependence is seen 






Figure 5-3. Sample inversion recovery at 0.55 T. This measurement corresponds to the rate 
constants seen in Figure 5-2 (plotted vs. concentration of contrast agent). The modeled inversion 
recovery equation is -3919 + 6814·exp(-1639·TI), therefore, the rate constant for this sample is 
0.6101 s-1 (i.e., 1/1.639 s). The inversion recovery data show no apparent deviations from the 





Figure 5-4. Sample inversion recovery (panel A) and calibration curve (panel B) at 4.7 T. Panel A: 
The inversion recovery data show no apparent deviations from the applied monoexponential 
signal model. Panel B: The calibration curve with flow (red line) was constructed with the 
relaxivity (slope) from the curve without flow (black line). Assuming that the slopes of the two 
calibration curves, with and without flow, are equivalent is justified in chapter 3 where multiple 
data points were collected for each curve. In practice, this technique allows individual calibration 






Figure 5-5. Results from the gold standard experiment to measure the fiber permeability 
coefficient with respect to Gd-BOPTA. Red squares correspond to aliquots sampled from the exit 
port of the suspended fiber (see figure 5-1). Blue circles correspond to aliquots sampled from the 
interior of the vial. The solid line corresponds to the modeled fit: 0.97-0.97·exp(-0.00025·t). 




Figure 5-6. Results from a representative DCE experiment with the multi-fiber phantom. The 
black circles correspond to data points. The black line is the applied mathematical model 
describing the contrast agent extravasation/kinetics. As noted in the text, deviations from the 
model occur in the first few data points following the indroduction of contrast agent into the 
lumenal solution (t~60 s). Therefore, the software used to model the data was configured to reject 
any outliers from the model. Those data points recognized as outliers are shown in red. The 
residuals (differences between the data and model) are shown as blue squares. The modeled 





Figure 5-7. Spin-echo images of a multi-fiber phantom immediately after perfusion with Gd-DTPA-
BSA (panels A and C) and following subsequent perfusion with water (B and D). All images were 
acquired without flow. Panel A was acquired immediately after Gd-DTPA-BSA perfusion of the 
phantom for 30 minutes, and panel B was acquired after one additional minute of water perfusion. 
Panel C was acquired immediately after Gd-DTPA-BSA perfusion of the phantom for 3 days, and 
panel D was acquired after one additional minute of water perfusion. Intensity scales are the 
same for panels A and B and panels C and D. 
  




Figure 5-8. Results from a DCE experiment with Gd-DTPA-BSA. Though no extravasation of 
contrast agent occurred (i.e., diffusion of the contrast agent from the lumenal to the extra-lumenal 
compartment), a slight increase in signal intensity is seen coincident with contrast agent 
“injection”. Arrows denote the time period (2-3 seconds) over which the deviations occur from the 
assumed stepped input function. 
 
5.8. Tables 
Table 5-1. Averaged results from DCE-MRI 
Flow rate Lumenal velocity Rate constant Permeability coefficient 
56 mL/min 48 mm s-1 0.051 ± 0.007 s-1 0.00035 ± 0.00005 cm s-1 
62 mL/min 44 mm s-1 0.06 ± 0.01 s-1 0.00039 ± 0.00009 cm s-1 





CHAPTER 6. CONCLUSION 
6.1. Summary of major findings 
 A review of the literature finds that DCE-MRI is 1) well established and 2) qualitatively 
validated by, among other methods, comparison with histologically determined microvascular 
density. Nevertheless, quantitative validation of the technique remains a challenge as determining 
the accuracy of estimated parameters is difficult (i.e., generally impossible in vivo). A first step 
toward this quantitative validation has been presented herein utilizing realistic tissue models 
(phantoms) that contain semi-permeable hollow fibers. 
 Two types of phantoms were described, single and multi-fiber. Their design and 
construction offer many benefits including: low cost and simple construction, small physical size 
(facilitating high spatially resolved imaging), controlled lumenal flow, and compartmental access. 
These phantoms are expected to aid in validation and control experiments for various perfusion-
sensitive techniques employing different imaging modalities. 
 An example of their utility was given by demonstrating, with single-fiber phantoms, 
diffusion driven longitudinal relaxation. In this experiment, the measured longitudinal relaxation 
rate constant in a single physical compartment was influenced by the diffusion of spins from 
another compartment. The effect was shown to result theoretically in a multi-exponential 
response to an inversion recovery experiment. However, interestingly, the data were well 
modeled by a simple bi-exponential function. A second example of diffusion driven longitudinal 
relaxation was also given, this time in a simple capillary tube in response to decreasing the slice 
thickness. An analogous bi-exponential response was observed. In addition to demonstrating the 
utility of such phantoms to probe basic science questions, these examples also stand as a 
cautionary example to the overestimation of multi-exponential relaxation data in MRI. 
 Finally, a mock-DCE experiment was validated and demonstrated in multi-fiber 
phantoms. Due to control of key aspects of experimental design, the DCE experiment was 
reduced in complexity. These aspects included, stepped or square contrast agent input functions, 
detection of signal from a single compartment due to time-of-flight effects, and use of a highly 
time slice-selective spectroscopy protocol rather than an imaging experiment. Ideally shaped 
 114 
 
contrast agent input functions were realized by fast switching within the magnet using a four-way 
valve. Deviations from these ideal shapes were transient when compared to the time scale of the 
entire experiment. When contrast agents of differing molecular weights were qualitatively 
compared, correlation was seen between molecular weight and the rate of contrast agent 
extravasation (see chapter 3). Last, comparison with gold standard measurements for a single 
contrast agent, Gd-BOPTA, demonstrated for the first time the accuracy of parameters estimated 
by DCE-MRI (see chapter 5). 
 
6.2. Future work 
 Though the outcomes of the various experiments were positive, further corrections must 
be made to the experimental design of the mock-DCE experiment. Foremost among these is 
diagnosing the underlying cause of and correcting for the error in estimation of contrast agent 
concentration from signal intensities. Currently, asymptotic (t = ∞) concentrations in the DCE 
experiment are underestimated by up to 20%. Potentially, this underestimation is not due to faulty 
experimental design, but physical phenomena not currently addressed in the DCE-modeling. If 
this be the case then an altered model should be constructed and proposed. 
 Future work also includes carrying out the phantom-DCE experiment under less ideal 
circumstances. For instance, as cited in chapter 5, one could grow cells in the extralumenal 
space of the multi-fiber phantom. This would result in a three compartment system with respect to 
water (lumenal, extralumenal extracellular, and extralumenal intracellular) and a two compartment 
system with repect to CA (lumenal and extralumenal extracellular). This is more representative of 
the compartmental environment found in vivo. Currently, disagreement exists concerning the 




APPENDIX A. DERIVATION OF DCE COMPARTMENTAL MODELS 
 
A.1. Abstract 
 Analysis of dynamic contrast enhanced (DCE) MRI data relies upon mathematical 
modeling of contrast agent perfusion. Current models describe in vivo physiology as multiple 
compartments that communicate via semi-permeable barriers. Derivation from Fick’s law of 
diffusion is herein presented. 
 
A.2. Derivation of the modified Tofts DCE model from Fick’s law of diffusion 
 
A.2.1. Fick’s law of diffusion 
Much of the following derivation follows that presented in Cellular Biophysics by Thomas 
Fisher Weiss (8). The phenomenological relationship known as Fick’s law of diffusion is 
expressed in one dimension as, 
    .,,
x
txCDtxJ 
          (A-1) 
J is flux (molecules m-2 s-1), x is position in one dimension (m), t is time (s), D is the diffusion 
coefficient (m2 s-1) of the diffusing molecule in the appropriate solvent, and C is concentration 
(molecules m-3) of the diffusing molecule. This equation states that flux of particles will occur in 
response to a concentration gradient at a rate determined by the diffusion coefficient in the 
direction to minimize the concentration gradient. 
 
A.2.2. The continuity relation 
Next, the continuity relation must be justified. Consider the volume in figure A-1 of width 
Δx, influx J(x,t), outflux J(x+Δx,t), and surface area A (m2) of the face orthogonal to the flux. 
Let Δx be small enough that the change in concentration from left to right is negligible. The net 
flux of particles into the volume in time Δt is thus, 
     tAtxxJtxJN  ,, .       (A-2) 
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.     (A-3) 
Here, the average concentration has been taken as that in the middle of the voxel. Equating 
these two and taking the limit as Δx and Δt go to zero one obtains the continuity equation, 








.         (A-4) 
In three dimensions this relationship is, 
   
t
tzyxCtzyxJ 
 ,,,,,, .       (A-5) 
Integration yields, 




VtzyxJ ,,,,,,  .       (A-6) 
V is volume (m3) and Gauss’s integral theorem was used to make the following substitution, 
dAJdVJ   .        (A-7) 
 
A.2.3. Steady state diffusion 
Assuming steady state diffusion is tantamount to taking both flux and concentrations as 
invariant with respect to time. Under this assumption, the continuity relationship then implies, 







.        (A-8) 
In other words, it implies that flux is invariant with respect to position as well as time. In this 
situation Fick’s first law reduces to, 
 
dx
xdCDconstJ  . .        (A-9) 
Furthermore, if D does not equal zero then, 
     oo xxD
JxCxC  .        (A-10) 




A.2.4. Steady state diffusion across a membrane 
Consider now steady state diffusion across a membrane according to figure A-2 where 
C1 (the concentration of compartment 1; molecules m-3) and C2 (the concentration of 
compartment 2; molecules m-3) are two well mixed pools (no spatial concentration dependence 
within the compartment) of constant concentration with respect to time. If C(0) is taken as a 
reference point the previous equation evaluated at x=d is, 
   
D
dJCdC  120 .        (A-11) 
D is the diffusion coefficient (m2 s-1) within the membrane. Rearrangement yields, 
    dCC
d
DJ  012 .        (A-12) 
J12 is the flux from compartment 1 to compartment 2 (positive if flux is from 1 to 2 and negative if 
flux is from 2 to 1 as D is always positive). 
Boundary conditions can be imposed by defining the partition coefficient as, 






Cz   10  z .       (A-13) 
The partition coefficient is thus unitless and allows rearrangement of the previous equation to 
yield what is know as Fick’s law for membranes, 
 2112 CCPJ  .         (A-14) 
P is the permeability (m s-1) and is defined by the following relationship, 
d
zDP  .          (A-15) 
The above relation holds for the situation where the only transport process is simple 
diffusion through a single permeable membrane. If the membrane is porous or if transport is not 
active then the analytical expression for P becomes more complex or possibly nonanalytical. 
 
A.2.5. Generalization of Fick’s law for membranes 
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Fick’s law for membranes can be generalized for application in the DCE-MRI experiment 
of interest. In this experiment there is not a steady state as concentrations in the compartments 
vary and concentrations within the compartments may not be homogeneous, there is not a single 
membrane, and there is the possibility of multiple transport processes (2). Thus a simple 
analytical form of P is insufficient. Fortunately, with a few additional assumptions the general form 
of Fick’s law for membranes is conserved.  
First, one must address the issue of permeability. If the membrane actually consists of 
multiple transport mechanisms then one can assume that the total permeability for the membrane 
(Pmem; m s-1) is equal to the n individual permeabilities (Pi; m s-1) in parallel which gives (2), 
 n
i
imem PP .          (A-16) 
Second, if there are multiple membranes we will assume that the total permeability of m 
overlapped complex membranes (Ptot; m s-1) is equal to all the individual membrane 




.         (A-17) 
Thus, Fick’s law for membranes becomes, 
 2112 CCPJ tot  .         (A-18) 
Ptot can be considered the effective permeability of these multiple complex membranes over an 
effective surface area S (m2). 
To address the issue of steady state it is required that one assumes: (1) concentration 
within each compartment is uniform, i.e., the contrast agent is well mixed within each 
compartment, and (2) clearance time of contrast agent from the vascular compartment is orders 
of magnitude longer than the time that it takes to reach steady state within the membrane, i.e., 
the intercompartmental flux is linear with respect to space (in figure A-2 with respect to the x axis) 
If these two assumptions are met then one can reintroduce time dependence upon both 
concentration and flux yielding, 
      tCtCPtJ tot 2112  .        (A-19) 
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Combination with the continuity relation, introduction of the general rate constant k12 (s-1), and 
rearrangement renders the working form of the equation, 




1  ,        (A-20) 
or, with respect to compartment two, 




2  .        (A-21) 
The rate constants are defined by the following relationships, 
1
12 V
PSk tot , and 
2
21 V
PSk tot .       (A-22) 
V1 being the volume of compartment one and S being the effective surface area referred to 
above. In this form it is evident that in the development an additional assumption was implied, 
namely that P12 is equal to P21.  
It is noteworthy that sometimes an alternate form of equation A-19 is seen in DCE 
literature (2). In the alternate form, P is replaced by P·S. In this formulation it should be 
remembered that flux is defined as the physical amount of substance that diffuses through the 
whole membrane of interest, i.e., the flux is not scaled, but is the flux of the system. 
 
A.2.6. Solution to the general rate equation in terms of the total concentration 
Consider first the three compartment system as shown in figure A-3 in accordance with 
the DCE experiment. Generally, one cannot monitor the concentrations C1, C2, and C3 
individually; rather, one can only monitor Ct (total concentration; molecules m-3).  Therefore, the 














t  .    (A-23) 
Vt is the total tissue volume (m3); v1, v2, and v3 are the fractional volumes of compartments one 
and two and three respectively; and C3 is the concentration in compartment three (molecules m-
3). If C3 is equal to zero then, 
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2211 CvCvCt  .         (A-24) 
This is essentially a two compartment system where the partial volumes of the two active 
compartments do not add up to 1, i.e. v3 does not equal zero which leads to, 
321321 11 vvvvvv  .      (A-25) 
A general rate equation can also be written in terms of Ct, 









1  .       (A-26) 
Substituting the previous expression for the time derivative of C2 one obtains, 







1  .     (A-27) 
If C1 is known (for instance, available directly from a second measurement) then a solution exists. 
The solution can be obtained by solving equation A-19 for C2 (9) which yields, 
        tkt tk eCdeCktC 2121 02
0
1212
     .     (A-28) 
If the initial concentration in compartment two is equal to zero then this simplifies to, 
       t tk deCktC
0
1212
21   .       (A-29) 
Inserting the result into the original expression for the total concentration (equation A-24) one 
obtains, 
     t tkt deCkvCvC
0
121211
21   ,      (A-30) 
where  is a dummy variable. This equation can be written with a convolution where the 
convolution operator  is defined as, 
         t dhtgthtg
0
 .       (A-31) 
This yields, 
     tCekvtCvtC tkt 121211 21   .      (A-32) 
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The two constants v2 and k21 are confounded in this equation. They are thus often expressed as a 
single constant Ktrans, the transfer constant (s-1) from compartment one to two, where, 
221 vkK
trans  .         (A-33) 
This yields the Tofts modified equation, commonly applied to DCE data, 
     tCeKtCvtC tktranst 111 21   .      (A-34) 
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A.4. Figures and captions 
 
Figure A-1. a small voxel with influx and outflux(8) 
 
 
Figure A-2. a schematic of diffusion through a permeable membrane 
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APPENDIX B. REPRINT OF MAGNETIC RESONANCE IMAGING DEFINES 
CERVICOVAGINAL ANATOMY, CANCER, AND VEGF TRAP ANTIANGIOGENIC 
EFFICACY IN ESTROGEN-TREATED K14-HPV16 TRANSGENIC MICE 
 
B.1. Abstract 
Noninvasive detection of dysplasia provides a potential platform for monitoring the efficacy 
of chemopreventive therapy of premalignancy, imaging the tissue compartments comprising 
dysplasia: epithelium, microvasculature, and stromal inflammatory cells. Here, using respiratory-
gated magnetic resonance imaging (MRI), the anatomy of premalignant and malignant stages of 
cervical carcinogenesis in estrogen-treated K14-HPV16 transgenic mice was noninvasively 
defined. Dynamic contrast enhanced (DCE)-MRI was used to quantify leakage across 
premalignant dysplastic microvasculature. Vascular permeability as measured by DCE-MRI, 
Ktrans, was similar in transgenic (0.053 ± 0.020 min-1; n = 32 mice) and nontransgenic (0.056 ± 
0.029 min-1; n = 17 mice) animals despite a 2-fold increase in microvascular area in the former 
compared with the latter. DCE-MRI did detect a significant decrease in vascular permeability 
accompanying diminution of dysplastic microvasculature by the antiangiogenic agent, vascular 
endothelial growth factor Trap (Ktrans = 0.052 ± 0.013 min-1 pretreatment; n = 6 mice versus Ktrans 
= 0.019 ± 0.008 min-1 post-treatment; n = 5 mice). Thus, we determined that the threshold of 
microvessel leakage associated with cervical dysplasia was <17 kDa and highlighted the potential 
of DCE-MRI to noninvasively monitor the efficacy of antiangiogenic drugs or chemoprevention 
regimens targeting the vasculature in premalignant cervical dysplasia. [Cancer Res 
2009;69(20):7945–52]  
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Cervical cancer is the second most common malignancy affecting women worldwide (1). 
Although effective screening has markedly diminished cervical cancer incidence in the United 
States, dysplasia remains a common clinical challenge requiring surgical extirpation for high-
grade lesions (1, 2). As such, noninvasive therapy for premalignant, but high-risk, dysplasias 
would be a tremendous boon to gynecologic care.  
Dysplastic lesions are characterized by disorganized epithelial differentiation. The uterine 
cervical squamous epithelium can harbor dysplasia initiated by oncogenic human 
papillomaviruses (HPV), most frequently types 16 and 18 (1). Normal cervical epithelium is 
composed of a basal layer that is immature and proliferative and multiple suprabasal layers of 
differentiating squamous cells that are ultimately shed from the top of the epithelium into the 
cervical canal or vaginal lumen. Increasing grades of dysplasia are characterized by progressive 
occupation of the suprabasal layer by basaloid squamous cells (1). High-grade dysplasia, if 
untreated, has an extremely high incidence of conversion to malignancy (2). Cervical dysplasia 
and dysplastic lesions, in general, activate an angiogenic switch that both increases the 
subepithelial microvasculature and produces stromal inflammation (3, 4). Angiogenesis and 
inflammation are features that could be exploited for imaging by a technique measuring tissue 
vascularity and leakage, such as dynamic contrast enhanced (DCE)–magnetic resonance 
imaging (MRI). DCE-MRI, studied extensively in solid malignancies (5–7), uses bolus contrast 
agent administration to noninvasively visualize tumor microvasculature and quantify leakage 
across microvessels (8, 9). Time-resolved images, collected as contrast agent enters and exits 
tissue (10), are pharmacokinetically modeled (11, 12), providing quantitative measures of 
important physiologic parameters, such as tissue microvascular integrity (vascular permeability).  
Here, we used respiratory-gated MRI to obtain high-resolution images of the entire 
mouse reproductive tract and delineated an invasive squamous carcinoma in a late-stage (13–
15), estrogen-treated K14-HPV16 transgenic mouse. We also interrogated the microvascular 
biology associated with premalignant dysplasia using DCE-MRI with a 17-kDa contrast agent, 
Gadomer. No differential dysplastic microvascular leak was detectable, consistent with 
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experiments showing undetectable physical leakage of an i.v. injected marker protein, suggesting 
that dysplastic microvessels have a maximal permeability pore size <17 kDa. However, DCE-MRI 
detected a significant decrease in dysplastic vascular leak following treatment with the 
antiangiogenesis agent, vascular endothelial growth factor (VEGF) Trap (16, 17). Thus, DCE-MRI 
can serve as a platform for noninvasively monitoring antiangiogenic drug efficacy, potentially 
deployed with chemoprevention programs, for high-risk premalignant disease. 
 
B.4. Materials and Methods  
Transgenic mice. One-month-old female K14-HPV16:FVB/n congenic transgenic mice 
and nontransgenic littermate controls were treated for 3 or 6 months with s.c. insertion of 17β-
estradiol pellets, 0.05 mg/60 day release (Innovative Research of America; ‘‘estrogen’’; refs. 13, 
15). The Animal Studies Committee of Washington University in St. Louis approved all 
procedures in this study. 
MRI. MR images were collected on a Varian NMR Systems 4.7T INOVA scanner 
described previously (18) using Stark Contrast 2.0 or 2.5 cm birdcage RF coils. Mice were 
anesthetized and maintained on isoflurane/O2 (1–1.25% v/v), and a 3-inch length of PE-10 tubing 
(Becton Dickinson) was inserted via the urethra into the bladder for drainage throughout data 
collection. Core body temperature was maintained at 37 ± 1°C by warm air circulation through the 
magnet bore. 
For anatomic imaging, 500 μL Omniscan (gadodiamide; GE Healthcare) contrast agent, 
diluted 1:10 in saline to yield a 50 mmol/L solution, was administered i.p. immediately before 
placing the animal into the magnet. High-resolution images were collected using a respiratory-
gated, two-dimensional, multi-slice spin-echo sequence (18), and all images were collected 
during post-expiratory periods. Imaging parameters were repetition time ~ 3 s, echo time 20 ms, 
field of view 2.5 x 2.5 cm2
 
(transaxial)/4.0 x 4.0 cm2
 
(coronal), 128 x 128 data points, and slice 
thickness 0.5 mm.  
DCE-MRI data were collected using a T1-weighted, gradient spoiled, multi-slice gradient-
echo sequence. Imaging parameters were flip angle 30°, repetition time 0.06 s, echo time 0.002 
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s, field of view 2.5 x 2.5 cm2, number of slices 15, in-plane resolution 195 μm, and slice thickness 
0.50 mm. The temporal resolution was ~ 15 s. Early DCE-MRI data were collected following i.v. 
injection of Omniscan. However, values of vascular permeability (Ktrans) were all derived from 
experiments using Gadomer (Bayer Schering Pharma). Pre-contrast, T1 maps were produced 
using a variable flip-angle, three-dimensional, gradient-echo sequence (19, 20) with flip angles of 
2.5°, 5.0°, 7.5°, 10.0°, and 15.0°. After 1 min of scanning (four images at 15 s/image), 60 μL of a 
solution of Gadomer that is 50 mmol/L Gd (a dose of 0.12 mmol Gd/kg body weight for a 25 g 
mouse) were injected over 10 s using a Harvard 2 dual syringe pump (Harvard Clinical 
Technology) via either a tail or a jugular venous catheter.  
Modeling DCE data. The starting point for our analysis was the Patlak model containing 
independent parameters vp (fractional blood-plasma volume) and (volume transfer constant 
between blood plasma and extravascular extracellular space; refs. 21, 22). Significant deviation 
from linearity in the Patlak plot led us to include a third independent parameter, ve (fractional 
volume of extravascular extracellular space), to account for contrast agent efflux from 
extravascular extracellular space to blood plasma (21, 23). Conversion of signal intensity to 
concentration of contrast agent was achieved by standard methods (10). Negligible T2* weighting 
of the images and the fast-exchange limit were both assumed (10, 12). Values of T10 were 1.6 s 




The determination of vp, ve, and Ktrans requires knowledge of contrast agent concentration 
in the blood plasma [arterial input function (AIF)] throughout the experimental time course. 
Traditionally, the AIF is measured from a large vessel within the image, carefully avoiding inflow 
and partial volume artifacts (10, 27, 28). However, direct AIF determinations in mice are often 
difficult due to small spatial dimensions and motion effects. Instead, we derived the AIF from leg 
muscle reference tissue (29, 30) using the following parameter values for muscle tissue: Ktrans 
(Gadomer) = 0.002 min-1, vp = 0.021, and ve =0.085 (31). To convert contrast agent concentration 
data into physiologic parameters, a region of interest (ROI) was drawn over the transformation 
zone of the cervix and the data were modeled in Matlab (Mathworks) using a variable projection 
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(VARPRO) nonlinear least-squares approach (32).  
Detection of antiangiogenesis mediated by VEGF Trap. K14-HPV16 transgenic mice 
were scanned by DCE-MRI before treatment, treated biweekly for 2 weeks with 500 μg VEGF 
Trap (Regeneron Pharmaceuticals) or vehicle (5 mmol/L phosphate, 5 mmol/L citrate, 100 
mmol/L NaCl, 0.005% Tween 20) via i.p. injection, and then rescanned to test therapy-associated 
microvascular permeability alterations.  
Determination of microvessel density. Isoflurane anesthetized mice were i.v. injected 
with 50 μg FITC-conjugated Lycopersicon esculentum lectin (Vector Laboratories); after 3 min, 
the left ventricle was perfused with 10% formalin (Fisher Scientific International) for 3 min 
followed by 10% sucrose for 1 min (Perfusion One Rodent System; McCormick Scientific). The 
entire reproductive tract was removed, and the vaginal cavity was filled with OCT freezing 
medium, embedded in OCT (posterior-side down), flash-frozen using liquid nitrogen, and stored 
at -80°C. Cryosections (60 Am) were mounted using SlowFade Gold with 4’,6-diamino-2-
phenylindole (Invitrogen) and viewed under appropriate filter sets using an Olympus BX61 
microscope equipped with a Fire Wire Colorview II camera (Olympus). Images of lectin-perfused 
vessels in the cervical transformation zone taken at x40 magnification were analyzed using 
Olympus MicroSuite Biological Suite software. For each image, four equally sized rectangular 
ROIs were identified along the epithelial-stromal border of the transformation zone. Subepithelial 
microvasculature was delineated by creating RGB color detection profiles to increase signal-to-
noise and identify as many vessels as possible. These profiles were used for all images.  
Determination of physical molecular leakage. ChromPure sheep IgG, Fc fragment, 50 
μg in 50 μL PBS (Jackson ImmunoResearch Laboratories), was injected i.v. and allowed to 
circulate for 2 h followed by FITC-lectin injection, formalin perfusion, OCT whole-organ 
embedding, and 60 Am cryosectioning as described above. Air-dried sections were rinsed in PBS 
three times, blocked for 3 h with DAKO protein block, incubated overnight at 4°C with anti-sheep 
Cy3-conjugated AffiniPure Donkey IgG (Jackson Immuno Research Laboratories), diluted 1:100 
in DAKO Antibody Diluent (DAKO), and mounted using SlowFade Gold with 4’,6-diamino-2-
phenylindole. For visualizing Fc Fragment leakage, images were captured using the Cy3 filter 
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from the sample with the highest signal, which was used to determine the optimal camera gain 
settings. A control image from a noninjected mouse was used to correct for the Cy3 background 
signal. A ROI obtained from the control image was used for background subtraction for analysis 
of signal intensity of Fc-injected experimental tissue sections using the MicroSuite software. 
Statistical analysis. Data are mean ± SD. Mann-Whitney U, paired or unpaired 
Student’s t tests were used to determine statistical significance (GraphPad Prism).  
 
B.5. Results 
Cervical transformation zone MRI and histopathologic correlation. First, we 
developed MRI techniques to visualize the entire mouse female reproductive tract, including the 
vagina, cervix, and lower uterus (Fig. 1B). High-resolution, in vivo respiratory-gated spin-echo 
coronal and transaxial MR images were obtained of a 3-month-old, estrogen-treated, 
nontransgenic mouse with an in-plane resolution of 150 μm (Fig. 1A and C). The coronal MR 
image (Fig. 1A) was a striking reproduction of the actual organ anatomy delineating the cervical 
isthmus, canal, outer cervix, and upper vagina (Fig. 1B). Transaxial images also delineated all 
three zones of the cervix: the upper cervical-uterine junction (data not shown), the mid-cervix with 
the transformation zone and isthmus division septum leading to the two uterine horns (Fig. 1C, 
top), and the lower cervix, here containing a single central canal and laterally bounded by the 
adjacent vaginal walls (Fig. 1C, middle), and the vagina (Fig. 1C, bottom).  
Anatomic MRI also detected cervical cancer that occurs in 80% of K14-HPV16 transgenic 
mice treated with estrogen for 6 months (refs. 13, 15; Fig. 2A and B, multiple delineating black 
and red arrowheads, respectively). The malignancy was first evident in the mid-cervix both 
histologically and in the MRI (data not shown). Histologic analysis further showed spread of the 
cancer to the lower cervix, as determined by the single ‘‘X’’-shaped lumen (Fig. 2A, green arrows 
indicate upper vagina), which invaded almost through the anterior cervical wall adjacent to the 
bladder (Fig. 2A, six o’clock position), and effaced the right portion of the cervical canal. MRI 
delineated the same extent of tumor invasiveness (Fig. 2B, red arrowheads), but with the 
additional feature of obliteration of the right cervical lumen, not evident on the histopathology (Fig. 
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2A). This slight discordance of the MRI vis-à-vis histology is due either to volume averaging in the 
former or, more likely, tissue shrinkage during processing in the latter.  
Differential histology and microvascular area in transgenic premalignant high-
grade dysplasia. As high-grade dysplasia, usually arising from the cervical transformation zone, 
is the source of subsequent invasive cervical cancer in both humans (1) and this transgenic 
model (13) and is a potential target for chemoprevention, we focused our histopathologic (Fig. 
3A-D), microvascular (Fig. 4A-D), and MRI analyses on this anatomic region and this stage of 
progression in the transgenic mice treated with estrogen for 3 months (13). Moderate to high-
grade cervical dysplasia (Fig. 3B and D), but no cervical cancer, was evident, similar to our 
previous experience (13). Nontransgenic littermates treated with the same dosage and duration 
of estrogen evidenced hyperplasia without dysplasia (Fig. 3A and C).  
Induction of angiogenesis and increased microvascularity has been documented 
previously in patients with cervical dysplasia and also in dysplastic skin lesions in K14-HPV16 
transgenic mice (33). Thus, we first determined differences in microvascular morphology in 
transgenic cervical dysplasia (Fig. 4A, top and bottom right) compared with nontransgenic 
estrogen-induced hyperplasia (Fig. 4A, top and bottom left). There were two distinct zones of 
microvasculature in the mouse cervix: the subepithelial region and the deep stromal area (Fig. 
4A, top left, white arrowheads and arrow). The subepithelial region was most affected by mouse 
genotype, with the transgenic microvasculature forming tufts and projections into the overlying 
dysplastic epithelium (Fig. 4A, top right, arrowhead, and higher-magnification image in bottom 
right). In contrast, nontransgenic microvasculature was flattened and linearly arrayed in the 
stroma immediately beneath the hyperplastic epithelium (Fig. 4A, top and bottom left). Image 
analysis revealed that the area of the subepithelial microvasculature in K14-HPV16 mice was 
42.6 ± 8.8% compared with 24.3 ± 8.5% in nontransgenic cervices (Fig. 4B). These data were 
similar to immunohistochemical analysis of dysplastic microvessel density in this model (14).  
Using DCE-MRI to detect vascular permeability changes in premalignant cervical 
dysplasia. The increased subepithelial microvascularity in 3-month-old, estrogen-treated 
transgenic cervices led us to investigate microvessel biology using DCE-MRI, particularly 
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because K14-HPV16 transgenic mice were known to accumulate activated stromal inflammatory 
cells that could, via chemokine/cytokine release, induce leakage even in premalignant dysplasia 
(14). Initially, we conducted these DCE-MRI experiments using Omniscan, a low-molecular 
weight, Gd-based contrast agent. Visual analysis of sequential temporal images from a DCE-MRI 
experiment using a nontransgenic mouse revealed a distinct pattern and distribution of Omniscan 
contrast agent over time (Fig. 5A; Supplementary Movie). Initial pre-injection images were dark 
(Fig. 5A, left). Immediately following injection, the pelvic branches of the internal iliac artery were 
visualized; coincidently, the luminal lining of the isthmus and cervical canal was brightly enhanced 
(Fig. 5A, middle). This compartment was presumably the subepithelial microvasculature. Finally, 
contrast was evenly distributed in the cervix, consistent with permeation throughout the deep 
cervical stroma (Fig. 5A, right). We observed a swift, large signal enhancement following 
Omniscan injection in both transgenic and nontransgenic animals, consistent with rapid 
extravasation, making it very difficult to collect high-resolution DCE-MRI data rapidly enough for 
determination of contrast agent kinetics.  
As such, we switched to Gadomer, a 17-kDa, dendrimer-based contrast agent with 
permeability that was significantly lower than that of Omniscan, for DCE-MRI. Following data 
collection, ROIs were drawn in the cervical transformation zone (Fig. 5B, left) and image intensity 
versus time curves were derived from within these ROIs (Fig. 5C, left). Intensity versus time data 
were converted to concentration versus time curves, and physiologic parameters were derived, 
as described above. The red circles in Fig. 5C are experimental data points, whereas the red 
curve represents the modeling of this concentration versus time data using an AIF derived from a 
reference tissue, muscle (refs. 29, 30; Fig. 5B, right). A representative contrast agent 
concentration versus time curve for muscle is plotted as the blue circles, whereas the derived AIF 
is shown as the dashed blue curve (Fig. 5C, left). Based on our analysis of the DCE data, we 
determined the transfer constant (Ktrans) for a ROI within the cervical transformation zone in 32 
transgenic and 17 nontransgenic mice (Fig. 5C, right). Average Ktrans values for the nontransgenic 
(0.056 ± 0.029 min-1) and transgenic mice (0.053 ± 0.020 min-1) were indistinguishable.  
To investigate the possibility of low-level microvascular leak to which DCE-MRI was 
 133 
 
insensitive, we determined the physical leakage (Fig. 5D). Injection of Fc fragments of 50-kDa 
molecular weight showed a robust microvascular leakage both within an invasive cancer (Fig. 5D, 
left) and within a dysplasia adjacent to the malignancy (Fig. 5D, middle). In contrast, we did not 
detect microvascular leak in dysplastic microvessels in 3-month-old, estrogen-treated transgenic 
mice (Fig. 5D, right). Thus, despite a 2-fold increase in microvascular density (Fig. 4B), the switch 
to leaky vessels occurred later in this model, possibly at the 4.5-month point wherein carcinoma 
in situ and microinvasive cancer first appear (15), or was restricted to frank invasive malignant 
lesions.  
Anatomic response of microvasculature associated with premalignant cervical 
dysplasia to antiangiogenic therapy. Noninvasive detection of the response of dysplastic 
lesions to antiangiogenic or antineoplastic therapies would be a tremendous boon to assess 
efficacy of cancer prevention. We determined the morphologic response of the transgenic cervical 
microvasculature to VEGF Trap and then the sensitivity of DCE-MRI to detect alterations of 
microvascular leakage. We used VEGF Trap (16, 17), because VEGF has also been shown to be 
incrementally up-regulated in both human dysplastic and malignant cervix (34) and the cervical 
dysplasias and malignancies of estrogen-treated, K14-HPV16 transgenic mice (14).  
Following a 2-week course of VEGF Trap, there was an obvious pruning of the epithelial 
tufting and a marked overall reduction in microvascular density in the treated mice (Fig. 6A, 
vehicle, left, and VEGF Trap–treated, right). Subepithelial microvascular area decreased 50% in 
VEGF Trap–treated mice compared with vehicle-treated transgenic mice (Fig. 6B), to a level 
below that of estrogen-treated nontransgenic controls (Fig. 4B). Despite the marked subepithelial 
microvascular pruning, there was no difference in the extent or grade of epithelial dysplastic 
histopathology in VEGF Trap–treated versus vehicle-treated transgenic mice (data not shown).  
DCE-MRI detects antiangiogenic efficacy in premalignant dysplasia. Next, we tested 
the ability of DCE-MRI to detect a permeability response that potentially accompanied the VEGF 
Trap–mediated decrease in microvascular area in cervical dysplasia. Pre-and post-VEGF Trap 
DCE-MRI showed a significant 63% decrease in Ktrans in all of the treated transgenic mice (0.052 
± 0.013 min-1 pretreatment versus 0.019 ± 0.008 min-1 posttreatment; n = 6 mice; Fig. 6D). DCE-
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MRI data in vehicle control transgenic mice were heterogeneous and bivariant (Fig. 6C), but all 
values fell within the range that we previously determined for this group (Fig. 5C, right). Overall, 
there was no statistical difference in the pretreatment/post-treatment values either for each 
vehicle-treated mouse in a paired Student’s t test (Fig. 6D) or within the entire vehicle-treated 
group (0.048 ± 0.015 min-1
 
baseline and 0.045 ± 0.021 min-1 after 2 weeks; n = 5 mice). The 
uniformity of Ktrans reduction in VEGF Trap–treated mice compared with the variable response of 
vehicle-treated transgenic mice suggests that, at a 17-kDa cutoff, DCE-MRI was detecting the 
marked reduction in microvascular area in VEGF Trap–treated mice rather than an inherent effect 
on the microvessel stability of neoplastic vessels.  
 
B.6. Discussion  
The estrogen-treated K14-HPV16 transgenic mouse model of cervical carcinogenesis 
has been extensively studied since inception (14, 35–37), and its relevance for human disease 
has been validated by both detailed histopathologic and genome-wide expression analysis (15, 
36, 38). Other work has shown angiogenesis induction coincident with high-grade dysplasia, 
similar to our findings (14). Moreover, dysplastic and malignant angiogenesis in this model has 
been linked to both macrophage and neutrophil expression of proteases and angiogenic factors 
(3, 14). Thus, the emerging importance of the K14-HPV16 transgenic mouse as a preclinical 
platform for testing drugs that target both malignant and dysplastic angiogenesis (3, 14) 
motivated us to undertake a detailed MRI-based analysis to both noninvasively determine 
cervicovaginal anatomy and interrogate microvascular biology associated with premalignant 
dysplasia.  
Here, in vivo MRI at 4.7 T clearly distinguished epithelium and subepithelial 
microvasculature from the relatively avascular deep cervical stroma and detected cervical 
cancers in transgenic mice. The next challenge was determination of microvascular leak in 
premalignant cervical dysplasia using DCE-MRI. DCE-MRI of the lower female reproductive tract 
poses several unique data acquisition and analysis challenges, including the relatively small size 
of the target organs (only a few pixels in many images), bladder proximity, and respiratory motion 
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effects. Nonetheless, we successfully determined the transfer constant (Ktrans), describing 
vascular permeability/leak in the cervical transformation zone. Within each of these groups of 
animals, we observed a wide range of Ktrans, although the average values for transgenic and 
nontransgenic mice were indistinguishable. The DCE-MRI data were supported, in part, by the 
lack of detection of immunofluorescent analysis of Fc fragment leakage, although the molecular 
mass of this protein (50 kDa) was larger than Gadomer (17 kDa). Thus, the DCE-MRI data 
suggest that microvessels associated with dysplastic lesions at the midpoint of carcinogenic 
progression do not elaborate fenestrations or other leakage-associated structures (39) despite 
their increased density, abnormal morphology, and associated stromal inflammation (3, 4, 14).  
In contrast, we were clearly able to detect and monitor the decrease in cervical 
microvasculature due to VEGF Trap (16, 17) in transgenic dysplasias. The antiangiogenic 
potency of VEGF Trap was highlighted by the marked 50% reduction in Ktrans in VEGF Trap–
treated compared with vehicle-treated transgenic mice. VEGF Trap also decreased dysplastic 
microvascular area to a level that was 25% lower than the estrogen-treated nontransgenic 
controls. These data suggested that VEGF was the predominant coordinator of angiogenesis of 
cervical dysplasia despite the documented contribution of platelet-derived growth factor-C and 
fibroblast growth factor-2 to this process in this model (4). These data also highlighted a 
correlation between Ktrans and microvascular area within the 17-kDa pore size cutoff.  
The lack of efficacy of VEGF Trap in ameliorating cervical dysplasia, despite its 
pronounced microvascular potency, suggests the need for combining antiangiogenic therapy with 
agents targeting dysplastic epithelium as in clinical scenarios for established malignancies (40). 
However, our study also highlights the ability of DCE-MRI to potentially detect reduction in the 
microvasculature that would likely accompany effective therapy for dysplasia. As a prominent 
goal of future prevention therapies is noninvasive ablation of high-risk dysplasia, DCE-MRI could 
become a valuable monitoring tool for treatment efficacy.  
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B.9. Figures and captions
  
Figure 1. Development and histologic validation of MRI of the mouse female reproductive tact. 
Coronal MRI delineated the mouse reproductive tract, consisting of proximal cervical horns, 
cervix, and vagina (A). Low-power histology of the reproductive tract validated the coronal MR 
image and highlights the same regions (B). Axial MRI delineated the lower transformation zone 





Figure 2. MRI detection of an invasive squamous cervical cancer. Paired transaxial MRI (B) and 
histologic cross-section of a cervix (A) obtained from a K14-HPV16 transgenic mouse treated with 
estrogen for 6 mo. A hyperintense lesion was detected extending from the upper to lower cervix 
on contrast agent–enhanced, T1-weighted images at the 6-mo time point (B, red arrowheads; 
green arrows, upper vagina). Matched cervical cross-sectional histology verified the cancer and 
distortion of the cervical canal (A, black arrowheads, cancer; green arrows, upper vagina). 





Figure 3. Histopathology of mid-to high-grade cervical dysplasia in estrogen-treated K14-HPV16 
transgenic mice. Histologic images of transformation zones in 3-month-old, estrogen-treated 
nontransgenic (A and C) and transgenic (B and D) mice. The sharp demarcation of squamous 
with columnar epithelium in a nontransgenic mouse (A and C, arrowheads) contrasted with the 
squamous metaplasia of the transgenic cervix extending into the lower uterine horns (B). 
Papillation of the dysplastic transgenic epithelium was also evident (B, arrowhead). Mid-to high-
grade dysplasia contained mitotic, apoptotic, enlarged, and anaplastic squamous epithelial cells 





Figure 4. Microvascular anatomyand density in estrogen-treated cervices. Fluorescent images of 
FITC-conjugated L. esculentum lectin-perfused cervices from nontransgenic (A, top and bottom 
left) and transgenic (A, top and bottom right) mice revealed subepithelial and interior stromal 
microvascular compartments (A, top left, arrowheads and arrow, respectively). Subepithelial 
microvessels were linearly arrayed in nontransgenic (NTG) mice, whereas they formed tufts 
projecting into the neoplastic epithelium in transgenic mice (A, top right, arrowhead,and bottom). 
Microvessel quantification (see Materials and Methods) revealed a statisticallysignificant increase 





Figure 5. T1-weighted, gradient-echo images of the mouse female reproductive tract (A), 
showing the time course for contrast illumination of the pelvic internal iliac artery branches, the 
presumed epithelial/subepithelial tissue, followed by stromal permeation following i.v. injection of 
Omniscan (60 μL of 50 mmol/L contrast agent over 10 s). A, collected pre-contrast, 1-min post-
contrast injection, and ~ 15 min post-injection. All other DCE-MRI data reported in this figure were 
collected following i.v. injection of Gadomer (60 μL of a solution that is 50 mmol/L Gd injected 
over 10 s). ROIs drawn in the cervical transformation zone (B, left) and in a reference muscle 
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region (B, right) were used to derive the AIF. For a typical mouse, the cervical transformation 
zone was defined by 30 to 50 pixels and the muscle region by 2,400 to 3,000 pixels. Contrast 
agent concentration versus time curves were constructed for a cervical transformation zone ROI: 
red circles, experimental data points; red curve, the model (C, left). The reference contrast agent 
concentration versus time curve for muscle, plotted with blue circles, and the derived AIF, shown 
as the dashed blue curve (C). Ktrans values (C, right) for a ROI within the cervical transformation 
zone were statistically indistinguishable. C, right, the horizontal line within each box is the median 
value of Ktrans, the dot at the middle of each box is the mean, the edges of the box are ± 1 SD, 
and the whiskers are the maximum and minimum values. Injection of sheep Fc fragment (50 kDa) 
and immunofluorescent analysis showed leakage in a large cervical cancer in a 6-month-old, 
estrogen-treated transgenic mouse (D, left), and adjacent dysplasia (D, middle), whereas leak 





Figure 6. Effect of VEGF Trap on the transgenic cervical microvasculature. VEGF Trap treatment 
of transgenic mice produced a marked pruning of the cervical microvasculature in VEGF Trap (A, 
right), compared with vehicle control transgenic mice (A, left), with a statistically significant 
decrease in subepithelial microvascular area (B). DCE-MRI detected a significant decrease in 
microvessel leakage within VEGF Trap–treated transgenic mice (D) compared with lack of 
significance within the highly variant vehicle-treated transgenic group (C). *, P < 0.05, Mann-




APPENDIX C. REPRINT OF MAGNETIC RESONANCE IMAGING OF HYPOXIC INJURY TO 
THE MURINE PLACENTA 
 
C.1. Abstract 
Tomlinson TM, Garbow JR, Anderson JR, Engelbach JA, Nelson DM, Sadovsky Y. 
Magnetic resonance imaging of hypoxic injury to the murine placenta. Am J Physiol Regul Integr 
Comp Physiol 298: R312–R319, 2010. First published November 18, 2009; 
doi:10.1152/ajpregu.00425.2009.—We assessed the use of magnetic resonance imaging (MRI) 
to define placental hypoxic injury associated with fetal growth restriction. On embryonic day 18.5 
(E18.5) we utilized dynamic contrast-enhanced (DCE)-MRI on a 4.7-tesla small animal scanner to 
examine the uptake and distribution of gadolinium-based contrast agent. Quantitative DCE 
parameter analysis was performed for the placenta and fetal kidneys of three groups of pregnant 
C57BL/6 mice: 1) mice that were exposed to FIO2 = 12% between E15.5 and E18.5, 2) mice in 
normoxia with food restriction similar to the intake of hypoxic mice between E15.5 and E18.5, and 
3) mice in normoxia that were fed ad libitum. After imaging, we assessed fetoplacental weight, 
placental histology, and gene expression. We found that dams exposed to hypoxia exhibited fetal 
growth restriction (weight reduction by 28% and 14%, respectively, P < 0.05) with an increased 
placental-to-fetal ratio. By using MRI-based assessment of placental contrast agent kinetics, 
referenced to maternal paraspinous muscle, we found decreased placental clearance of contrast 
media in hypoxic mice, compared with either control group (61%, P < 0.05). This was 
accompanied by diminished contrast accumulation in the hypoxic fetal kidneys (23%, P < 0.05), 
reflecting reduced transplacental gadolinium transport. These changes were associated with 
increased expression of placental Phlda2 and Gcm1 transcripts. Exposure to hypoxia near the 
end of mouse pregnancy reduces placental perfusion and clearance of contrast. MRI-based DCE 
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C.3. Introduction 
FETAL GROWTH RESTRICTION (FGR) complicates up to 8% of all pregnancies, 
adversely impacts perinatal outcome, and results in life-long complications for adult survivors 
(14). Placental insufficiency is the major cause of FGR in developed countries, where it remains 
prevalent despite improvements in obstetrical care. Diverse causes of placental injury, such as 
chronic hypertension, preeclampsia, connective tissue disease, diabetes, and abruption, alter 
placental perfusion and may cause hypoxic and reperfusion injury (42).  
Doppler ultrasound is useful in assessing FGR-related blood flow changes in the 
preplacental (uterine) and postplacental (umbilical, fetal) vasculature (1, 21). While the detection 
of these changes has limited diagnostic value, changes in post-placental flow are presently used 
to assist clinicians in management and timing of delivery of pregnancies with an established 
diagnosis of FGR (1, 30). Notably, Doppler ultrasound detects umbilical vessel flow changes that 
result from parenchymal damage but cannot directly assess intraplacental per-fusion 
abnormalities (1, 28, 30).  
Magnetic resonance imaging (MRI) offers superb visualization of anatomy and allows 
quantitative analysis of spatial and temporal changes in tissue morphology. MRI studies of pla-
cental anatomy and perfusion have been conducted in different species (16, 29, 31, 35, 36, 44, 
51). Contrast agents (typically gadolinium-based chelates) were noted to easily cross the 
placental barrier in both the mouse and human placenta, and appeared in the fetal bladder soon 
after maternal intravenous administration (8, 49, 52). Dynamic contrast-enhanced (DCE) MRI is a 
powerful imaging technique for characterizing tissue vasculature. In DCE-MRI experiments, time-
resolved images are collected as contrast agent washes in and out of the tissue, providing insight 
into blood flow, fractional blood volume, and vascular permeability (18, 53).  
Mice are particularly useful for studying placental biology. Akin to the human placenta, 
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the mouse placenta is hemochorial, with maternal blood perfusing labyrinthine trophoblasts in a 
manner analogous to the branched villous tree that is bathed by the maternal human intervillous 
space (2, 10). In addition, the mouse is particularly amenable to targeted mutations, designed to 
analyze mechanisms underlying placental development and function (41). Not surprisingly, we 
previously found that several genes that are critical for murine placental development also 
regulate the differentiation of human trophoblasts (20, 39, 46, 47).  
Hypoxia hinders the process of cytotrophoblast differentiation, induces apoptosis, and 
diminishes hormone production in the human placenta (9, 21, 25, 34). Exposure to hypoxia during 
murine pregnancy results in FGR (15, 27), although the precise mechanism underlying placental 
villous injury during hypoxia is unclear. Specifically, it is not known whether systemic hypoxia 
elicits preplacental hypoperfusion or causes placental parenchymal perfusion abnormalities. To 
elucidate mechanisms underlying placental hypoxic injury associated with FGR, we hypothesized 
that dynamic MR imaging could help to define hypoxia-induced placental dysfunction.  
 
C.4. Materials and Methods 
Animals. Care for the mice and all procedures were conducted in the Association for 
Assessment and Accreditation of Laboratory Animal Care-approved facility of Washington 
University School of Medicine in accordance with the standards set forth in the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of Health. All experimental procedures 
were approved by the Animal Studies Committee of Washington University.  
Experiments were performed using pregnant C57BL/6 mice. Timed matings were carried 
out by pairing strain-matched males and nulligravida females for one night, with the morning after 
mating designated as embryonic day 0.5 (E0.5). Pregnancy was assumed based on a 10% 
weight gain on E10.5. Mice were kept under constant conditions until day E15.5. They were given 
a standard rodent chow and water ad libitum, and kept on a 12:12-h light-dark cycle in room air. 
Deliveries typically occur in these mice on E19.5. All procedures were initiated on E15.5, when 
the mice were allocated to one of three groups: 1) exposure to FIO2 = 12% between E15.5 and 
E18.5 (hypoxic or Hpx group), 2) exposure to normoxia with food restriction similar to the intake 
 151 
 
of hypoxic mice between E15.5 and E18.5 (N-FR group), and 3) exposure to normoxia with ad 
libitum feeding (N-AL group).  
Body weight and food intake were recorded daily. Food matching between the N-FR and 
Hpx groups was based on daily assessment of food intake by mice in the Hpx group. For 
normobaric hypoxia exposure we used a Polymer Hypoxic Glove Box with a Purge Airlock system 
with CO2 and O2 control indicators (Coy Laboratory Products, Grass Lake, MI), which is 
specifically designed for experiments in live rodents and regulates ambient temperature, humidity, 
and gas composition. Oxygen concentration was maintained within a narrow preset range by 
introducing small amounts of nitrogen as required. The main chamber has a connected side 
chamber, equipped with a separate door to allow uninterrupted maintenance of a predefined FIO2 
when the mice and their food were weighed daily. Dams were euthanized by CO2 asphyxiation 
following MR imaging on E18.5 (see below). Embryos and placentas were collected immediately 
after death, weighed, and processed for further analysis (see below).  
Imaging procedure. All MR images were collected and analyzed in Washington 
University’s Biomedical MR Laboratory. Images were acquired with a small-animal MR scanner 
based on an Oxford Instruments (Oxford, UK) 4.7 tesla, 40-cm bore magnet. The magnet is 
equipped with Magnex Scientific (Oxford, UK) actively shielded, high-performance (10 cm ID, 60 
gauss/cm, 100 µs rise time) gradient coils and Techron gradient power supplies and is interfaced 
with a Varian NMR Systems (Palo Alto, CA) INOVA console. Data were collected using a Stark 
Contrast (Erlangen, Germany) 3-cm diameter birdcage radio frequency (RF) coil. Prior to the 
imaging experiments, mice were anesthetized with isoflurane and were maintained on an 
isoflurane/O2 inhalation mixture (1–1.5% vol/vol) throughout data collection. Animal core body 
temperature was supported at 37 ± 1°C by circulation of warm air through the bore of the magnet. 
Dams in the Hpx group were removed from the hypoxia chamber 1 h before imaging on the 
morning of E18.5. Hence, none of the dams were hypoxic during scanning.  
Sagittal, axial, and coronal scout images were collected to ensure correct positioning of 
the animal within the RF coil, allowing visualization of all fetoplacental units. Images were 
acquired with a field of view of 30 × 30 mm2
 
(transaxial) or 40 × 40 mm2
 
(sagittal, coronal) and a 
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data matrix of 128 × 128, leading to an in-plane resolution of 234 µm (transaxial) or 313 µm 
(sagittal, coronal). Eighteen to twenty-two contiguous, 1-mm thick slices were acquired to cover 
all of the fetoplacental units.  
DCE-MRI experiments were performed using a T1-weighted two-dimension multislice 
gradient echo sequence. Typical imaging parameters were: repetition time (TR) = 100 ms, echo 
time (TE) = 2 ms, flip angle (α) = 30°, and eight signal averages; producing a temporal resolution 
of ~100 s. Two baseline images were acquired at the start of the time course and the contrast 
agent was administered prior to the collection of 28 additional images. Total imaging time for the 
DCE experiment was ~50 min.  
Contrast agents and contrast distribution controls. A standard gadolinium chelate 
(gadoversetamide, OptiMark; Covidien, St. Louis, MO) injected on a weight-based protocol was 
used throughout. Injection was performed via a 28-gauge catheter that was placed into the 
internal jugular vein prior to the start of imaging. To characterize placental transport to the fetus, a 
single bolus of 2.7 µl/g of undiluted contrast, corresponding to a gadolinium concentration of 2 
mmol/kg, was administered over 10 s using a Harvard 2 dual syringe pump (Harvard Clinical 
Technology, South Natick, MA). To define the systemic distribution of contrast under different 
physiological conditions, DCE-MRI (1:10 dilution of contrast agent, 0.2 mmol/kg; 33 s temporal 
resolution) was performed on four groups of dams: normoxic pregnant, hypoxic pregnant, 
normoxic nonpregnant, and hypoxic nonpregnant. Gadolinium distribution was measured in the 
paraspinous muscles in these paradigms, and these data served as a reference for the placental 
flow results, as described below.  
DCE data analysis. Regions of interest (ROIs) were drawn over the placentas, 
paraspinous muscle, and fetal kidneys by a single operator (T. M. Tomlinson) using ImageJ 
(http://rsbweb.nih.gov/ij). Although not blinded to the experimental group of the dam being 
analyzed, this operator followed standard procedures for unbiased ROI selection. These 
procedures were determined prior to data analysis. Placentas analyzed were those that could be 
easily visualized in sagittal images of the dam and around which ROIs could be clearly drawn. 
The coronal slice chosen for each placenta’s time course analysis was the one having the largest 
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(midplacental) cross-section in the sagittal image. Similarly, for fetal kidney analysis, the kidney 
ROI was drawn on the coronal slice that provided the largest image of the kidney.  
All subsequent image analysis calculations were performed in Matlab (Mathworks, 
Natick, MA) by using programs developed in our laboratory. Assuming the fast-exchange limit, 
signal intensity data for placenta and muscle were converted to concentrations by standard 
methods (18) using Eq. 1 and Eq. 2.  
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Here, S(t) is the signal at time t, S(0) is the signal in the absence of contrast agent (CA), T1(t) is 
the longitudinal relaxation rate constant at time t, T1(0) is the longitudinal relaxation rate constant 
in the absence of CA, TR and α are the repetition time and flip angle of the pulse sequence, 
respectively, [CA] is the concentration of the contrast agent, and r1 is the relaxivity of the CA [4.4 
mmol/s (40)]. Precontrast T1(0) values for both murine paraspinous muscles and term placentas 
were determined from a series of T1-weighted spin-echo images.  
In the fetal kidneys, in which T1(0) could not be measured, relative signal increase, itself 
proportional to contrast agent concentration, was calculated (18). 
   
    tCAtS StS α0          (3) 
Intradam variations in image intensity (placenta and fetal kidney) were partly attributed to 
variations in RF coil sensitivity and to fetal position within the coil. To account for these variations, 
a straightforward normalization procedure was adopted. This normalization assumed the same 
vascular input function for all placentas/fetuses within a given dam, a reasonable assumption 
given that each dam received a single bolus injection of contrast agent. For each placenta, an 
individual concentration vs. time curve was calculated, and an average concentration curve for all 
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placentas within a specific dam was then computed. Next, each individual placenta’s 
concentration vs. time curve was compared analytically, on a point-by-point basis, with the 
placental average concentration curve for its corresponding dam. A single scale factor was 
derived for each placenta by performing a linear, least-squares minimization of the variation 
between these curves. Finally, for each placenta, all data values were multiplied by its computed 
scale factor. This normalization procedure has the effect of scaling the overall intensity without 
altering the shape of the individual placental concentration curves. An analogous procedure was 
followed for normalizing the relative signal intensity curves for each fetal kidney within a given 
dam.  
Complete characterization of the complex vasculature of the placenta, which contains 
multiple permeable barriers and compartments, is beyond the scope of small-animal DCE-MRI. 
While a full kinetic analysis is not possible, the time course DCE data can still be quantified using 
a model-free parameter approach (18). In all cases, analysis of DCE data requires accurate 
knowledge of the concentration of the CA in the blood throughout the time course experiment, a 
factor known as the arterial input function (AIF). Traditionally, the AIF is measured from a large 
vessel within the image, taking care to avoid inflow and partial volume artifacts (18, 37, 38). 
However, determining the AIF directly is difficult in mice, due to small spatial dimensions and the 
effects of motion. Instead, in analogy to our model-free analysis of the DCE data, we can derive a 
model-free vascular input parameter from a reference tissue, such as muscle (23, 55). As 
detailed below, we then computed the ratio of CA concentration in the placenta to that in the 
reference tissue, as previously described (13).  
Quantification of dynamic data was achieved using three model-free parameters: initial 
area under the curve (IAUC), final slope, and area under the curve (AUC) (18). The IAUC was 
evaluated for the first 1,200 s postinjection (IAUC1200) by calculating the areas under each 
placental concentration curve and the corresponding curve for paraspinous muscle from time 0 to 
1,200 s postinjection. Placental values were then referenced to the muscle signal by forming the 
ratio IAUC1200, placenta/IAUC1200, muscle (13). The final slope was calculated by measuring the slope of 
each placental concentration curve from 1,300 s to 2,800 s postinjection. The complexity of 
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transport of contrast agent to the fetal kidneys, with numerous points of (bidirectional) transfer, 
prevents the calculation of CA concentration in these organs. Instead, AUC was calculated for 
each fetal kidney by calculating the area under its relative signal curve. As with IAUC in placenta, 
these values were normalized by forming the ratio AUCkidney/AUCplacenta, where for each fetal 
kidney, AUCplacenta is the area under the relative signal vs. time curve for its corresponding 
placenta.  
Placental histology. Each placenta was divided in half by making a midline incision 
immediately adjacent to the cord insertion site, from the chorionic to the basal plate. One half was 
randomly selected for routine histology processing, following fixation overnight in fresh 4% 
paraformaldehyde. Tissues were dehydrated with alcohol, embedded in paraffin blocks, and cut 
into 5-[m sections. The sections were stained using standard hematoxylin and eosin staining and 
qualitatively evaluated for changes in the labyrinthine, spongiotrophoblast, and giant cell layers as 
routinely performed in our lab (47). To enhance assessment of the spongiotrophoblast layer, 
parallel slides from a portion of the placentas were stained with periodic acid Schiff staining (4, 
47).  
Assessment of gene expression using quantitative RT-PCR. The second half of each 
harvested placenta was snap frozen in liquid nitrogen and stored at -80°C for RNA isolation. RNA 
was extracted as previously described (47). Complementary DNA was prepared from 1 µg RNA 
in 50 µl reaction volume using the TaqMan Gold RT-PCR kit with the supplied random hexamer 
primers (Applied Biosystems, Foster City, CA). Quantitative PCR was performed in duplicate 
using 3 µl samples of cDNA and 12.5 µl SYBR Green PCR Master Mix (Applied Biosystems) in a 
total reaction volume of 25 µl that contained 300 nM of forward and reverse primers. Reactions 
were run and analyzed using Applied Biosystems Geneamp 7300 Sequence Detection Systems. 
Dissociation curves were performed on all reactions to ensure amplification of a single product 
with the appropriate melting temperature. The transcript levels were normalized to the 
housekeeping gene L32 RNA levels, and the data expressed as fold change relative to a single 
N-AL control placenta. The fold increase relative to control cultures was determined by the ΔΔCt 
method (26). All PCR primer pairs were checked for specificity using BLAST analysis. The list of 
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primers is provided in Table 1.  
Statistics. We calculated our sample size based on attainment of 20% reduction in 
embryo weight in the Hpx group compared with the N-AL group. To achieve this difference at 
80% power and α = 0.05 required at least 12 dams in each paradigm. Data are expressed as 
means ± SD, and statistical significance was determined using the one-way ANOVA and 
Bonferroni post hoc test. Significance was determined at P < 0.05. For the data in Fig. 4, which 
are further analyzed in Table 2, we plotted binned data and confirmed symmetrical or near-
symmetrical distributions about the means.  
 
C.5. Results 
Maternal food consumption and weight. We first sought to examine the effect of 
normobaric hypoxic environment on maternal food intake and weight gain. We exposed pregnant 
mice to FIO2  = 12% or to standard atmosphere over a period of 3 days at the end of pregnancy 
(E15.5–E18.5) with ad libitum supply of chow. We found that dams in the Hpx group (n = 22) 
exhibited lower food intake on the first day in hypoxia (Fig. 1A). Although food intake by hypoxic 
dams was increased in the subsequent 2 days in hypoxia, it remained lower than that of the N-AL 
dams (n = 25). Therefore, to control for food intake, we generated a third group, N-FR dams (n = 
15), in which food was restricted to match exactly that of hypoxic dams (Fig. 1A). As expected, 
maternal weight gain in the N-AL group over the 3 days of the experiment was markedly higher 
than that of N-FR or Hpx groups (Fig. 1B).  
Fetal and placental weights. As shown in Fig. 2A, murine pups (n = 126) harvested on 
E18.5 from Hpx dams were significantly smaller than pups from the N-FR dams (n = 99), which, 
in turn, were significantly smaller than those from N-AL dams (n = 113). We also observed a 
small, but statistically significant, difference in mean placenta weights from each of the three 
cohorts, with the largest placentas originating from the N-AL dams and the smallest from the N-
FR dams (Fig. 2B). Not surprisingly, the placental-to-fetal ratio was greatest in the Hpx group 
(Fig. 2C). We found no significant differences in mean litter size (N-AL = 7.5, N-FR = 8.3, Hpx = 
8.4). Fetal survival was > 95% in all three groups.  
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Fetoplacental MR and DCE imaging. Representative contrast-enhanced MR images of 
mouse fetuses and placentas placentas on E18.5 are shown in Fig. 3. Maximum placental 
enhancement by the contrast agent was observed at 7–10 min following contrast injection, with 
fetal enhancement lagging behind that of the placenta. Control experiments revealed that 
pregnancy did not noticeably impact the systemic distribution of contrast agent. Muscle-derived 
measures of vascular gadolinium concentration were used for referencing all of the placental data 
(see Materials and Methods).  
DCE analysis of transplacental gadolinium distribution in each of the three experimental 
groups was limited to placentas that were reliably identified in coronal sections. T1(0) values for 
placenta (1.8 s) and paraspinous muscle (1.4 s) were computed from representative T1 maps of 
the placenta and paraspinous muscle (reference tissue). CA concentrations, as a function of time, 
were calculated as described in Materials and Methods. Fig. 4 depicts representative 
concentration curves for one dam from each of the three experimental groups. IAUC was 
calculated for all placentas on a per dam basis. This calculation revealed a statistically significant 
difference in IAUC1200 for the N-FR mice relative to the N-AL and Hpx groups (Table 2). 
Furthermore, while contrast concentration decreased in all placentas toward the end of the 
measurement period, the concentration in Hpx placentas decreased at a significantly slower rate 
compared with the other two groups (Table 2). Figure 5 highlights the difference in residual 
placentas and control. Together, these data point to greater washout of contrast from the N-AL 
and N-FR placentas compared with the Hpx placentas.  
We anticipated that both maternal and fetal blood flow might contribute to contrast 
clearance from the placenta. Noting enhancement of the fetal kidneys early in the experimental 
time course, we sought to assess contrast accumulation in the fetal kidneys as a surrogate for 
fetal clearance of placental contrast. The adjusted fetal kidney AUC was lower in the Hpx group 
than in the N-AL group (Fig. 6), suggesting diminished transfer of contrast agent to the Hpx 
fetuses.  
Placental histology and gene expression. To determine whether the perfusion changes 
assessed using DCE imaging were associated with discrete placental morphological changes, we 
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examined the placentas from the three experimental group using hematoxylin and eosin and 
periodic acid Schiff staining. While the placentas from the Hpx and N-FR groups were smaller 
than those from N-AL, we could not detect any differences in thicknesses of the labyrinth, spon-
giotrophoblast, or giant cell layers. Similarly, we did not identify any differences in labyrinth 
density, dilatation of the labyrinthine blood spaces, or any other discrete structural alterations 
(data not shown). To expand our assessment of region-specific changes, we measured the 
expression of several placental genes that are expressed in specific layers of the murine 
placenta. As shown in Fig. 7, the expression of labyrinthine Gcm1 and Phlda2 was increased in 
placentas from Hpx dams relative to those derived from the N-FR controls. No significant 
differences were found between these two groups in the expression level of spongiotrophoblastic 
Tpbpa and Mash2, or in the level of Plf (primarily giant cells), although some of the genes 
exhibited decreased expression in one or both injured groups relative to the N-AL controls.  
 
C.6. Discussion 
We used DCE-MRI with gadolinium contrast to assess placental perfusion in a mouse 
model of hypoxia at the end of pregnancy. We found that the initial uptake of contrast was similar 
for the Hpx and N-AL mice. The uptake was delayed in the Hpx mice compared with the N-FR 
mice, possibly reflecting reduced perfusion in hypoxia-exposed mice. Importantly, the clearance 
of contrast was reduced in the Hpx placentas, which manifested as a lower final slope of the 
gadolinium concentration vs. time curve in the Hpx group relative to the two normoxic controls. 
We emphasize that these results were normalized to the arterial input function, derived by 
assessing perfusion of a reference tissue, thereby correcting to general alterations in perfusion.  
The initial appearance of contrast in the chorionic plate is consistent with rapid labyrinth 
perfusion by maternal blood, delivered directly from the uterine spiral arteries via central arterial 
canals into labyrinthine sinusoids (2). Our data suggest that the clearance of contrast from the 
adjacent labyrinth was slowed in Hpx placentas. Whereas our findings are consistent with the 
notion that hypoxia influences preplacental vasoconstriction (17), our data illuminate hypoxia-
induced changes within the labyrinth, the site of maternal-fetal exchange in the murine placenta 
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(7, 32). Finally, we found that the accumulation of contrast in the kidneys of fetuses of Hpx dams 
was reduced. While we cannot rule out a direct influence of hypoxia on fetal renal function, our 
findings are consistent with diminished fetal perfusion.  
We induced FGR using global maternal hypoxia for 3 days, as described previously (11, 
48, 54). Importantly, the level of FGR, placental weight, and mean placenta-to-fetus ratio 
achieved in our studies was similar to that achieved by others (11, 22, 24). Furthermore, we did 
not observe an increase in fetal mortality, which might have introduced an additional variable. 
Because there is a plateau in murine placental growth after E14 (50), it is not surprising that we 
observed a minimal effect of E15.5 injury on placental size. We note that DCEMRI measurements 
were performed in standard atmospheric oxygen. Rather than hemodynamic changes that might 
be found during hypoxia, our results reflect tissue changes that were caused by hypoxia, but 
detected after the insult. We also did not rule out the possibility that some of the observed 
changes could have reflected reoxygenation injury, which might have taken place immediately 
prior to imaging. Nevertheless, we find it less likely that the FGR, CA dynamics changes, and 
altered gene expression could have been explained by changes that occurred over a brief 
reoxygenation period (2 h or less at the end of the experiment).  
In vivo dynamic imaging of fetoplacental perfusion in mice poses a significant 
technological challenge (44, 51). First, high-quality DCE-MRI data must be acquired for several 
fetoplacental units within each pregnant dam. Second, these data must be referenced to an 
appropriate measure of vascular input, derived in our case from paraspinous muscle reference 
tissue. Third, a detailed evaluation of the fetus via imaging of the fetal kidney requires a higher 
dose of contrast agent than is commonly administered when imaging the dam. Despite these 
challenges, we were able to perform a quantitative analysis of temporal changes in contrast-
medium concentration in both the placenta and fetal kidney. The accuracy of our measurements 
was limited by the subjective choice of ROIs, defined for analysis of the DCE images. In addition, 
partial volume effects could have contributed to errors in these measurements. Because of their 
small size and fetal movements, measurements of fetal kidney were particularly prone to this 
limitation. Finally, heterogeneity among mice within a given experimental group and among the 
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fetoplacental units within each dam accounts, in part, for the variability in measurements that was 
independent of the experimental paradigm.  
Our analysis of placental histology was restricted to morphological changes that might be 
identified using standard staining techniques. The lack of clear evidence for tissue damage likely 
reflects the short duration of injury that was inflicted at a relatively late point in gestation, after the 
period of rapid placental growth. Using quantitative PCR to probe for tissue response to hypoxia, 
we found that the expression of Phlda2, a maternally imprinted gene that is expressed mainly in 
the labyrinth and negatively regulates placental growth (5, 43), was increased in placentas from 
the Hpx group compared with N-FR controls. In Hpx placentas we also detected a small yet 
statistically significant increase in the expression of Gcm1, a gene associated with labyrinthine 
layer branching and differentiation (3, 6, 33). In contrast, we did not detect any significant change 
in the expression of Tpbpa, Mash2, or Plf1 between the Hpx and N-FR groups (12, 19). Although 
the role of these gene products in placental response is presently uncertain, our results point to 
concomitant changes in expression of labyrinthine genes that are expressed in regions of 
placental exchange function. These changes might be a part of a placental adaptive response to 
hypoxic injury. Notably, our analysis was restricted to histological changes, and therefore, we 
cannot rule out mild changes in labyrinthine fetal or maternal blood spaces that might have been 
uncovered using more refined stereology or electron microscopy. Interestingly, using pregnant 
mice prior to full placental development (E7.5–E10.5), Schaffer et al. (45) showed that short-term 
normobaric hypoxia (6–24 h) influenced primarily the giant cells and spongiotrophoblasts, with no 
evidence for hypoxic changes in the labyrinth. These differences may reflect the fact that our 
mice were exposed to hypoxia for a longer interval during the embryonic maturation phase, not 
the developmental period.  
Perspectives and Significance. Although placental insufficiency is one of the leading 
causes of perinatal morbidity and mortality worldwide, our limited understanding of its 
pathophysiology has hindered the development of new diagnostic tools for this condition or 
successful prophylactic or therapeutic interventions designed to mitigate fetoplacental injury. 
DCE-MR is a novel imaging tool for in vivo assessment of placental function. The combination of 
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DCE-MRI and gene-expression analysis in placentas exposed to hypoxic injury may illuminate 
unrecognized pathways in placental adaptation to hypoxic injury. In addition to its research use to 
interrogate patterns of blood flow in the injured placenta, DCE-MRI may have clinical utility for the 
detection of placental injury in women at risk for FGR.  
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C.11. Figures and captions 
 
Fig. 1. Influence of hypoxia on dams’ food intake and weight change. A: daily food intake in 
grams for each experimental group during the 3 experimental days (E15.5–E18.5, n = 7 for N-AL, 
n = 15 for N-FR, and n = 16 for Hpx). B: dams’ weight change during the 3 experimental days 
(E15.5–E18.5, n = 8 for N-AL, n = 11 for N-FR, and n = 8 for Hpx). N-AL, normoxia ad libitum 
group; N-FR, normoxia food-restricted group; Hpx, hypoxic group. Values are means ± SD; *P < 






Fig. 2. Influence of hypoxia on fetal and placental weight. Measurements were performed during 
E15.5–E18.5 (n = 113 for N-AL, n = 99 for N-FR, and n = 126 for Hpx). Values are means ± SD; 






Fig. 3. Representative 4.7 tesla in vivo MRI images of control (N-AL) mice on E18.5. Respiratory-
gated spin-echo images were collected following intraperitoneal administration of the contrast 
agent. Transaxial image of murine placentas (A; arrows) and coronal image of murine fetuses (B; 
arrows) are shown. Enhancement of the chorionic plate preceded enhancement of the remainder 
of the placental parenchyma and occurred within 30 s of contrast agent injection in all 3 





Fig. 4. Effect of hypoxia on placental and paraspinous muscle contrast kinetic curves. Each 
dynamic contrast-enhanced (DCE) time course curve represents 1 dam and a set of placentas 
from that dam for 1 of the 3 experimental groups, showing the concentration of gadolinium 
contrast in these tissues during the course of imaging. Solid color lines represent different 
placentas within each dam. For each dam, an average concentration vs. time curve was 
computed for all placentas in that dam. Individual placental concentration vs. time curves were 
normalized based upon this average concentration curve, as detailed in the text. Note that 
negative concentration values immediately after contrast administration stem from a T2* effect 




Fig. 5. DCE-MRI images (4.7 tesla) of control (N-AL) and hypoxic (Hpx) E18.5 mice. Images of a 
control mouse (A and B) and a Hpx mouse (C and D) are shown. A and C were collected at 400 s 
after injection of contrast agent [corresponding to 600 s (peak intensity) in the uptake curves of 
Fig. 4]. B and D were collected at 2,200 s postinjection. The diminished clearance of the contrast 
agent from placentas in the Hpx mouse (D) relative to the N-AL (B) is clearly evident in the later 
time images (arrows).  
 
 
Fig. 6. Effect of hypoxia on contrast agent concentration in the fetal kidney. Values were 
determined as total area under the curve (AUC) calculated for each fetal kidney, normalized to 
the placental AUC of the same fetus as defined in MATERIALS AND METHODS. Values are 
means ± SD, n = 34 for N-AL, n = 32 for N-FR, and n = 38 for Hpx. *P < 0.05 compared with the 




Fig. 7. Influence of hypoxia on placental gene expression. Quantitative RTPCR for genes 
expressed in the murine placenta performed on RNA prepared from E18.5 placentas from each 
experimental group (n = 74–98 for Gcm1, Phlda2, and Mash2; n = 32–47 for Tpbpa and Plf1). 
Each fold change was calculated as relative transcript expression in the placenta vs. control (N-
AL). Data are expressed as box plots showing median value, upper and lower quartiles, range, 






Table 1. Primer sequences used for standard PCR expression analysis 
Name Accession no. Direction & site  Sequence 
Gcm1 NM_008103 














F, forward; R, reverse 
 
Table 2. Quantitative analysis of signal intensity in dynamic contrast-enhanced placentas 
 N-AL N-FR Hpx 
IAUC 1.87±0.35 2.28±0.40* 1.93±0.59 
Final slope -2.59×10-5±0.86×10-5 -2.93×10-5±1.12×10-5 -1.34×10-5±1.67×10-5 
Values are ± SD; n = 56/group. N-AL, normoxic ad libitum; N-FR, normoxic food restricted; Hpx, 








Calcineurin inhibitors (CNI) are powerful immunomodulatory agents that produce marked 
renal dysfunction due in part to endothelin-1-mediated reductions in renal blood flow. Ligand-
stimulated Gq protein signaling promotes the contraction of smooth muscle cells via 
phospholipase Cβ-mediated stimulation of cytosolic calcium release. RGS4 is a GTPase 
activating protein that promotes the deactivation of Gq and Gi family members. To investigate the 
role of G protein-mediated signaling in the pathogenesis of CNI-mediated renal injury, we used 
mice deficient for RGS4 (rgs4-/-). Compared to congenic wild type control animals, rgs4-/- mice 
were intolerant of the CNI, cyclosporine (CyA), rapidly developing fatal renal failure. Rgs4-/- mice 
exhibited markedly reduced renal blood flow after CyA treatment when compared to congenic 
wild type control mice as measured by magnetic resonance imaging (MRI). Hypoperfusion was 
reversed by coadministration of CyA with the endothelin antagonist, bosentan. The MAPK/ERK 
pathway was activated by cyclosporine administration and was inhibited by cotreatment with 
bosentan. These results show that endothelin-1-mediated Gq protein signaling plays a key role in 
the pathogenesis of vasoconstrictive renal injury and that RGS4 antagonizes the deleterious 
effects of excess endothelin receptor activation in the kidney.  
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Vascular smooth muscle cells regulate renal blood flow depending on their contractile 
state (1). Extracellular ligands, such as endothelin-1 and angiotensin II, regulate vascular tone by 
binding to transmembrane receptors on smooth muscle cells (2,3). Calcineurin inhibitors were 
first demonstrated to induce renal vasoconstriction through the endothelin receptor by Lanese et 
al. (4). Several ligands thought to play a critical role in the regulation of vascular tone bind to 
seven transmembrane receptors (STRs), also called G protein coupled receptors (GPCRs) (5). 
When endothelin-1 binds to the endothelin type A (ET-A) GPCR, activated Gαq, finally stimulates 
cytosolic calcium levels to increase promoting contraction of smooth muscle cells (6,7). The Gq-
coupled adrenergic receptor is also capable of phosporylating ERK1/2 in vascular smooth muscle 
cells (8– 11). This signaling pathway promotes the metabolic adaptation to increased mechanical 
load (8,12).  
Regulator of G protein signaling (RGS) proteins are a family of GTPase activating 
proteins for heterotrimeric G proteins (13,14). They are differentially expressed in the renal cortex 
and medulla and include RGS1, RGS2, RGS4 and RGS13 (15). RGS4 is a small RGS protein 
that consists of an amino-terminal polybasic region and a single RGS core domain. It has GAP 
activity towards both Gi and Gq proteins when tested in vitro and in vivo (13,14). Its amino 
terminal sequence contains an N-degron degradation signal, which targets the protein for 
proteasomal degradation (16). RGS4 mRNA expression is present in both the cortex and the 
medulla, however the inner and outer medulla of the human kidney have relatively increased 
levels of expression (21).  
Calcineurin inhibitors (CNI) are powerful immunomodulatory agents that are used by 98% 
of renal transplant recipients (17) to prevent transplant rejection, but often cause marked renal 
dysfunction (18). Several hypotheses seek to explain the mechanism of acute cyclosporine 
toxicity (19), including oxidant stress (20,21), the renin–angiotensin–aldosterone system (22), 
nitric oxide inhibition (23) and enhancement of endogenous ligands to GPCRs (24).  
A longstanding explanation of acute cyclosporine renal toxicity is that cyclosporine-
triggered endothelin-1 release by vascular endothelial cells promotes renal vasoconstriction and 
 177 
 
reduced renal blood flow (4,25,26). Albig and Schiemann showed that RGS4 overexpression in 
endothelial cells prevented endothelin from activating extracellular signal-regulated kinase 
(ERK1/2) (27). Therefore, we proposed that RGS4 might play a critical role in limiting acute 
renovascular smooth muscle cell Gq activation after endothelin-1 release by endothelial cells. To 
test this model, mice deficient for RGS4 were generated and treated with cyclosporine. RGS4-
deficient mice were highly sensitized to cyclosporine-induced renal failure and reduced renal 
blood flow.  
 
D.4. Materials and Methods 
Targeted disruption of the rgs4 gene  
Murine 129/SvJ embryonic stem cells with targeted disruption of one allele of the rgs4 
gene were generated. The details of this procedure are found in the online supplemental data.  
Cell culture  
Kidneys from rgs4-/-
 
and congenic wild type control mice were procured after injecting 
mice with pentobarbital (0.05 mg/g). Tissue was washed in 10 mM PBS, cut in 2 mm sections and 
plated in endothelial cell media (Cell Applications, Inc., San Diego, CA) pretreated with endothelin 
(0.25 µM) (Sigma Aldrich; St. Louis, MO) or cyclosporine (20 µg/mL) (Sigma Aldrich). Tissue was 
then processed after a 10 minute incubation time.  
Nephrectomy followed by Cyclosporine A and/or Bosentan Treatment in Mice  
All research involving the use of mice was performed in strict accordance with protocols 
approved by the Animal Studies Committee of Washington University School of Medicine. At 12 
weeks of age, wild type congenic and rgs4-/-
 
C57/B6 mice were subjected to unilateral 
nephrectomy as previously described (28). After a 7-day recovery period, mice were administered 
a daily dose of intraperitoneal cyclosporine A (0.25 mg/g/day) (29), or cyclosporine + bosentan for 
7 days. Intraperitoneal cyclosporine dose was determined by the smallest daily amount needed to 
achieve renal cortical vasoconstriction. Bosentan (Actelion Ltd, Switzerland) was administered 
through the animals’ drinking water (2.35 mg/mL) to achieve a daily dose of 100 µg/g of body 
weight (30) based on an average urine output of 850 µL/day.  
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Renal histology and morphometry  
Mice were weighed, and kidneys isolated. Tissue was fixed in 10% formalin, paraffin-
embedded, microtome sectioned and stained with hematoxylin and eosin (H&E). Tissue slices 
with maximum longitudinal dimension were used to estimate glomerular number. Separate slices 
were prepared and stained immunohistochemically with phospho-ERK 1/2 (Thr183/Tyr185) (Ab-
cam Inc.; Cambridge, MA). Tissue cross-sectional areas from medulla of four mice were 
measured at low power (2.5 times) and were calculated on an Axioskop microscope (Carl Zeiss, 
Inc., Jena, Germany) using ImageJ (version 1.24) software. Lean body mass was measured by 
EchoMRI 3-in-1 (Echo Medical Systems, Houston, TX) at 8 weeks after SIRI.  
Gene expression analysis  
Gene expression profiles were constructed using the GeneChip® Mouse Genome 430A 
2.0 (Affymetrix, Southern Oaks, CA) high-density olignouncleotide microarray technique. mRNA 
purification and analysis were performed by the Siteman Cancer Center GeneChip Facility as 
previously described (31). Expression signaling was analyzed used Affymetrix Expression 
Console Software.  
Quantitative real-time RT-PCR analysis on RNA extracted from kidney tissue lysates with 
Trizol reagent (Invitrogen Corp, Carlsbad, CA) was carried out with the Taqman master mix kit 
(Applied Biosystems, Foster City, CA) using RGS4 oligonulceotide primers (SABiosciences 
Corp., Frederick, MD) according to the manufacturer’s specifications. The measured abundances 
of RGS4 mRNA were normalized to GAPDH in each sample as an internal loading control.  
Protein analysis  
Cytosolic protein lysates from kidney tissue were obtained as previously described (32). 
In brief, tissue was recovered from mice, and lysates were processed in the presence of protein 
lysis buffer. Once processed, protein bound to nitrocellulose filters were washed and incubated 
with murine monoclonal antiphospho-p44/42 (Thr202/Tyr204) and antitotal-p44/42 (Cell Signaling 
Technology, Inc., Beverly, MA). Bands were visualized by use of the ECL system (Amersham). 
Densitometry was performed using ImageJ software v1.24.  
Vascular flow measurements  
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Transthoracic echocardiography and renal artery doppler sonography was performed in 
mice using a VEVO-770TTM Micro-Imaging System (Visual Sonic,Toronto, ON, Canada) 
equipped with a 15 MHz transducer. Before the imaging experiments, mice were anesthetized 
with isoflurane and were maintained on isoflurane/O2 (1–1.25% v/v) throughout data collection. 
The sonographer was blinded in all cases to the transgenic status of the mice. Ten consecutive 
waveforms were averaged to obtain a mean systolic velocity for each animal.  
Renal artery blood velocity was measured using an Advanced Laser Flowmeter 21 
(ALF21, ADVANCE Co., Tokyo, Japan). Mice were anesthetized with a mixture of xylazine (16 
mg/kg) and ketamine (0.080 mg/g). A sham procedure was performed exposing the right kidney 
but maintaining its blood supply. The flow meter probe was applied directly to the renal artery and 
then to the hilum.  
A volume pressure recording (VPR) device (Kent Scientific Corp., Torrington, CT) was 
used for tail cuff blood pressure measurements of mice at baseline. Mice were trained for 2 days 
immediately followed by measurements on day 3. Mice were constrained in an adjustable 
plexiglass tube provided as a part of the VPR apparatus. A heating pad was placed under the 
tube to maintain a constant temperature between 31 and 33°C. Five training cycles were followed 
by five measurement cycles and then averaged.  
Magnetic resonance imaging of renal blood flow in mice  
MR images were collected using a dedicated small-animal MR scanner built around a 4.7 
tesla, 40-cm bore magnet and interfaced with a Varian INOVA console. A home-built, actively 
decoupled volume coil (transmit)/surface coil (receive) pair were used for all image acquisitions. 
Before the imaging experiments, mice were anesthetized with isoflurane and were maintained on 
isoflurane/O2 (1–1.25% v/v) throughout data collection. Animal core-body temperature was 
maintained at 37 ± 1°C via a heating pad formed with circulating warm water. Dynamic contrast 
enhanced (DCE) MRI (33,34) data were collected using a T1-weighted, gradient spoiled, 
multislice gradient-echo sequence. Further details of this procedure are found in the online 
supplemental data.  
Quantitation of body fluid constituents  
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Levels of whole blood hemoglobin and serum blood urea nitrogen were measured in the 
Department of Comparative Medicine Diagnostic Laboratory at Washington University School of 
Medicine. Because of the imprecision of the Jaffe method in measuring mouse serum creatinine 
we collaborated with Satish Ramachandrarao at University of California, San Diego, California, to 
perform serum creatinine by HPLC as previously described (28,35).  
Cyclosporine trough levels were measured with the automated Dimension® RxL Max® 
clinical chemistry system from Siemens. Healthcare Diagnostics, Ltd. using an immunoassay 
technique. The assay was performed using a Flex®
 
reagent cartridge. Each sample of whole 
blood lysate was processed with the Dimension® system platform.  
Statistical analysis  
All data are presented as mean values ± standard error of the mean. Static group 
analysis was performed with SigmaStat® 3.1 (Systat Software, Inc., San Jose, CA). Statistical 
relationships were determined by the Student’s t-test where significance was achieved when a 
population’s mean value was separated from controls by two or more standard deviations (p = 
0.05). All p-values calculated were two-sided. One-way ANOVA analysis was used in comparisons 
of greater than two groups, and Holm-Sidak pairwise comparisons were calculated between 
groups. Kaplan–Meier survival curves and Mantel Cox log-rank analysis was performed with 
SPSS v13.0 (SPSS Inc., Chicago, IL). Pearson’s correlation coefficient was performed on signal 
intensities generated from two separate gene expression microarrays. The Bootstrap algorithm 
for error estimation of gene expression microarray data (36) was performed using the Wessa.Net 
server version 1.1.23-r4.  
 
D.5. Results  
To generate mice deficient for RGS4 we created a genetic construct that eliminated 
exons 3–5 of the rgs4 gene, encoding the RGS box (Figure S1). Rgs4-/-
 
mice appeared normal at 
birth and were fertile. Mating of rgs4+/-
 
heterozygotes yielded live-born homozygotes with 
Mendelian frequencies. Analysis of rgs4-/-
 
mice in the absence of provocative stimulation 
demonstrated that these animals had comparable physiologic parameters. Normalized kidney 
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weight was equal with no evidence of hypertension by noninvasive testing. These findings were 
correlated with equivalent glomerular number. Renal function as estimated by serum creatinine 
was nearly identical in rgs4-/-
 
and wild type mice (0.106 ± 0.002 mg/dL vs. 0.105 ± 0.007 mg/dL, p 
= 0.89) (Table S1). Normalized mRNA expression of RGS2, RGS5, RGS10, RGS12 and RGS16 
was not increased in rgs4-/-
 
mice (Figure 2A and B; Table S2).  
Calcineurin inhibitors are among the most commonly used immunomodulatory agents in 
transplantation, but they often cause marked renal dysfunction (18). Specifically, cyclosporine A 
(CyA) causes acute renal injury due to decreased intrarenal blood flow (4,25,26). Chronic injury 
mimics this mode of injury with histologic changes consistent with long term hypoxic injury 
described as striped fibrosis (37). To determine whether rgs4-/- mice were sensitized to 
cyclosporine-mediated renal injury, we subjected animals to unilateral nephrectomy followed 1 
week later by treatment with CyA. Congenic wild type control mice developed renal dysfunction 
within 1 week following CyA administration. By HPLC, serum creatinine increased 108% (0.2201 
mg/dL vs. 0.106 mg/dL) (Figure 1A) and BUN increased 274% (71 mg/dL) (Figure 1B) in rgs4-/-
 
mice versus controls after 7 days of cyclosporine exposure while whole blood cyclosporine levels 
were equivalent between groups (Figure S3). Furthermore, there was no evidence that rgs4-/-
 
mice metabolized cyclosporine less efficiently than congenic controls (Figure S4). Serum 
creatinine by HPLC approximates serum creatinine by the Jaffe method using a correction factor 
of 3.125. The Jaffe-equivalent measure in rgs4-/-
 
given cyclosporine mice was 0.688 ± 0.044 
mg/dL (35). Disruption of the apical membrane of proximal tubular cells, indicative of acute tubu-
lar necrosis, was seen by light microscopy and electron microscopy (Figure 2A and B). Renal 
artery blood flow to the kidney was decreased in cyclosporine-treated mice as measured by 
noninvasive Doppler sonography (Figure S5A and B), further implicating CyA exposure in the 
development of acute tubular necrosis. Noninvasive measurements could not differentiate the 
decrease in blood flow between rgs4-/-
 
and controls, however, rgs4-/-
 
mice had a decreased 
average renal artery flow velocity compared to congenic wild type control animals using invasive 
monitoring techniques (Figure S6). Smaller intrarenal vascular substructures could not be 
interrogated due to the limitations of current modalities of measuring in vivo renal blood flow.  
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To determine whether rgs4-/-
 
mice developed more profound regional intrarenal 
vasoconstriction after CyA treatment, dynamic-contrast enhanced magnetic resonance imaging 
(DCE-MRI) (34,38,39) was used to quantitatively measure the uptake and clearance kinetics of a 
low molecular weight, Gadolinium-based MR contrast agent (CA). High-resolution, T1-weighted 
kidney images allowed clear visualization of the cortex, medulla and renal pelvis together with 
accompanying intrarenal vasculature (Figure 3). Selected images from the DCE time course and 
complete plots of adjusted signal intensity versus time allowed the CA kinetics to be accurately 
measured. A 42% decrease in blood flow was identified in the renal cortex (Figures 4A and 5A). 
In contrast to congenic wild type controls, IAUC60 decreased by 62% in the medulla of CyA-
treated rgs4-/-
 
mice, indicative of a significant decrease in regional blood flow (Figures 4B and 
5B). Blood flow was restored to both the medulla and the cortex with the coadministration of 
bosentan (5A, 5B). Cyclosporine’s specific ability to activate an RGS-dependent signal 
transduction pathway is supported by the amelioration of its deleterious effect by administration of 
the endothelin receptor antagonist bosentan. 
The ability of bosentan to reduce cyclosporine-mediated renal toxicity may be due to 
altered cyclosporine blood levels. To investigate this possibility, rgs4-/-
 
mice were given escalating 
doses of cyclosporine with bosentan (100 µg/g/day) (see Figure S7). Cyclosporine blood levels 
increased with higher doses of cyclosporine and were not affected by coadministration of 
bosentan.  
Mice were next observed for a month while being treated with cyclosporine. Rgs4-/- mice 
exhibited significantly reduced survival in response to treatment with CyA when compared to 
congenic wild type control mice (Figure 6). The mean survival time was 25 days for congenic wild 
type control mice in response to CyA administration, but rgs4-/- mice had a mean survival time of 
only 9 days (Mantel-Cox log rank test, p = 0.002). Rgs4-/- mice coadministered cyclosporine and 
bosentan exhibited a significantly increased survival rate compared to rgs4-/- mice given 
cyclosporine alone. 
CyA renal toxicity is thought to be due to the action of endothelin-1. Given the reduced 
intrarenal blood flow observed in CyA-treated rgs4-/- mice, we hypothesized that the absence of 
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RGS4 protein would sensitize kidney to CyA-and endothelin-1-stimulated intracellular signal 
transduction. Sections of freshly obtained rgs4-/- and wild type congenic kidneys were treated in 
vitro with CyA or endothelin-1 for 10 minutes and processed for immunoblotting with an 
antiphospho-ERK1/2 primary antibody. Rgs4-/- kidney slices exhibited markedly increased ERK 
activation in response to endothelin-1 (Figure 7A and C). Similarly, rgs4-/- kidney slices exposed 
to CyA for 10 minutes showed increased ERK activation (Figure 7B and D). In vivo experiments 
demonstrated that ERK activation was increased in the kidneys of rgs4-/- mice treated with 
cyclosporine for 1 week (Figure 8A and B). Interestingly, RGS4 mRNA levels rose by 1.75-fold in 
wild type congenic kidneys after 7 days of CyA treatment (Figure 8C).  
Rgs4-/- kidneys were sensitized to CyA-mediated reduction in renal blood flow and were 
also sensitized to endothelin-1 mediated ERK activation. Given that CyA-mediated acute renal 
toxicity correlates with increased endothelin-1 release, and that bosentan is a widely used ET-A/B 
receptor antagonist, mice were treated with this agent. Administration of bosentan to rgs4-/- mice 
abrogated the effect of CyA on blood perfusion in the kidney (Figures 4A, B and 5A, B) and ERK 
phosphorylation decreased to pre-cyclosporine levels in bosentan-treated animals (Figure 8A and 
B).  
 
D.6. Discussion  
Calcineurin inhibitors are the most commonly used immunosuppressive agents in the 
prevention of solid organ transplant rejection (17), but cause progressive renal toxicity (40,41). 
CNI nephrotoxicity is in part due to endothelin-1 release by vascular endothelial cells promoting 
renal vasoconstriction and reduction in renal blood flow. The mechanism by which cyclosporine 
causes endothelin-1 release is unclear. Although cyclosporine directly binds to L-type calcium 
channels in vitro (42), the secondary release of endothelin-1 stimulates Gq signaling that results 
in inositol triphosphate binding to L-type calcium channels (43). Therefore the direct link between 
calcineurin inhibition and elevated sarcoplasmic calcium levels is contested (44). However, after 
endothelin-1 is released acutely, cyclosporine initiates a maintenance phase of endothelin 
release and up-regulation of endothelin gene expression. Marsen and colleagues determined that 
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both cyclosporine and tacrolimus promote the transcription of preproendothelin-1 mRNA in 
human vascular endothelial cells (45).  
In this work, we described for the first time, the in vivo vasoactive effects of cyclosporine 
A in a minimally invasive mouse model. Because the compact size of the mouse model system is 
more difficult to analyze than larger mammals, innovative methods are needed to analyze mouse 
renal and renovascular physiology in a reproducible manner. These adaptations are vital for the 
translation of animal studies to human therapy.  
We hypothesized that RGS4 plays a key role in regulating renal vascular resistance 
through modulation of Gq activation. We found that rgs4-/- mice were uniquely susceptible to a 
reduction in renal medullary blood flow mediated by cyclosporine. Previous studies by Lee et al., 
Mazzali et al. and Neria et al. (29,46,47) could not demonstrate an increase in serum creatinine 
after exposure to cyclosporine and therefore relied predominantly on histologic markers of renal 
injury. In this study, we showed that rgs4-/- mice had a 108% increase in serum creatinine and 
274% increase in BUN compared to congenic controls after both groups were exposed to 
cyclosporine for 1 week. These results link RGS4 deficiency and a susceptibility to renal failure.  
The specificity of cyclosporine’s action through the G-protein signaling cascade was 
demonstrated when bosentan, an endothelin A/B receptor antagonist, prevented the deleterious 
effect of cyclosporine on renal function. We also found that endothelin-1-mediated activation of 
ERK was enhanced in rgs4-/- kidney. This result follows the previous findings of Albig et al who 
showed that in vitro overexpression of RGS4 prevented ERK activation in the presence of 
endothelin-1 (27). These results establish that RGS4 is a key regulator of endothelin-1 action in 
the kidney, probably via effects on Gq. 
The use of bosentan in transplantation is relatively contraindicated because of increased 
hypotension when coadministered with cyclosporine A. Only one human study to date by Binet et 
al. has evaluated the renal hemodynamic effects of endothelin receptor antagonists on 
calcineurin inhibitors (48). Binet et al. reported a mean systolic/diastolic blood pressure of 135 ± 
6/80 ± 4mmHginseven patients given cyclosporine A alone which was comparable to internal 
controls given cyclosporine A and bosentan (136 ± 8/80 ± 7 mmHg). Limited animal studies 
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remain unclear (49,50). Further studies are needed to delineate the potentional hypotensive 
effects of calcineurin inhibitors when used in combination with endothelin receptor antagonists.  
Our MRI results showed that CyA-treated rgs4-/- kidneys exhibited a greater decrease in 
signal intensity in the renal medulla than in the renal cortex, suggesting that RGS4 modulates 
vasoconstriction proximal to the vascular network of the medulla. Studies of CyA thus far have 
investigated the ligands responsible for initiating the intracellular signaling cascade that leads to 
smooth muscle vasoconstriction in the kidney (49,51–54). Lanese and colleagues were the first to 
show that cyclosporine was specific to the endothelin ligand (4). In our current study we describe 
a specific intracellular pathway that is activated by cyclosporine, and directs future studies to 
targeted inhibition of the G-protein signaling system or promotion of the inhibitory activities of 
RGS4.  
To study the vasoconstrictive properties of cyclosporine we used a novel DCE-MRI, and 
were able to describe, in detail, contrast-agent uptake and clearance kinetics in the mouse 
kidney. Our studies focused on monitoring the regionalized effects of CyA treatment. These 
observed changes in CA kinetics following treatment with CyA reflect physiologic changes in the 
kidney that are consistent with a stepwise reduction of renal blood flow in the cortex and the 
medulla. While microbead radioisotope methods remain the gold standard for measuring end-
organ perfusion (55,56), these methods can not be applied in vivo. Measuring alteration of organ 
blood flow with microbeads is limited by the need for postmortem tissue preparation. MR methods 
are non-invasive, enabling longitudinal, time-course studies of blood-flow patterns in response to 
interventions. 
 
D.7. Conclusions  
The large number of RGS family members implies that there is specific requirement for 
particular members in various cell types and organ systems. The role of RGS proteins in the 
management of renal vascular insult is not well understood. In this work, we demonstrated that 
RGS4 plays a specific role in modulating renal insults that occur as a consequence of 
overstimulation of the Gq signaling pathway. Increasing RGS4 protein levels by inhibiting pro-
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teasomal degradation or increasing activity through in the kidney may be therapeutically 
beneficial for patients with renal dysfunction.  
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D.11. Figures and captions 
 
Figure 1: Increased renal injury in rgs4-/- mice treated with cyclosporine A. After 7 days of 
treatment with cyclosporine, (A) serum creatinine (sCr) was measured in rgs4-/- (RKO+C) (n = 10) 
and wild type congenic mice (WT+C) (n = 10). SCr was increased in RKO+C compared to other 
groups by one-way independent ANOVA: F(3,31) = 43.88, composite p < 0.001; WT versus RKO 
= *(p = 0.89); RKO versus RKO+C = #(p = <0.0001); WT+C versus RKO+C = ?(p < 0.0001), (B) 
Blood urea nitrogen (BUN) was increased in RKO+C(n = 10) compared to other groups by one-
way independent ANOVA: F(3,35) = 31.12, composite p < 0.0001; WT versus RKO = *(p = 0.89); 






Figure 2: Light and electron microscopy of congenic wild type + cyclosporine (WT+C) (n = 
4) and rgs4-/- + cyclosporine (RKO+C) (n = 4). (A) The lumenal membrane of proximal tubule 
cells is disrupted and intralumenal debris is present in RKO+C (arrows) (magnification 400×). 
Scale bar = 200 micron. (B) The ciliary brush border on the apical membrane of epithelial 
proximal tubule cells (arrows) is also disrupted in RKO+C mice (n = 4) compared to WT+C (n = 4) 






Figure 3: High-resolution, T1-weighted image of a kidney from an rgs4-/- mouse, allowing 
clear visualization of the cortex, medulla and renal pelvis and the intrarenal vasculature 






Figure 4: Dynamic-contrast enhanced magnetic resonance imaging (DCE-MRI) data 
collected following bolus injection of a low molecular weight, Gd-containing contrast 
agent (adjusted signal intensity). Selected images from the (A) cortical and (B) medullary 
regions of interest are shown for: (top) a rgs4-/- mouse (RKO); (middle) a rgs4-/- mouse treated 
with Cyclosporine (RKO+C); (bottom) and a rgs4-/- mouse treated with Cyclosporine and 
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bosentan (RKO+C+B). Images were collected 12 s (left panel), 38 s (middle panel) and 90 s (right 
panel) post-contrast injection. At the right, in each panel are the complete adjusted signal 
intensity versus time curves for a (A) cortical ROI and (B) medullary ROI for each of these mice.  
 
 
Figure 5: Average initial area under the curve (IAUC60) values, computed for the (A) cortical 
cohorts of wild-type (WT) (n = 6), rgs4-/- (n = 6), Cyclosporine-treated wild-type (WT+C) (n = 
6), cyclosporine-treated rgs4-/- (n = 4) and rgs4-/- + cyclosporine + bosentan mice (n = 5). 
Decreased rate of agent uptake in the cortex was evident in RKO+C by one-way independent 
ANOVA, F(3,61.7) = 5.5 (composite p = 0.009). Blood flow was then restored with bosentan 
cotreatment comparing RGS4KO + cyclosporine + bosentan (RKO+C+B) to WT, RKO and WT+C 
(one-way independent ANOVA, F(4,21) = 5.48 (composite p = 0.003). WT versus RKO, p = 0.79, 
?; RKO versus RKO+C, p = 0.01, #; RKO versus RKO +C+B, p = 0.10, ?. (B) Medullary cohorts of 
wild-type (WT) (n = 6), rgs4
−/− 
(n = 6), Cyclosporine-treated wild-type (WT+C) (n = 6), 
cyclosporine-treated rgs4
−/− 
(n = 4) and rgs4
−/−
+ cyclosporine + bosentan mice (n = 5), showed a 
greater decrease in renal medullary blood flow than cortical blood flow in rgs4-/- mice after 
cyclosporine treatment (RKO+C). (One-way independent ANOVA, F(4,21) = 13.2.0 (composite p 
< 0.0001). Medullary blood flow was restored when rgs4-/- mice were cotreated with bosentan. 
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Figure 6: Increased mortality after daily cyclosporine treatment in rgs4-/- mice (n = 6) 
versus congenic wild type controls (n = 6) treated with cyclosporine and rgs4-/- 
coadministered cyclosporine and bosentan (n = 7). Survival with daily cyclosporine A 






Figure 7: In vitro modulation of MAPK signaling in rgs4-/- after endothelin, or cyclosporine 
A treatment. Increased ERK1/2 activation in rgs4-/- kidney tissue after (A, C) endothelin-1 
treatment (p < 0.0001, ?) and after (B, D) cyclosporine A treatment (p = 0.0003, #). Kidneys were 
isolated from rgs4-/- (RKO) (n = 6) and wild type congenic mice (WT) (n = 6), quickly sliced into 2 
mm sections and treated with endothelin-1 (E). Sections were used to generate protein lysates 
that were analyzed by antiphospho-ERK1/2 immunobloting. Membranes were re-probed with an 
antitotal-ERK1/2 primary antibody to control for protein loading. Densitometric analysis of 




Figure 8: ERK1/2 activation in rgs4-/- mice induced by cyclosporine A is inhibited after 1 
week of cotreatment with bosentan. (A) After 1 week of daily cyclosporine A treatment, WT+C 
(n = 4), RKO+C (n = 4) and RKO+C+B (n = 6) kidneys were isolated from wild type congenic 
mice rgs4-/- mice, fixed and embedded. Upper panels, embedded kidney tissue was analyzed by 
 200 
 
immunohistochemical staining with antiphospho-ERK1/2 primary antibodies. Lower panels, 
digitized immunohistochemical images were converted to black-white contrast and analyzed with 
ImageJ software (B) to quantify ERK1/2 activation. ANOVA composite, p = < 0.0001; WT+C versus 
RKO+C, p = 0.0006, ?;RKO+C versus RKO+C+B, p = 0 < 0.0001, #. (C) Increased renal RGS4 
mRNA expression in wild type mice treated with C(n = 4) for 1 week compared to untreated wild 
type mice. Student’s t-test, p = 0.0003.  
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Figure S6: Renal artery (RA) blood flow in rgs4-/- (RKO+C) (n = 4) decreased after 1 week of 
daily cyclosporine A treatment compared to WT+C (n = 5).  
Figure S7: Cyclosporine blood levels correspond with increasing dose of daily 
cyclosporine injection in the presence or absence of bosentan.  
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